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 Transcriptome profiling of bovine blastocysts developed under alternative culture 
conditions during specific stages of development 
 
The aim of this study was to determine the influences of different environmental 
conditions during specific stages of early bovine embryos on the transcriptome profile 
of produced blastocysts and subsequent effects on molecular mechanisms and pathways 
controlling embryo development. Using the advent of transvaginal endoscopy-mediated 
technology, different bovine blastocyst groups were produced under alternative culture 
conditions. In the first experiment, transcriptome analysis was performed between day 7 
blastocysts which were developed either in superovulated heifers (High P4) or in 
unstimulated recipients (Normal P4) from day 2 onward using Affymetrix GeneChip 
Bovine Genome Array. In the second experiment, four different blastocyst groups were 
produced under alternative in vivo and in vitro culture conditions before or after major 
embryonic genome activation (EGA) stage. Completely in vitro and in vivo produced 
blastocysts were used as contrasts. Transcriptome profile of each blastocyst group has 
been compared to in vivo control group using EmbryoGENE’s bovine microarray. 
Abnormal environmental conditions either in vivo or in vitro showed a dramatic effect 
on the transcriptome profiles of produced blastocysts. A total of 454 genes were 
differentially regulated between blastocysts derived from superovulated animals and 
those which cultured in unstimulated recipients from day 2. Blastocysts which 
developed under high P4 conditions due to superovulation treatment showed higher 
cellular and metabolic activities, as genes involved in the oxidative phosphorylation 
pathway and different metabolic processes, in addition to genes expressed in response to 
stress, were highly expressed compared to embryos which developed in the oviduct of 
unstimulated animals. In vitro culture conditions during EGA stage have critically 
influenced gene expression patterns, irrespective to embryo origin. Compared to 
complete in vivo group, blastocyst groups which spent EGA stage under in vitro 
conditions showed higher number of differentially regulated genes than those which 
spent EGA stage under in vivo conditions. Ontological classification showed a clear 
contrast in expression patterns for lipid metabolism and oxidative stress between 
blastocysts generated in vivo vs. in vitro, with opposite trends. These results will help 
for future efforts to modify culture conditions at the critical stages of development 
which will allow more efficient production of developmentally competent blastocysts.
 
  
Transkriptionsprofile boviner Blastozysten unter alternativen Kulturbedingungen 
während den spezifischen Entwicklungsstufen 
 
Ziel dieser Studie war es, den Einfluss verschiedener Umweltbedingungen auf die frühe 
Embryogenese zu untersuchen. Transkriptionsprofile wurden von den erzeugten 
Blastozysten erstellt, um die Effekte verschiedener Umweltbedingungen auf 
molekularer Mechanismen und Pathways im Bezug auf die embryonale Entwicklung zu 
erfassen. Durch die Anwendung transvaginaler Endoskopietechniken, konnten 
unterschiedliche bovine Blastozysten Gruppen unter verschiedenen Kulturbedingungen 
erzeugt werden. Im ersten Experiment wurden Tag 7 Blastozysten zum einen in 
superovulierenden Färse (High-P4) oder zum anderen ab Tag 2 in unstimmulierten 
Rezipienten (Normal-P4) entwickelt. Das Transkriptionsprofil der Blastozysten wurde 
mittels des Affymetrix GeneChip Bovine Genome Array untersucht. In einem zweiten 
Experiment wurden vier alternativen Blastozystengruppen, sowohl vor als auch nach 
der zentralen embryonalen Genom Aktivierung (EGA), unter verschiedenen in vivo und 
in vitro Kulturbedingungen erzeugt. Als Kontrolle wurden gänzlich in vivo oder in vitro 
erzeugte Blastozysten verwendet. Transkriptionsprofile jeder Blastozystengruppe 
wurden mittels des bovinen EmbryoGENE Mikroarrays erstellt und mit der in vivo 
Kontrollgruppe verglichen. Abnormale Umweltbedingen zeigten einen dramatischen 
Einfluss auf das Transkriptionsprofil der erzeugten Blastozysten. Ingesamt waren 454 
Gene unterschiedlich reguliert bei dem Vergleich von Blastozysten aus superovolierten 
Tieren und Blastozysten kultiviert ab Tag 2 in unstimmulierten Rezipienten. 
Blastozysten, die unter High-P4 Bedingungen auf Grund der Superovulation 
entwickelten, zeigten höhere zelluläre und metabolische Aktivitäten von Gene, die am 
Pathway der oxidativer Phosphorylierung und verschiedener metabolischer Prozesse 
beteiligt waren. In dieser Gruppe waren im Vergleich zur Gruppe der unstimmulierten 
Rezipienten, Gene der Stressantwort sehr hoch exprimiert. In vitro Bedingungen 
während der EGA haben einen kritischen Einfluss auf die Genexpressionsmuster, 
ungeachtet der Embryoherkunft. Im Vergleich zur gänzlich in vivo Gruppe, zeigten 
Blastozystengruppen, die während dem EGA Stadium unter in vitro Bedingungen 
verbrachten, deutlich mehr unterschiedliche regulierte Gene als auch die Gruppen, die 
das EGA Stadium unter in vivo Bedingungen waren. Ontologische Klassifizierungen 
zeigten deutliche Unterschiede in den Genexpressionsmustern des Lipidmetabolismus 
und des oxidativen Stresses zwischen in vivo und in vitro erzeugten Blastozysten. Diese 
Ergebnisse werden zukünftige Bestrebungen von modifizierten Kulturbedingungen 
während den kritischen Stadien der embryonalen Entwicklung fördern, welches zu einer 
effizienteren Erzeugung entwicklungskompetenter Blastozysten beiträgt. 
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Introduction 1 
1.1 Introduction 
 
Early embryonic development, the period from maturation until blastocyst formation, is 
one of the most critical periods of mammalian development involves various 
morphological, cellular, and biochemical changes related to genomic activity. This 
period including three major steps: oocyte maturation, oocyte fertilization and embryo 
culture. Under normal in vivo conditions, mammalian oocytes and embryos develop in a 
complex and dynamic environment. Bovine oocyte grows and matures in the ovarian 
follicle, subsequently undergoes fertilization in the midpoint of the oviduct (Hunter 
1988). First cleavage occurs approximately 1 to 2 days after fertilization. Between days 
3 and 4 after fertilization, at the 8- to 16-cell stage, the embryo moves from the oviduct 
to the uterus (Hackett et al. 1993). The embryo reaches the 16- to 32-cell stage between 
days 5 and 6 and the cells begin to form intimate junctions (Boni et al. 1999), forming a 
compact ball of cells termed the morula. Compaction is a prerequisite to trophectoderm 
differentiation and is essential for blastocyst formation (van Soom et al. 1997). At Day 
7 to 8, a blastocoelic cavity develops and the cells of the early blastocyst differentiate 
into inner cell mass cells, mainly destined to form the fetus, and trophectoderm cells, 
destined to form the placental tissues. At this stage, the blastocyst comprises about 120 
cells with the inner cell mass constituting about 25% and the trophectoderm about 75% 
of the total cell number (Rizos et al. 2010). This embryonic development is initially 
supported by maternal RNAs and proteins synthesized during oogenesis. As 
development proceeds these proteins degrade, and embryogenesis becomes solely 
dependent on embryonic derived genes. Transcriptional activation of the embryonic 
genes is the result of a gradual degradation of the maternal RNAs and proteins due to 
the reprogramming of the cell nucleus (Memili and First 2000). Thus a well-
orchestrated expression of genes derived from both the maternal and embryonic 
genomes is required to allow normal development. Clearly any modification to the 
culture environment can have profound effect on gene expression pattern and 
subsequently on the quality and developmental competence of the resulting embryos 
(Lonergan et al. 2003b). 
Over the past three decades, applications of assisted reproductive technology (ART) 
include multiple ovulation and embryo transfer (MOET) and in vitro production (IVP) 
of embryos have been widely increased. These technologies offers several advantages 
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over natural breeding through their great potential for speeding up genetic improvement 
in farm animals, as well as greatly advanced our basic understanding of embryo 
development. Despite ongoing advances in ARTs, pregnancy rates remain low and 
embryos produced in this way still differ than ‘golden standard’ embryos (i.e. embryos 
derived from natural cycles). The differences involve morphological and molecular 
aspects that impair embryo quality and developmental efficiency.  
MOET is one of the most widely used technology in order to increase the number of 
offspring during the lifetime of individual animals. Females of high genetic merit are 
typically stimulated with gonadotrophins to induce the ovulation of a variable but a 
large number of follicles. These superovulated animals are then artificially inseminated 
and the resulting embryos are non-surgically flushed from the uterus on Day 7 for 
transfer to surrogate recipients or for cryopreservation and transfer at a later date. It is 
clear that oocytes and embryos in superovulated animals develop under abnormal 
endocrine conditions, which differ substantially from those in unstimulated (i.e. single-
ovulating) animals. This modification of oviductal conditions and/or composition of 
oviduct fluid due to ovarian steroids subsequently affect the embryonic developmental 
competence (Greve and Callesen 2001, Murray et al. 1995). However, the exact 
influences of this abnormal conditions on the transcriptome profile of produced 
embryos are still unknown. Although these embryos are differ than golden standard 
embryos, it is well recognised that bovine embryos derived in vivo, typically following 
superovulation, artificial insemination and non-surgical recovery, are of higher quality 
than those derived from in vitro maturation (IVM) fertilization (IVF) and culture (IVC). 
The superiority of in vivo derived embryos is reflected in the most recent published data 
from commercial cattle embryo transfer practice (Stroud 2011) with 990,993 bovine 
embryos were transferred worldwide in 2010 of which 63% were in vivo derived and 
the remaining 37% being produced in vitro. Moreover, approximately 55% of in vivo 
derived embryos were transferred frozen compared with only 7% of those produced in 
vitro, reflecting the poorer quality and cryotolerance of such embryos.  
In vitro production of embryos has emerged as a reliable alternative method to 
conventional ovarian superstimulation methods and as an important research tool for 
animal and human embryology (Bavister 1995). However, embryos developed under in 
vitro conditions have been associated with several deviations from the normal in vivo 
development that resulted in development rate limited to 30–40% (Gutierrez-Adan et al. 
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2001, Niemann and Wrenzycki 2000), higher incidence of chromosomal abnormalities 
(Lonergan et al. 2004, Viuff et al. 2002), gross morphological abnormalities (Abd El 
Razek et al. 2000, Pollard and Leibo 1994) and a dramatic effect on gene expression 
pattern in embryos, which in turn has serious implications for the quality of blastocyst, 
lowering cryo-tolerance and decreasing pregnancy rates (Lonergan et al. 2003a, Rizos et 
al. 2003, Tesfaye et al. 2004). Previous studies have clearly demonstrated that, while the 
intrinsic quality of the oocyte determines the proportion of oocytes developing to 
blastocysts (i.e., oocyte developmental competence), the post-fertilization culture 
environment has the biggest influence on blastocyst quality, irrespective of the origin of 
the zygote (Lonergan et al. 2003a, Rizos et al. 2002a, Russell et al. 2006). The period of 
post-fertilization culture involved several major developmental events, including: (1) 
the first cleavage division, (2) embryonic genome activation (EGA), when the embryo 
transfers from a reliance on maternal RNA derived from the oocyte to expression of its 
own genome, (3) compaction of the morula, which involves the establishment of the 
first intimate cell to-cell contacts in the embryo and (4) formation of the blastocyst, 
involving the differentiation of two cell types, the trophectoderm and the inner cell 
mass. However, the exact influence of culture conditions during each of these critical 
events is still unknown. Major EGA in bovine embryos occurs around the 8- to 16-cell-
stage (Memili and First 2000). This event found to be one of the most critical events 
during preimplantation period and also associated with the first differentiative events, 
successful embryo implantation, and fetal development (Misirlioglu et al. 2006). 
Gene expression has a fundamental role in the coordination of homeostatic and 
metabolic mechanisms during preimplantation period of development. This period 
involves various morphological and biochemical changes related to genomic activity 
and comprise a complex set of physiological processes, many of which are still 
unknown. These processes are controlled by a harmonized expression of about 10,000 
sequential and temporal genes and strongly influenced by culture conditions (Niemann 
and Wrenzycki 2000). Transcriptomics have been employed successfully to contrast 
gene expression in mammalian oocytes and early embryos. Recent advances in 
bioinformatics and high-throughput technologies such as Next-generation sequencing 
and microarray analysis have revolutionized the way we can analyze the entire 
transcriptome within a population of cells which improve our understanding of the 
molecular mechanisms underlying normal and dysfunctional biological processes 
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(Marguerat and Bahler 2010, Marioni et al. 2008, Wang et al. 2009). Comparative 
analysis of mRNA expression patterns between embryos produced under different in 
vitro culture systems and in vivo allows the isolation of genes associated with embryo 
quality and investigation of the influence of suboptimal culture conditions on embryonic 
gene expression (Cote et al. 2011, Lee et al. 2001, Natale et al. 2001, Smith et al. 2009). 
These studies confirmed that there are alterations in gene expression of embryos 
developed under different culture conditions, which consequently resulted in reduced 
qualities and subsequently associated with fetal and neonatal abnormalities. Moreover, 
alterations in gene expression profile of oocytes and embryos which have different 
developmental potential have been reported (Mamo et al. 2006). A common finding 
between different studies in different mammalian species is that most genes in embryos 
cultured in vitro were down-regulated compared to their in vivo counterparts (Bauer et 
al. 2010, Miles et al. 2008) and that might be a result of decreased expression of genes 
associated with transcription and translation processes (Corcoran et al. 2006). In 
addition, It has been shown that stress response genes are up-regulated during in vitro 
development while metabolism related genes are down-regulated compared to in vivo 
derived embryos (Gutierrez-Adan et al. 2004). As a result of studying gene expression 
profiles to compare in vivo and in vitro derived blastocysts, some genes emerged and 
suggested to be as candidate genes for developmental competency and embryonic 
quality which can be used to modify the current culture systems. An example of these 
genes is the genes controlling the process of pluripotency during embryo culture: Oct4, 
Nanog, and Sox2 (Botquin et al. 1998, Chambers et al. 2003, Masui et al. 2007, Nichols 
et al. 1998). In different studies, the expression patterns of these candidate genes 
showed higher relative amount in in vivo produced embryos when compared to in vitro 
derived ones (Kumar et al. 2007, Magnani and Cabot 2008) which support the idea that 
inadequate culture conditions alter gene expression and contribute to impaired 
development. 
In accordance with many studies done in this field as well as future perspectives, there 
is an inevitable need for combining different culture systems during critical stages of 
embryonic development to facilitate a comprehensive understanding of early embryo 
development regulation and to improve success of embryo culture. For that, two 
different experiments were conducted in this thesis to achieve the following aims: 
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1- Examine the effect of an abnormal endocrine environment due to superovulation 
treatment on embryo development and its influence on the blastocyst 
transcriptome profile. 
2- Examine the effect of alternative in vivo and in vitro culture conditions during 
the time of major EGA on embryo development and the transcriptome profile of 
bovine blastocyst. 
3- Determine molecular mechanisms and pathways that control embryo 
development and influenced by alternative culture conditions during specific 
stages of preimplantation bovine embryos.    
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1.2 Materials and methods 
 
To achieve the objectives of this research several materials and methods were used. The 
materials and methods are described in details in the different chapters of this thesis. 
The importance of some methods and their descriptions are briefly summarized here.  
 
1.2.1 Transvaginal endoscopy-mediated method for embryo recovery and transfer 
Transvaginal endoscopy promises to be an approach for embryo transfer and collection 
by introduce tubal-stage embryos into the physiological environment of the oviducts as 
well as recover specific developmental stage embryos (Besenfelder et al. 2008, 
Besenfelder et al. 2001). As a result of progress in optimization of this nonsurgical 
endoscopic access to the oviduct, there has been a steady increase in pregnancy rate 
after transfer of early cleavage-stage embryos to the oviduct (Besenfelder et al. 2010). 
Therefore, it is suggested that this could be a good system to produce embryos under 
conditions appropriate for addressing limits for physiological mechanisms during in 
vitro production as well as for production of embryos for commercial purposes. For 
embryo transfer, a universal tube including a traumatic trocar was introduced through 
the mid-dorsal area of the fornix vagina. After removal of the trocar, a bi-tubular inlay 
was inserted bearing the endoscopic as well as the transfer system. The transfer system 
consisted of a 1-mL syringe connected to a perfusor tube and the curved glass capillary 
was filled with embryos (n=25-50) and the contents were transferred into the oviduct 
ipsilateral to the corpus luteum with as little as 100 µl medium. For embryo collection, 
procedure was composed of the deposition of a uterine embryo flushing catheter, as is 
routinely done on day 7 in superovulated cows, and the endoscopic technique similar to 
the described transfer. However, we used a metal flushing catheter for insertion into the 
oviduct. The oviducts were flushed using 40 to 60 mL of medium leading to visible 
medium flow in the embryo filter, which was attached to the uterine flushing catheter. 
Additionally, each uterine horn was flushed with about 300 mL medium. 
With the advent of this technology two different experiments have been done to produce 
bovine blastocysts cultured under alternative environmental conditions at specific time 
points during embryonic preimplantation period. For the first experiment, two different 
bovine blastocyst groups (3 replicates; each with 5 blastocysts) were produced. In the 
first group blastocysts were developed in superovulated heifers until day 7. In the 
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second group blastocysts were flushed by endoscopy at day 2 from superovulated 
heifers and then transferred (in groups of 25-50) to the ipsilateral oviduct of 4 
unstimulated (i.e. single-ovulating) synchronized recipients by endoscopic tubal 
transfer. At day 7 all animals were non-surgically flushed to collect bovine embryos. 
For the second experiment, four different blastocyst groups (3 replicates; each with 10 
blastocysts) were produced under alternative in vivo and in vitro culture conditions. The 
first two groups (Vitro_4-cell and Vitro_16-cell) were transferred from in vitro 
conditions to synchronized recipients at 4- and 16-cell stage, respectively and cultured 
in vivo until day 7 blastocyst stage. The second two groups (Vivo_4-cell and Vivo_16-
cell) were flushed out from donor heifers at 4- and 16-cell stage, respectively and 
cultured in vitro until day 7 blastocyst stage. In addition complete in vitro (IVP) and in 
vivo produced  blastocysts were produced and used as contrasts. 
 
1.2.2 RNA isolation, amplification and microarray hybridization  
Total RNA isolation was performed using the PicoPureTM RNA Isolation Kit (Arcturs, 
Munich, Germany). Genomic DNA contamination was removed by performing on-
column DNA digestion using RNase-free DNase (Qiagen GmbH, Hilden, Germany). 
Quantity and quality of the extracted total RNA was verified on a 2100 Bioanalyzer 
(Agilent Technologies Inc, CA, USA). In the first experiment (chapter 1), two rounds of 
RNA amplification were performed as described in the GeneChip® Expression Analysis 
Technical Manual using 100 ng of total RNA as a starting material. The resulting 
double-stranded cDNA in the second round was then amplified and labelled using a 
biotinylated nucleotide analog/ribonucleotide mix in the second in vitro transcription 
(IVT) reaction using GeneChip IVT Labeling Kit (Affymetrix, Inc., Santa Clara, CA, 
USA). The biotin labelled cRNA was fragmented and analyzed in the Bioanalyzer. The 
samples were then hybridized to the Affymetrix GeneChip Bovine Genome Array 
consisting of 24128 probesets. For each group, three biotin-labelled cRNA 
hybridizations were performed. The arrays were washed and stained using the Fluidics 
Station 450/250 and scanned using the GeneChip® scanner 3000 integrated with 
Affymetrix® Microarray Suitesoftware. In the second experiment (chapter 2), two 
rounds of RNA amplification were performed using RiboAmp HS RNA amplification 
kit (Applied Biosystems). Two micrograms of aRNA from each sample were 
conjugated with either Cy-3 or Cy-5 dyes using ULS Fluorescent labelling kit for 
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Agilent arrays (Kreatech Diagnostics, Amsterdam, Netherlands). Samples from the 
three pools (biological replicates) of each blastocyst group and in vivo control 
blastocyst were hybridized on EmbryoGENE’s bovine microarray (Made by Agilent 4 x 
44k)  using a dye-swap design (technical replicates) for a total of six arrays. Slides were 
scanned using Agilent’s High-Resolution C Scanner (Agilent Technologies, CA, USA) 
and features were extracted with the Agilent's Feature Extraction software (Agilent 
Technologies, CA, USA).   
 
1.2.3 Quantitative real-time polymerase chain reaction 
Real-time polymerase chain reaction (PCR) has emerged as a robust and widely used 
methodology for biological investigation. It can detect and quantify very small amounts 
of specific nucleic acid sequences in rapid and accurate assessment. The cDNA 
synthesized from blastocyst samples was subjected to real-time PCR using GAPDH to 
test for any variation in the expression of this internal control gene. After confirming 
that there were no differences in the relative abundance of GAPDH between samples, all 
transcripts were quantified using independent real-time PCR runs. In the first 
experiment (chapter 1), a serial dilution of 101-109 copy number of molecules for each 
quantified gene was prepared from the plasmid DNA. Quantitative real-time PCR was 
performed using cDNA samples from three independent biological replicates of each 
blastocyst group in addition to the samples used for array analysis. In each run, beside 
each cDNA sample, plasmid standards for the standard curves and no-template control 
(NTC) were used. The PCR was performed in a 20 µl reaction volume containing iTaq 
SYBR Green Supermix with ROX (Bio-Rad) in ABI PRISM® 7000 instrument (Applied 
Biosystems). Melting curve analysis was constructed to verify the presence of gene-
specific peak and the absence of primer dimer. Final quantitative analysis was carried 
out using the relative standard curve method and results were reported as the relative 
expression after normalization of the transcript amount relative to the endogenous 
control. In the second experiment (chapter 2), each pair of primers was tested to achieve 
efficiencies close to 1. The PCR was performed in a 20 µl reaction volume containing 
iTaq SYBR Green Supermix with ROX (Bio-Rad) in StepOnePlus™ real time PCR 
system (Applied Biosystem) and the comparative cycle threshold (Ct) method was used 
to quantify expression levels. 
 
Materials and methods 9 
1.2.4 Data analysis 
Data were analysed using the Statistical Analysis System (SAS) version 8.0 (SAS 
Institute Inc., Cary, NC, USA) software package. Mean developmental rates of embryos 
were analysed by ANOVA followed by a multiple pair wise comparison (Tukey Test). 
The relative expression data were analysed using General Linear Model (GLM) of SAS, 
and differences in mean values were tested using ANOVA followed by a multiple pair 
wise comparison using t-test. Differences of p-value < 0.05 were considered to be 
significant. Array data analyses were performed using R version 2.12.1 and Linear 
Models for Microarray Data Analysis (LIMMA) package version 3.6.9. For Affymetrix 
array data analysis (chapter 1), data normalization and background correction were 
performed using Guanine Cytosine Robust Multi-Array Analysis method. However, for 
Agilent array data analysis (chapter 2), data were submitted to a simple background 
correction, a Loess within array normalization and Quantile between array 
normalization. Differentially expressed genes (DEGs) were obtained using LIMAA 
(Smyth 2005). Genes were considered differentially expressed at a fold-change >2 with 
adjusted P-value of < 0.05 using the Benjamini and Hochberg false discovery rate 
(FDR) method. A list of the DEGs from each comparison was uploaded into the 
Ingenuity Pathway Analysis software (IPA, Ingenuity Systems, www.ingenuity.com) to 
identify relationships between the genes of interest and to uncover common processes 
and pathways. 
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1.3 Results 
 
Some of the important results are briefly described here. The detailed results can be 
found in the respective chapters in this thesis. 
 
1.3.1 Effect of maternal environment on developmental rates and blastocyst 
transcriptome profile 
In the first experiment (Chapter 1), embryos which were developed either in the 
reproductive tract of superovulated heifers (High P4) or in unstimulated recipients 
(Normal P4) from day 2 onward showed differences in developmental rate and 
blastocyst:morula ratio. The percentage of embryos which developed to the morula or 
blastocyst stage was higher (P < 0.05) when cultured in superovulated heifers compared 
to unstimulated heifers (68.3% versus 52.1%). However, significantly more embryos 
developed to the blastocyst stage in the unstimulated heifers compared to those 
developing in superovulated heifers (33.6% versus 22.1%). The blastocyst:morula ratio 
was significantly higher (P < 0.05) in unstimulated heifers compared to superovulated 
heifers (1.81 vs. 0.48). A total of 454 DEGs with p < 0.05, fold change ≥ 2 and FDR ≤ 
0.3 were differentially regulated between blastocysts derived from superovulated 
animals and those which cultured in unstimulated recipients from day 2 onward. The 
majority of the DEGs (429 gene) were up-regulated in blastocysts which developed 
under superovulation conditions. A high proportion (40%) of these DEGs fell into 
functional categories related to metabolic processes including carbohydrate, lipid, 
nucleic acid, amino acid, vitamin and mineral metabolism. Other functional categories, 
including protein synthesis, RNA post-transcriptional modification, gene expression, 
cell-to-cell signalling, energy production and molecular transport were also 
overrepresented in the same blastocyst group. Pathway analysis using IPA revealed that 
the oxidative phosphorylation pathway was the dominant pathway among 5 different 
canonical pathways and all DEGs (26 genes) involved in this pathway were highly 
abundant in the blastocysts derived from superovulated heifers compared to those 
derived from unstimulated heifers. These genes can be classified into 4 main categories: 
NADH dehydrogenase, cytochrome c reductase, cytochrome c oxidase and ATP 
synthase, representing 4 out of 5 protein complexes involved in the electron transport 
and oxidative phosphorylation pathway. The results of microarray have been validated 
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using quantitative real-time PCR that confirmed the expression profile of 11/14 (79%) 
of the selected genes for validation. 
 
1.3.2 Effect of alternative culture conditions during major EGA on developmental rates 
and blastocyst transcriptome profile 
In the second experiment (Chapter 2), there was no effect of culture conditions (in vivo 
or in vitro) either before or after the time of major EGA on embryo developmental rates. 
However, the origin of the oocyte was the main factor determines the developmental 
rates. In vitro originated blastocyst groups (Vitro_4-cell, Vitro_16-cell and IVP) 
showed lower developmental rates (24.1, 27.5 and 33.6%, respectively) than in vivo 
originated blastocyst groups (Vivo_4-cell and Vivo_16-cell; 64.4 and 68.2%, 
respectively). Vitro_16-cell group showed the lowest blastocyst:morula ratio (0.2). In 
contrast, Vivo_4-cell group showed the highest blastocyst:morula ration (9.9) 
comparing to all other groups.  Principal component analysis (PCA) of microarray data 
from different blastocyst groups revealed that the source of greatest variation in the 
transcriptional profile was the in vitro culture conditions during the time of major EGA. 
Blastocyst groups which spent the time of major EGA under in vitro conditions either 
originated in vitro (Vitro_16-cell) or in vivo (Vivo_4-cell) showed higher number of 
differentially expressed genes (882 and 1918 DEGs, respectively) than those which 
spent the time of major EGA under in vivo culture conditions either originated in vitro 
(Virtro_4-cell) or in vivo (Vivo_16-cell) (633 and 311 DEGs, respectively), or than IVP 
group (841 DEGs) compared to the complete in vivo control group. Chromosome 
distribution comparison between all groups for DEGs showed a higher percentage of 
genes to be located on X-chromosome and most of these genes were up-regulated in all 
blastocyst groups compared to their complete in vivo blastocyst counterparts. 
Ontological classification of DEGs indicated that metabolic processes including: lipid, 
carbohydrate, nucleic acid and amino acid, cell related functions including: cell death, 
cellular growth and proliferation, cell cycle and cell-to-cell signalling, as well as 
embryonic development and gene expression processes were the most significant 
common functions affected in all blastocyst groups exposed to some in vitro conditions 
compared to the in vivo control group. Interestingly, lipid metabolism was the most 
significant biological function affected in Vitro_16-cell group with down-regulation for 
most of the genes involved in this function comparing to in vivo control group. The 
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same pattern of lipid metabolism related genes has been found in Vitro_4-cell and IVP 
blastocyst groups but with lower number of genes involved. In contrast, Vivo_4-cell 
group showed opposite pattern in which most of DEGs involved in lipid metabolism 
were up-regulated compared to in vivo group. Pathway analysis using IPA revealed that 
NRF2-mediated oxidative stress response pathway was the dominant pathway in 
Vivo_4-cell group and showed up-regulation for most of the involved genes, especially 
genes encoding for antioxidant enzymes (PRDX1, SOD, TXNRD1, GPX2 and CAT). 
Antioxidant related genes in this pathway showed an opposite pattern in the groups 
which spent major EGA time under in vitro culture conditions with up-regulation in 
Vivo_4-cell group and down-regulation in Vitro_16-cell group which showed also 
down-regulation of NRF2 gene, central gene acting as a transcriptional factor and 
regulating the expression of sets of genes including antioxidant, detoxifying, stress 
response and proteasomal degradation related genes. Quantitative real-time PCR 
confirmed the differences in the expression of 14 out of 15 (93%) genes selected to 
validate the results of microarray. 
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1.4 Conclusions  
 
In this study we identified the effect of culture environment at specific stages of 
preimplantation bovine embryos on the transcriptome profiles of the resulting 
blastocysts. The results showed that abnormal culture conditions either in vivo due to 
superovulation treatment or in vitro due to suboptimal culture conditions can influence 
the development and gene expression patterns of embryos. Culture of embryos under 
hormonal stimulation conditions until day 7 lead to a delay in development, as greater 
proportion of morula than blastocysts flushed from the superovulated heifers at day 7 
compared to unstimulated heifers has been observed. This delay in embryo 
developmental rate under superovulation conditions has been reported in mice (Ertzeid 
and Storeng 2001, Van der Auwera and D'Hooghe 2001). Likewise, embryos from 
superovulated hamsters had significantly reduced mean cell numbers and lower viability 
than controls (McKiernan and Bavister 1998). However, the reasons for the 
developmental retardation, loss of developmental competence and low quality of 
embryos from superovulated donors are still unknown. We also showed that, although 
changing culture conditions from in vivo to in vitro or vice versa either before or after 
the time of major EGA have no effect on the embryo developmental rates, oocyte origin 
seem to have a critical effect on the developmental rates. In which, in vivo originated 
embryos had higher overall transferable embryo rates compared to in vitro originated 
ones. These results were in agreement with previous studies which proved that while the 
in vivo or in vitro origin of oocyte (the oocyte quality) is the main factor determining 
embryo developmental rate (Hendriksen et al. 2000, Rizos et al. 2002b), the post 
fertilization culture environment is known to be the most important factor determining 
the quality of the resulting embryos (Rizos et al. 2003, Rizos et al. 2002a). 
Expression of genes during early embryonic developmental stages is one of the good 
indicators for embryo quality and viability. In this study, microarray analysis revealed 
that embryos developing to the blastocyst stage in superovulated heifers showed 
significant up-regulation for most of the DEGs which are involved in metabolic 
processes, protein synthesis and energy production via the oxidative phosphorylation 
pathway compared to embryos developing to the blastocyst stage in unstimulated 
heifers. This indicated that embryos under superovulation conditions are metabolically 
active and they are in high demand for ATP to reach the blastocyst stage. In addition, 
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higher expression of heat shock protein related genes (HSPA14 and HSPE1) has been 
observed in blastocysts derived from superovulated heifers which may indicate that the 
oviductal environment under superovulation conditions provided some stress factors to 
the preimplantation embryos. These findings are supported by the ‘quiet embryo 
hypothesis’ put forward by Leese (2002) which proposed that viable embryos have a 
‘quieter’ metabolism than those with less viability and this quietness can be lost in 
response to environmental stress (Leese et al. 2008). In accordance, metabolic processes 
including lipid, carbohydrate, nucleic acid and amino acid were the most significant 
functions affected in all blastocyst groups exposed to in vitro conditions compared to 
the in vivo control group. Blastocysts which spent the time of major EGA under in vitro 
conditions showed higher number of DEGs than those spent major EGA time under in 
vivo conditions compared to in vivo control blastocyst. This disturbance in gene 
expression highlight the sensitivity of embryos towards in vitro culture conditions 
during major EGA time. Interestingly, lipid metabolism and oxidative stress response 
related genes were the most affected genes in the two blastocyst groups which were 
cultured in vitro during major EGA time either originated in vivo or in vitro. However, 
they showed opposite patterns of expression. A clear pattern of down-regulation for 
lipid metabolism and oxidative stress response related genes has been found in the in 
vitro originated group compared to in vivo originated one. This was also reflected on 
the morphology of in vitro originated embryos which showed a darker cytoplasm at 
different developmental stages as indicator for lipid accumulation in the cytoplasm. 
This finding could highlight the critical influence of culture conditions during 
maturation and early developmental stages on the metabolic activity and the ability of 
embryos to adapt with changing culture conditions.  
This is the first comprehensive study provided more information about molecular 
mechanisms and pathways that influenced by altered culture conditions during specific 
embryonic developmental time points. This will enable to launch strategies to modify 
culture conditions at the critical stages of development to enhance the development of 
competent blastocyst and will aid in determining new candidate genes to be used as 
markers of embryo quality. 
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Abstract 
In mammals, the reproductive tract plays a crucial role in the success of early 
reproductive events and provides an optimal microenvironment for early embryonic 
development. However, changes in the reproductive tract environment associated with 
controlled ovarian hyperstimulation and the influence on the embryo transcriptome 
profile have not been investigated. Therefore, we investigated differences in 
development rate and transcriptome profile of bovine blastocysts developing in the 
reproductive tract of unstimulated or superovulated heifers. Nineteen Simmental heifers 
were synchronized, superovulated and artificially inseminated; nine heifers were 
flushed on day 2 after insemination and 2- to 4-cell stage embryos were recovered and 
endoscopicaly transferred to the ipsilateral oviduct of unstimulated (i.e. single-
ovulating) synchronized recipients (n=4 recipients; 25-50 embryos per recipient). The 
remaining ten superovulated heifers and the unstimulated recipients were then non-
surgically flushed on day 7 to collect embryos. The blastocyst transcriptome profile was 
examined using the Affymetrix GeneChip Bovine Genome Array. The proportion of 
embryos which developed to the blastocyst stage was lower in superovulated heifers 
than unstimulated heifers (P<0.05). Blastocysts which developed under the abnormal 
endocrine conditions associated with superovulation showed higher cellular and 
metabolic activities, as genes involved in the oxidative phosphorylation pathway, 
different metabolic processes and translation and transcription processes, in addition to 
genes expressed in response to stress, were highly expressed compared to embryos 
which developed in the oviduct of unstimulated animals. The environment in which the 
embryo develops in the oviduct/uterus significantly alters gene expression patterns, 
especially those genes which regulate metabolic activity in the embryo. 
 
Introduction 
Controlled ovarian hyperstimulation (COH) is a routine procedure utilized in assisted 
reproduction to stimulate the growth of multiple follicles in naturally single-ovulating 
species including cattle and humans. In cattle, in order to increase the number of 
offspring during the lifetime of individual animals, females of high genetic merit are 
typically stimulated with gonadotrophins to induce the ovulation of a variable but large 
number of follicles (hence the routine use of the term 'superovulation' in domestic 
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species, as ovulation actually takes place). These embryo ‘donors’ are then artificially 
inseminated with semen from a high genetic merit sire and the resulting embryos are 
non-surgically flushed from the uterus on day 7 for transfer to surrogate recipients, or 
for cryopreservation and transfer at a later date (see Lonergan and Boland 2011 for 
review). Similarly, women undergoing IVF treatment undergo COH to induce the 
development of multiple dominant follicles. In contrast to cattle, multiple mature 
oocytes are recovered by transvaginal follicle aspiration just prior to ovulation, 
inseminated in vitro with partner/donor sperm and then, in contrast to cattle, because of 
the very different objectives, embryos are transferred back to the same women, often in 
the same cycle. Thus, while the objective of producing multiple mature oocytes is the 
same, the term 'superovulation' is inappropriate in routine human IVF, as ovulation does 
not take place. Therefore, while in cattle embryos are transferred into a synchronised 
recipient animal with a normal endocrine profile, in humans, the embryo(s) is routinely 
transferred into an endocrinologically abnormal uterine environment associated with 
controlled ovarian stimulation. 
Despite significant advances in assisted reproduction technology (ART) protocols in 
humans, pregnancy rates are still relatively low and have not increased significantly in 
the last decade (Andersen et al. 2007). Similarly, in cattle, despite constant refinement 
of superovulation protocols, mainly driven by more efficient management demands, 
embryo yield per superovulated donor has not changed significantly (Bo et al. 2008). 
The yield and quality of embryos produced following superovulation of cattle is highly 
variable and may be affected either through effects on the oocyte during follicular 
growth (Sirard et al. 2006) or directly during embryo development in the oviduct and/or 
uterus (Killian 2004, Looney and Pryor 2010). It is clear that oocytes and embryos in 
superovulated animals develop under abnormal endocrine conditions which differ 
substantially from those in unstimulated (i.e, single-ovulating) animals and that they 
may exhibit a reduced developmental potential (Greve and Callesen 2001). Previous 
studies in mice have shown that COH procedures can result in delayed embryo 
development, decreased implantation and increased postimplantation loss (Ertzeid and 
Storeng 1992, 2001). Similarly, Van der Auwera and Hooghe (2001) reported delayed 
blastocyst formation, increased incidence of zona lysis and blastocyst collapse of 
embryos derived from stimulated mice compared with naturally cycling controls. In 
rabbits, embryos removed from superovulated donors at the one-cell stage and 
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immediately transferred to unstimulated recipients tended to have higher cell numbers 
than embryos residing continuously in superovulated animals (Carney and Foote 1990). 
The oviduct and the fluid contained in it provide a beneficial environment for gamete 
maturation, gamete transportation, fertilization and early embryonic development. 
These events are key processes in mammalian reproduction and are under the control of 
steroids (Murray et al. 1995) and prostaglandins (PG) (Lim et al. 1997). Studies in mice 
and humans have shown that COH can lead to incorrect genomic imprinting and 
decreased embryo quality (Fauque et al. 2007, Rossignol et al. 2006, Sato et al. 2007), 
suggesting that ovarian hormonal stimulation may affect embryo development and gene 
expression in many different ways. In addition, an increase in chromosomal 
abnormalities has been reported in human embryos after conventional stimulation, 
mainly resulting from an increased incidence of chromosome segregation errors during 
the first embryonic divisions, and abnormalities were lowest in embryos which divided 
within the expected time frame (Baart et al. 2009).  
Development of transvaginal endoscopy in cattle (Besenfelder et al. 2008, Besenfelder 
et al. 2001) has allowed unrivalled access to the bovine oviduct for the recovery and/or 
transfer of embryos at different developmental stages, and offers an excellent tool for 
studying the early kinetics of embryo development as well as the effects of hormonal 
stimulation on embryo physiology. As a result of progress in optimization of this 
nonsurgical endoscopic access to the oviduct, there has been a steady increase in 
pregnancy rate after transfer of early cleavage-stage embryos to the oviduct 
(Besenfelder et al. 2010). 
To our knowledge, the changes in the oviduct and uterine environment related to 
hormonal treatments and subsequent influence on transcriptome profile of embryos 
have not been investigated. It is well known that COH leads to deviant oocyte 
maturation in the follicle (Hyttel et al. 1989) as well as an abnormal endocrine 
environment in the reproductive tract. Therefore, this study aimed to separate these two 
processes and examine the effect of an abnormal endocrine environment on embryo 
development to day 7 and its influence on the blastocyst transcriptome. To do this, a 
state-of-the-art nonsurgical endoscopy method was used to recover 2- to 4-cell stage 
embryos from superovulated donors and transfer them to non-stimulated single-
ovulating recipients. The proportion of embryos which developed to the blastocyst stage 
and the transcriptome of the resulting blastocysts was compared between groups. These 
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data have relevance not only for cattle embryo production but also for assisted human 
reproduction where oocytes derived from women undergoing COH are routinely 
replaced in the uterus of the same women during the same cycle, in contrast to the 
situation in cattle, where transfer to unstimulated surrogate recipients is the norm. This 
relevance is highlighted by the fact that high-quality embryos transferred into women 
who are acting as surrogate mothers have a higher likelihood of implanting than if they 
are transferred back into the donors (Check et al. 1992, Stafford-Bell and Copeland 
2001). 
Materials and Methods 
Animals for embryo collection 
All experimental animals were handled according to the animal protection law of 
Germany. Simmental heifers (n= 23) aged between 15 and 20 months and weighing 
between 380 and 500 kg were used in this study. All animals were kept under identical 
farm conditions within the same herd. A total of 19 heifers were superovulated using 
FSH (see below) and artificially inseminated three times with the same frozen-thawed 
commercial bull semen. Nine animals were flushed by endoscopy at day 2 to recover 2- 
to 4-cell stage embryos which were then transferred (in groups of 25-50) to the 
ipsilateral oviduct of 4 unstimulated (i.e. single-ovulating) synchronized recipients by 
endoscopic tubal transfer. The remaining 10 superovulated heifers were not flushed 
until day 7. At day 7 all animals were non-surgically flushed to collect bovine embryos 
which have thus developed either in a superovulated or an unstimulated environment. 
The overall experimental design is indicated in Figure 1.  
Hormonal treatment 
Pre-synchronization was performed by i.m. administration of 500 µg cloprostenol 
(PGF2α, Estrumate®; Essex Tierarznei, Munich, Germany) twice within 11 days. Two 
days after each of the PGF2α treatments animals received 10 µg GnRH (Receptal®; 
Intervet, Boxmeer, The Netherlands). Twelve days after the last GnRH injection heifers 
received the first of eight consecutive FSH-injections over 4 days in decreasing doses 
(in total 300–400 mg FSH equivalent according to body weight; Stimufol, University of 
Liege, Belgium). Two PGF2α treatments were performed 60 and 72 h after the initial 
FSH injection. Finally, 48 h after the first PGF2α application, ovulation was induced by 
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simultaneous administration of 10 µg GnRH with the first of a total of three artificial 
inseminations within a 12 h interval. The time of the second insemination (60 h after the 
first PGF2α application) was defined as day 0 (D0). The oestrous cycles of recipient 
animals were synchronized as mentioned above but were not inseminated. 
Blood sampling and progesterone assay 
Daily blood samples were collected from each animal from day 1 until the day of 
embryo recovery (D7) by jugular venipuncture. Following collection, blood samples 
were refrigerated at 4°C for 12-24 h before being centrifuged at 1500 g at 4°C for 20 
min. Serum was separated and stored at -20°C until assayed to determine progesterone 
concentration by time-resolved fluoroimmunoassay using an AutoDELFIA™ 
Progesterone kit (Perkin Elmer, Wallac Oy, Turku, Finland). The sensitivity of the 
assay was 0.01 ng/ml.  
Collection of embryos at 2- to 4-cell stage 
Embryos at the 2- to 4-cell stage were collected 48-54 h after the expected onset of 
ovulation (D0). Flushing was accomplished as described previously (Besenfelder et al., 
2001). Briefly, after restraining the recipients, administering 5 mL of a 2% lidocaine-
solution (Xylanest purum1, Richter Pharma,Wels, Austria) for epidural anesthesia and 
disinfecting the vulva (Octenisept1, Schϋlke/Mayer, Vienna, Austria), a trocar set 
consisting of an universal metal tube (12.5 mm _ 52 cm, Storz, Vienna, Austria) and an 
atraumatic mandrin was placed caudodorsal of the fornix vagina. The mandrin was 
replaced by a sharp trocar and the trocar set was inserted through the vaginal wall into 
the peritoneal cavity. The trocar was replaced by a shaft bearing the endoscope (5.5 mm 
08 forward Hopkins endoscope, Storz, Vienna, Austria) and the transfer system. The 
site was illuminated by a fiberoptic cold light (250 W, Storz, Austria) and visualized 
with a camera (Telecam PAL-Endovision, Storz, Vienna, Austria) connected to a 
monitor.  
The flushing system consisted of a 20 ml syringe connected to a perfusor tube (No. 
08272514; Braun, Melsungen, Germany) and a metal tube (14 cm x 2.5 mm) with 
numerous lateral holes covered by a silicon tube. Thus, after the metal tube was inserted 
via the infundibulum into the ampulla, the careful management of the flushing pressure 
allowed the balanced adjustment of tubal sealing to avoid medium reflux. Oviducts 
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were flushed with 50 ml flushing medium (phosphate-buffered saline supplemented 
with 1% fetal calf serum). Flushing medium (approx. 50 ml) was forced through the 
uterotubal junction into the uterine horn and from there was collected via the uterus 
flushing catheter (CH15, Wörrlein, Ansbach, Germany) into an embryo filter (Emcon 
filter®, No. 04135; Immuno Systems Inc., Spring Valley, WI, USA). 
Tubal transfer of 2- to 4-cell stage embryos 
Tubal transfer was performed as described previously (Besenfelder and Brem, 1998) by 
transvaginal endoscopy. Briefly, after getting access into the peritoneal cavity 
(described above), the glass capillary of the transfer system, consisting of a 1 mL 
syringe attached to a perfusor tube (no. 08272514, Braun, Meslungen, Germany) and a 
glass capillary (Transferpettor Caps1, 100–200 mL, no. 701910, Brandt, Wertheim, 
Germany) which was crosier shaped at the tip, was filled with embryos (n=25-50) and 
the contents were transferred into the oviduct ipsilateral to the corpus luteum with as 
little as 100 µl medium. 
Embryo recovery at day 7 
The embryos were collected on day 7 after insemination. Access into the peritoneal 
cavity and endoscopic tubal flushing was performed in the same way as described above 
for flushing of 2- to 4-cell stage embryos. Following flushing of the oviduct towards the 
uterus, the uterus was flushed nonsurgically as described above. 
RNA isolation and biotin labeled cRNA synthesis  
Total RNA extraction from blastocysts was performed at two different time points 
during the whole experiment: (1) a total of six pools (three from superovulated and 
three from unstimulated heifers; each with 5 blastocysts) was used for array 
hybridization after amplification, and (2) a total of six pools (three from superovulated 
and three from unstimulated heifers; each with 5 blastocysts) was used for quantitative 
real-time PCR validation of array results. In all cases, total RNA isolation was 
performed using the PicoPureTM RNA Isolation Kit (Arcturs, Munich, Germany) 
according to the manufacturer's instruction. Genomic DNA contamination was removed 
by performing on-column DNA digestion using RNase-free DNase (Qiagen GmbH, 
Hilden, Germany). The concentration (ng/µl) and the quality of the extracted total RNA 
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were assessed using the Nanodrop 8000 spectrophotometer (Biotechnology GMBH, 
Erlangen, Germany). RNA integrity was evaluated using the Agilent 2100 Bioanalyzer 
with RNA 6000 Nano LabChip® Kit (Agilent Technologies Inc, CA, USA). Two rounds 
of RNA amplification were performed as described in the GeneChip® Expression 
Analysis Technical Manual using 100 ng of total RNA as a starting material. After 
cDNA synthesis in the first cycle, an unlabeled ribonucleotide mix was used in the first 
cycle of IVT amplification using MEGAscript® T7 Kit (Ambion, Inc., Austin, TX, 
USA). The unlabeled cRNA was then cleaned using GeneChip® IVT cRNA Cleanup 
Kit (Affymetrix, Inc., Santa Clara, CA, USA) and reverse transcribed in the first-strand 
cDNA synthesis step of the second cycle using random primers. Subsequently, the T7-
Oligo (dT) Promoter Primer was used in the second-strand cDNA synthesis to generate 
double-stranded cDNA template containing T7 promoter sequences. The resulting 
double-stranded cDNA was then amplified and labelled using a biotinylated nucleotide 
analog/ribonucleotide mix in the second IVT reaction using GeneChip IVT Labeling Kit 
(Affymetrix, Inc., Santa Clara, CA, USA). The biotin labelled cRNA was fragmented 
and analyzed in the Bioanalyzer. The success of fragmentation was evaluated by the 
RNA peaks in the Bioanalyzer.  
Affymetrix array hybridization and scanning  
A Bovine Genome GeneChip 100 Format Array was used for hybridization. For this, a 
hybridization cocktail consisting of fragmented and labelled cRNA (15 µg), control 
oligonucleotide B2 (3 nM), 20X eukaryotic hybridization controls (bioB, bioC, bioD, 
cre), 2X hybridization mix, dimethylsulphoxide and RNAse-free water was mixed to a 
final volume of 200 µl and heated to 99°C for 5 min followed by warming at  45°C  for 
5 min. The samples were then hybridized to the Affymetrix GeneChip Bovine Genome 
Array consisting of 24128 probesets. Hybridization was performed for 16 h. For each 
group, three biotin-labelled cRNA hybridizations were performed. The arrays were 
washed and stained using the Fluidics Station 450/250 and scanned using the 
GeneChip® scanner 3000 integrated with Affymetrix® Microarray Suitesoftware.  
Affymetrix data analysis 
The microarray data normalization and background correction were performed using 
Guanine Cytosine Robust Multi-Array Analysis as described previously (Vardhanabhuti 
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et al. 2006). The quality of the arrays after hybridization was assessed by the absent and 
present calls of the control probesets. Differentially expressed genes were obtained 
using Linear Models for Microarray Data Analysis (Smyth 2005). The differentially 
regulated genes were selected based on p < 0.05, fold changes > 2 and false discovery 
rate (FDR) ≤ 0.3. The raw data have been submitted to Gene Expression Omnibus under 
series GSE21030. 
Pathways and networks analysis 
A list of the differentially expressed genes (DEGs) was uploaded into the Ingenuity 
Pathway Analysis software (IPA, Ingenuity Systems, www.ingenuity.com) to identify 
relationships between the genes of interest and to uncover common processes and 
pathways. Networks of the genes were then algorithmically generated based on their 
connectivity. The ‘‘Functional Analysis’’ tool of the IPA software was used to identify 
the biological functions that were most significant to the data set. Canonical pathway 
analysis was also utilized to identify the pathways from the IPA library of canonical 
pathways that were most significant to the data set. Fishers exact test was used to 
calculate a p-value determining the probability that each biological function or 
canonical pathway assigned to the data set was because of chance alone. In addition, the 
significance of the association between the data set and the canonical pathway was 
calculated as the ratio of the number of genes from the data set that mapped to the 
pathway divided by the total number of genes that mapped to the canonical pathway 
Validation of results using quantitative real-time PCR 
Sequence specific primers (Table 1) were designed using Primer Express v 2.0 
(Applied Biosystems, Foster City, CA, USA). For each primer a serial dilution of 101-
109 copy number of molecules was prepared from the plasmid DNA. Quantitative real-
time PCR was performed using cDNA samples from three independent biological 
replicates of each blastocyst group in addition to the samples used for array analysis. 
The cDNA synthesized from blastocyst samples was subjected to real-time PCR using 
GAPDH to test for any variation in the expression of this internal control gene. After 
confirming that there were no differences in the relative abundance of GAPDH between 
samples, all transcripts were quantified using independent real-time PCR runs. The 
PCR was performed in a 20 µl reaction volume containing iTaq SYBR Green Supermix 
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with ROX (Bio-Rad laboratories, Munich, Germany), the cDNA samples, the specific 
forward and reverse primer in ABI PRISM® 7000 sequence detection system 
instrument (Applied Biosystems). The thermal cycling parameter was set as 95 °C for 3 
min, 40 cycles of 15 sec at 95 °C  and 45 sec at 60 °C. Final quantitative analysis was 
carried out using the relative standard curve method and results were reported as the 
relative expression after normalization of the transcript amount relative to the 
endogenous control. 
Statistical analysis  
Data were analysed using the Statistical Analysis System (SAS) version 8.0 (SAS 
Institute Inc., Cary, NC, USA) software package. Developmental rates of embryos were 
analysed by 2 -test. The relative expression data were analysed using General Linear 
Model of SAS. Differences in mean values were tested using analysis of variance 
followed by a multiple pairwise comparison using t-test. Differences of P < 0.05 were 
considered to be significant. 
Results 
Embryo recovery and development 
In superovulated heifers (n=10), the overall embryo recovery rate following non-
surgical flushing on day 7 was 78% [calculated based on number of corpora lutea (CL)] 
with a mean of 14.5 structures recovered per donor. Of these flushed embryos, 68.3% 
had developed to the morula or blastocyst stage (Table 2). Heifers (n=9) flushed at day 
2 delivered a total of 177 embryos; 164 of these embryos were transferred by endoscopy 
to the oviducts of 4 synchronized unstimulated recipients, while 13 embryos were 
discarded owing to retarded development. Following nonsurgical flushing on day 7, 146 
embryos (89%) were recovered of which 76 (52.1%) were of transferable quality. Based 
on the number of heifers which had been superovulated initially, the mean embryo 
number per heifer was 16.2. Based on the estimated total number of CL (174) of the 
superovulated heifers (n=9) the recovery rate was 84%. The percentage of embryos 
which developed to the morula or blastocyst stage was higher (p<0.05) when cultured in 
superovulated heifers compared to unstimulated heifers (68.3% versus 52.1%). 
However, significantly more embryos developed to the blastocyst stage in the 
unstimulated heifers compared to those developing in superovulated heifers (33.6% 
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versus 22.1%). The developmental rate of the embryos (defined as Blastocyst : Morula 
ratio) was significantly higher (P < 0.05) in unstimulated heifers compared to 
superovulated heifers (1.81 versus 0.48) (Table 2). 
Circulating progesterone profile 
The progesterone profiles of the superovulated and unstimulated heifers are shown in 
Figure 2. The mean progesterone concentration from day 1 to day 6 was 11.37 ± 1.3 and 
0.62 ± 0.11 ng/ml in the superovulated and unstimulated heifers, respectively. The 
progesterone concentrations diverged significantly from day 1 onwards between the two 
groups (P < 0.01). 
Blastocyst transcriptome profile 
The microarray data analysis revealed a total of 454 DEGs with p < 0.05, fold change ≥ 
2 and FDR ≤ 0.3 between the two groups of blastocysts (Supplementary Table S1). 
From these, 429 genes were highly abundant in blastocysts derived from superovulated 
heifers and 25 were more abundant in blastocysts derived from unstimulated recipients. 
The overall expression pattern of the differentially regulated genes in all hybridizations 
and the hierarchical clustering are indicated in Figure 3a. The most highly abundant 
genes (with fold change ≥ 8) in the blastocysts derived from superovulated heifers 
included HSPA14, ZNF238, PTGES3, HSPE1, IFT122, RPS17, CPSF3, POLR2F, 
SLC30A5 and TMEM184B. Blastocysts derived from unstimulated heifers were 
enriched with genes such as CLGN, FUT1, MGC and CHMP1B (Fig. 3b). 
Biological functions, canonical pathways and gene networks identified 
Of the 454 DEGs, 333 could be assigned to a specific functional group based on the 
information in the IPA. A high proportion of the DEGs (40%) which were enriched in 
the blastocysts derived from superovulated heifers fell into functional categories related 
to metabolic processes including carbohydrate, lipid, nucleic acid, amino acid, vitamin 
and mineral metabolism. Other functional categories, including protein synthesis, RNA 
post-transcriptional modification, gene expression, cell-to-cell signalling, energy 
production and molecular transport were also overrepresented in the same blastocyst 
group. A graphical representation of this functional classification of the genes 
overexpressed in blastocysts derived from superovulated heifers is shown in Figure 4, in 
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which the 13 functional groups with the lowest p-values (P ≤ 0.05) are highlighted. The 
genes classified into each of these groups are listed in Table 3. In addition, the IPA 
analysis assigned 57 of the DEGs to 5 different canonical pathways. The five selected 
pathways had ratios (proportion of DEGs involved in the pathway out of the total genes 
of this pathway) ranging from 5% to 16% and p-values lower than 0.05 (Figure 5). The 
genes assigned to these pathways are presented in Table 4. Interestingly, the oxidative 
phosphorylation pathway was the dominant pathway and all DEGs (26 genes) involved 
in this pathway were highly abundant in the blastocysts derived from superovulated 
heifers compared to those derived from unstimulated heifers (Table 5). These genes can 
be classified into 4 main categories: NADH dehydrogenase, cytochrome c reductase, 
cytochrome c oxidase and ATP synthase, representing 4 out of 5 protein complexes 
involved in the electron transport and oxidative phosphorylation pathway (Figure 6).  
Finally, the DEGs in our data set were mapped onto 17 networks, each containing 8–29 
genes that shared direct or indirect relationships. The transcripts involved in each 
network and the top functions for each network are presented in Supplementary Table 
S2. An example of networks created from our data is shown in Figure 7. In this network 
the relationships between molecules overexpressed in the blastocysts derived from 
superovulated heifers and involved in cytochrome c reductase (Complex III in oxidative 
phosphorylation pathway) are represented by arrows. DEGs involved in the four protein 
complexes of oxidative phosphorylation pathway were mapped in four different 
networks (Networks 2, 7, 12 and 14; Supplementary Table S2). 
Validation of microarray results 
Quantitative real-time PCR validation on an independent group of blastocysts in 
addition to that used for the microarray analysis confirmed the expression profile of 
79% (11/14) of the selected genes (Figure 8). The expression of 9 up-regulated genes 
(MDH2, HSPE1, COX7B, ALDH7A1, POMP, ATPIF1, HSPA14, COX5A and CDC2) 
and 2 down-regulated genes (PNRC2 and CLGN) was found to be significantly different 
between blastocysts derived from superovulated heifers and those derived from 
unstimulated heifers. The expression of TEMTM was not different between the two 
groups and the expression of KRT18 and CPSF3 showed a different pattern than the 
microarray results with no significant differences. 
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Discussion 
The majority of spontaneous human conceptions do not result in a live birth; the 
maximal chance of achieving successful implantation is ~40% per cycle, and this rate 
declines with age (Ferrara et al. 2002, Achard et al. 2005). Similarly, in cattle despite 
high fertilization rates following artificial insemination (>90%), calving rates to a single 
insemination are approximately 55-60% indicating embryonic mortality of about 30-
40%. The majority of this loss is believed to occur prior to maternal recognition of 
pregnancy at Day 16 (Diskin et al. 2006, Diskin and Morris 2008) and is likely to the 
result of a combination of poor embryo quality and suboptimal reproductive tract 
environment (Lonergan 2009). 
We have previously demonstrated that the postfertilization culture environment of the 
bovine embryos can significantly alter the quality of the resulting blastocysts, assessed 
in terms of morphology, cryotolerance and the expression of key candidate genes 
(Lonergan et al. 2003, Rizos et al. 2002). In particular, culture of in vitro-derived bovine 
zygotes in vivo in the sheep (Enright et al. 2000, Rizos et al. 2002) or bovine (Tesfaye 
et al. 2007) oviduct significantly improves the quality of the resulting blastocysts.  
Under normal conditions, the oviduct provides the ideal environment for sperm 
transportation and final capacitation, mature oocyte transportation and fertilization, and 
supports the development of early mammalian embryos. The modification of oviductal 
conditions and/or composition of oviduct fluid caused by ovarian steroids subsequently 
affects the embryonic developmental competence during these critical processes 
(Murray et al. 1995). Thus, understanding the molecular changes that occur in 
preimplantation embryos because of changes in the female reproductive tract 
environment is fundamental to improving pregnancy rates using ART. 
In humans, the luteal phase of all stimulated IVF cycles is abnormal (see review by 
Fatemi 2009). The supra-physiological concentrations of steroids associated with the 
development of multiple dominant follicles during the early luteal phase seems to be the 
main cause of the so-called luteal phase defect in stimulated cycles in women 
undergoing IVF, and this in turn directly inhibits LH release via negative feedback 
actions at the hypothalamic−pituitary axis level (Fauser and Devroey 2003). In addition, 
recent reports have suggested that the neonatal outcome of singletons born after embryo 
cryopreservation was better than those born after fresh embryo transfer (Pinborg et al. 
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2010, Veleva et al. 2009, Shih et al. 2008). Although the reason for the better outcome 
after cryopreservation is not known, adverse effects of hormone stimulation in fresh 
cycles is one of the mechanisms which has been put forward (reviewed by Wennerholm 
et al. 2009). 
Elevated concentrations of circulating progesterone in the immediate post-conception 
period have been associated with an advancement of conceptus elongation (Carter et al. 
2008, Garrett et al. 1988, Satterfield et al. 2006), an associated increase in interferon-tau 
production and higher pregnancy rates in cattle (Inskeep 2004, McNeill et al. 2006, 
Stronge et al. 2005) and sheep (Ashworth et al. 1989, Satterfield et al. 2006). This effect 
is likely a result of downstream effects of well described progesterone-induced changes 
in gene expression in the tissues of the uterus (Bauersachs et al. 2006, Forde et al. 2009, 
Satterfield et al. 2006) resulting in changes in composition of the histotroph to which 
the developing embryo is exposed. Our previous data would suggest that elevated 
progesterone does not influence the proportion of oocytes reaching the blastocyst stage 
(Carter et al. 2008, Clemente et al. 2009). Furthermore, we have more recently shown 
that elevating progesterone concentrations in vivo, within physiological ranges, by 
inserting an intravaginal progesterone-releasing device on day 3 does not alter 
blastocyst developmental rates but does lead to subtle changes in blastocyst gene 
expression (Carter et al. 2010). Here we build on these observations and describe 
significant changes in the global transcriptome of bovine blastocysts, induced by the 
supra-physiological progesterone concentrations associated with superovulation.  
The potential implications of circulating progesterone on the composition of oviduct 
and uterine fluid are interesting but data on the composition of these fluids are sparse. 
Hugentobler et al. (2007, 2008) described the concentration of ions (Na+, K+, Ca+, Mg+, 
Cl-, PO4--, SO4), eighteen amino acids and energy substrates (glucose, lactate, pyruvate) 
in oviduct, uterine fluid and blood throughout the oestrous cycle in beef heifers. More 
recently, the same group (Hugentobler et al. 2010) characterized the effects of changes 
in systemic progesterone on amino acid, ion and energy substrate composition of 
oviduct and uterine fluids on day 3 and day 6, respectively, of the oestrous cycle. 
Infusion of progesterone had no effect on oviduct fluid secretion rate, however, uterine 
fluid secretion rate was lowered. Progesterone increased uterine glucose, decreased 
oviduct sulphate and, to a lesser extent, oviduct sodium but had no effect on any of the 
ions measured in the uterus. The most marked effect of progesterone was on oviductal 
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amino acid concentrations with a 2-fold increase in glycine, while in the uterus only 
valine was increased. These data provide evidence of progesterone regulation of oviduct 
amino acid concentrations in cattle; while the effect of superovulation on oviduct fluid 
composition has not, to our knowledge, been reported, such changes may partly explain 
the differences in embryo development and gene expression observed in the current 
study.  
The number of embryos in the oviducts of unstimulated and stimulated animals in this 
study was different. This is an unavoidable consequence of the inherent individual 
variability in response associated with superstimulation treatments. While, in theory, 
this may have affected development, our previous studies in sheep (Enright et al. 2000, 
Rizos et al. 2002) and cattle (Tesfaye et al. 2007, Rizos et al. 2010) strongly suggest 
that there is a wide range in the number of embryos that can be successfully developed 
in the oviduct (up to 100 embryos) without a deleterious effect on blastocyst 
development. The greater proportion of morula than blastocysts flushed from the 
superovulated heifers at day 7 compared to unstimulated heifers, most likely results 
from a negative effect of hormonal stimulation on embryo developmental rate. In 
support of this fact several studies have shown a delay in embryo developmental rate 
under superovulation conditions in mice (Ertzeid and Storeng 2001, Van der Auwera 
and D'Hooghe 2001, Van der Auwera et al. 1999). Likewise, embryos from 
superovulated hamsters had significantly reduced mean cell numbers and lower viability 
than controls (McKiernan and Bavister 1998). The reasons for the developmental 
retardation, loss of developmental competence and low quality of embryos from 
superovulated donors are still unknown.  
Understanding changes in the molecular profile of embryos developing in different 
oviductal/uterine environments could help to clarify the reasons for the developmental 
retardation and loss of developmental competence of embryos under superovulation 
conditions. To our knowledge, this is the first study to investigate differences in gene 
expression between bovine blastocysts produced in vivo in superovulated versus 
unstimulated conditions. The ‘quiet embryo hypothesis’ put forward by Leese (2002) 
proposed that viable embryos have a ‘quieter’ metabolism than those with less viability. 
This quiet metabolism represents the basal turnover required for normal cellular and 
developmental processes. This quietness can be lost in response to environmental stress 
(Leese et al. 2007, 2008) in which less viable embryos have more molecular/cellular 
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damage or are less well equipped at the transcriptome and proteome levels to cope with 
damage present. Damaged cells may carry out repair and/or resort to rescue strategies or 
undergo apoptosis with the consumption of a greater quantity of nutrients, reflected as a 
more ‘active’ metabolism and consequently cells will expend energy to repair damage 
as part of normal ‘housekeeping’ processes. In agreement with this hypothesis we found 
that the majority of the DEGs were upregulated in blastocysts which developed under 
superovulation conditions. Functional grouping of the DEGs using IPA indicated a 
number of distinct differences between the two groups of blastocysts (Figure 4). A 
higher proportion of genes which were over-expressed in the blastocysts derived from 
superovulated heifers were involved in metabolic processes, including cellular 
metabolic process, macromolecule metabolic process, protein metabolic process and 
RNA metabolic process. Our findings also reveal progressive up-regulation of different 
genes involved in protein synthesis and cellular growth and proliferation processes. 
The increase in metabolic processes as the preimplantation embryo develops to more 
advanced stages has been associated with the increase in energy demand for the 
initiation of the processes of compaction and blastocyst formation (Harvey et al. 2004, 
Thompson et al. 1996). Like most mammalian cells, preimplantation embryos derive 
ATP predominantly by oxidative phosphorylation, initially from pyruvate, lactate and 
amino acids (Leese 1995). Based on our data, oxidative phosphorylation was the main 
pathway and all the DEGs which mapped to this pathway were over-expressed in the 
blastocysts derived from superovulated heifers (Table 5). These genes can be classified 
into 4 main categories representing 4 out of 5 protein complexes involved in the 
pathway: NADH dehydrogenase, cytochrome c reductase and cytochrome c oxidase, 
which are members of electron transport chain complexes, and ATP synthase which is 
the enzyme complex that carries out the oxidative phosphorylation reaction (Fig. 6). 
Bovine pre-elongation embryos are highly dependent on oxidative phosphorylation as 
the primary energy production pathway (ATP generating pathway): this is particularly 
true during pre-compaction development, during which it is estimated that 
approximately 90% of all ATP is derived from oxidation (Thompson et al. 1996). 
During compaction and blastulation, the demand for ATP increases during an increase 
in protein synthesis (Thompson et al. 1998). The increased demand for ATP causes 
increases in consumption of the major substrates, including oxygen, pyruvate and 
glucose (Thompson et al. 1996). There is evidence that the O2 tension of the 
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reproductive tract decreases as the embryo passes from the oviduct to the uterine cavity 
(Fischer and Bavister 1993) and subsequently there is a shift in the metabolic pathway 
preference for embryonic ATP production from oxidative phosphorylation to glycolysis, 
to correspond with development within the uterus, an environment with limited O2 
availability. This shift in metabolic pathway has been reported in human (Gott et al. 
1990) and rat (Brison and Leese 1991) embryos. Partial down-regulation of 
mitochondrial ATP production via oxidative phosphorylation during the compaction 
and blastulation stages improves in vitro development of bovine embryos (Thompson et 
al. 2000). This may indicate that bovine embryos produced in vivo tend to shift the 
metabolic pathway, as in human and rat embryos, during compaction and blastulation 
stages in response to the low O2 tension in the reproductive tract. However, under the 
abnormal endocrine environment associated with superovulation, as reported in this 
study, the oxidative phosphorylation pathway was the main metabolic pathway in 
blastocyst stage embryos. This supports the notion that embryos developing in a 
superovulated environment need more ATP to reach the blastocyst stage and any shift in 
metabolic pathway will not provide the required energy. 
Protein synthesis processes, including transcription and translation, appear to be one of 
the main biological processes which are over-expressed in the blastocysts derived from 
superovulated heifers. One of the main regulatory molecules which is derived from ATP 
and plays an important role in intracellular signal transduction and the induction of 
transcription of many eukaryotic genes is cAMP (Roesler et al. 1988). The downstream 
actions of cAMP are dependent upon its binding to cAMP-dependent protein kinase A 
(PKA) which mediates the intracellular actions of cAMP via phosphorylation of specific 
target proteins (Büchler et al. 1988). In humans and mice, there are four regulatory 
subunit genes: PRKAR1A, PRKAR1B, PRKAR2A, and PRKAR2B. Of the four regulatory 
subunits, PRKAR1A was found to be the most highly and ubiquitously expressed 
(Amieux et al. 2002). In our study, we found that PRKAR1A was highly abundant in the 
blastocysts derived from superovulated heifers. Moreover, one of the networks 
generated by IPA showed the involvement of FSH and LH in the expression of 
PRKAR1A (Fig. 7). In the same network the protein-protein interaction showed a direct 
relationship between PRKAR1A and UQCRB. UQCRB, which is member of the 
ubiquinol-cytochrome-c reductase complex in the oxidative phosphorylation pathway. 
This may explain the indirect relationship between superovulation hormone treatment 
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and the higher abundance of genes involved in oxidative phosphorylation pathway. A 
significant elevation of two heat shock protein transcripts (HSPA14 and HSPE1) was 
noted in blastocysts produced under superovulation conditions. Heat shock proteins play 
a protective role within a cell, also exerting antiapoptotic actions (Betts and King 2001), 
and they also act as molecular chaperones and prevent from protein degradation (Levy 
2001). As expression of the heat shock proteins is induced by stress factors, the 
transcript level reflects both cell response and stress intensity (Neuer et al. 2000). The 
higher expression of HSPA14 and HSPE1 in blastocysts derived from superovulated 
heifers may indicate that the oviductal environment under superovulation conditions 
provided some stress factors to the preimplantation embryos. This stress is may be 
related to an increase in expression of genes related to metabolic processes, protein 
synthesis and ATP production to face the developmental delay which is abnormal when 
compared to embryos produced under normal conditions. In addition, as byproducts of 
oxidative phosphorylation, reactive oxygen species resulting from in situ leakage from 
the mitochondrial electron transport chain are stress factors which can damage cellular 
components including nucleic acids, proteins and membranes (Burton et al. 2003).   
In conclusion, the present study demonstrated the differences in transcriptome profile of 
the blastocysts cultured under different oviductal/uterine conditions, either in 
superovulated heifers until day 7 or in unstimulated heifers from the 2- to 4-cell stage 
onwards. Embryo development under the supra-physiological progesterone 
concentrations which are associated with superovulation was slower compared to that in 
the unstimulated reproductive tract. Microarray analysis revealed that embryos 
developing to the blastocyst stage in superovulated heifers showed significant up-
regulation for most of the DEGs which are involved in metabolic processes, protein 
synthesis and energy production via the oxidative phosphorylation pathway.  
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Table 1 Details of primers used for real-time PCR quantitative analysis. 
 
 
 
 
 
 
 
 
 
Gene Accession 
number Primer sequences 
Annealing 
temperature 
(°C) 
Product 
size (bp) 
 
HSPA14 
 
KRT18 
 
CPSF3 
 
HSPE1 
 
TMEM184B 
 
COX7B 
 
COX5A 
 
ATPIF1 
 
ALDH7A1 
 
POMP 
 
CDC2 
 
MDH2 
 
PNRC2 
 
CLGN 
 
GAPDH 
 
NM_001046388 
 
XM_582930 
 
NM_174284 
 
NM_174346 
 
NM_001081522 
 
NM_175795 
 
AY528254 
 
NM_175816 
 
NM_001045969 
 
NM_001034376 
 
NM_174016 
 
NM_001013587 
 
NM_001076957 
 
NM_001034205 
 
BC102589 
 
F: 5´- GGGAGTTGATGAATCAGGAG -3´ 
R: 5´- AATCTTGGAGCACAACCTGT -3´    
F: 5´- CCTGGACTCCATGAGAAATC -3´ 
R: 5´- CTTGACCTTGACATTCAGCA -3´ 
F: 5´- AATGCACGTTTACAGCAAGA -3´ 
R: 5´- TCTTCACTGCCTTCTTCACA -3´ 
F: 5´- GTGAGAGCAGGGTACGAACT -3´ 
R: 5´- GAATCTCTCCACCCTTTCCT -3´ 
F: 5´- CCTTCCTAGGATGTGTAGCC -3´ 
R: 5´- ACTCATGGCAGTCATACACG -3´ 
F: 5´- TCGTCTGAGAGTTCAAAGCA -3´ 
R: 5´- ATGGGTTCCACTCTATTCCA -3´ 
F: 5´- AGACGAGGAGTTTGATGCTC -3´ 
R: 5´- GAGGTCCTGCTTTGTCCTTA -3´ 
F: 5´- AAGAAATTGAGCGGCATAAG -3´ 
R: 5´- GGAAGCACACAGGTTGATTT -3´ 
F: 5´- AAGGAGGTTCTCCATCTTCC -3´ 
R: 5´- TCAGAGAAAACTTCTGGAGTCA -3´ 
F: 5´- AAATTTCCAGCTCAACCAAG -3´ 
R: 5´- TCATCGTTACCCCTCAAAAT -3´ 
F: 5´- AGCATCCCATGTCAAAAACT -3´ 
R: 5´- TTGACACAACACAGGGAAAC -3´ 
F: 5´- CCCTTTCGAAGAGAAGATGA -3´ 
R: 5´- AGGGGTGGTTCGTTAATACA -3´ 
F: 5´- TTTCGACAGCTTGTGTAACC -3´ 
R: 5´- ACTGGGATGGCTGTTGTAAT -3´ 
F: 5´- AGATGGGCCAATAAAGTCAG -3´ 
R: 5´- AGTAGAAAAGGGGTGTGCAG -3´ 
F: 5´-ACCCAGAAGACTGTGGATGG-3´ 
R: 5´-ACGCCTGCTTCACCACCTTC-3´ 
 
52 
 
52 
 
50 
 
54 
 
54 
 
52 
 
52 
 
50 
 
52 
 
50 
 
50 
 
52 
 
52 
 
52 
 
60 
 
191 
 
190 
 
165 
 
216 
 
164 
 
179 
 
212 
 
154 
 
158 
 
171 
 
178 
 
218 
 
176 
 
151 
 
247 
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Table 2 Overall and structures recovery rate between superovulated and unstimulated heifers. 
 
 
Estimated no. 
CLs 
No. embryo 
transferred 
Structures 
recovered 
Recovery 
rate 
Total transferable  
N (%) 
Morula 
N (%) 
Blastocyst 
N (%) 
Blastocyst/Morula 
Ratio 
 
Superovulated, flushed Day 7(n=10) 
 
187 
 
- 
 
145 
 
0.78* 
 
99 (68.3)a 
 
67 (46.2)a 
 
32 (22.1)a 
 
0.48a 
 
Superovulated, flushed Day 2 (n=9) 
 
177 
 
- 
 
177 
 
1.00* 
 
- 
 
- 
 
- 
 
 
Unstimulated, flushed Day 7 (n=4) 
 
- 
 
164 
 
146 
 
0.89** 
 
76 (52.1)b 
 
27 (18.5)b 
 
49 (33.6)b 
 
1.81b 
- Not applicable 
*Recovery rate = number of structure(s) recovered/number of CL x 100 
**Recovery rate = number of structure(s) recovered/ transferred embryos x 100     
    a,b
 values with different superscripts within columns differ significantly (p < 0.05) 
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Table 3 The functional categories and the corresponding genes that were over-expressed in blastocysts derived from superovulated heifers  
 
 
Functional category p-valuea Transcripts 
 Protein Synthesis 2.75E-10 - 3.66E-02 
RPL24, FN1, RPL27A, PDPK1, RPL31, RPL14, EIF4E, HNRNPK, IGF2BP1, NCL, RPL6, PEPD, RPS3A, 
EIF5, RPL19, ERRFI1, RPL13, RPL3, RPS17, EIF3F, RPL34, RPS19, THOP1, NDUFA13, RPS12, 
LAMP2, RPS10, RPS5, RPL39, RPL28, SNRNP70, AARS, RPL38, UBE2E1, UBE2C, HSPB1, SSB 
 RNA Post-Transcriptional Modification 2.46E-08 - 4.94E-02 
LUC7L3, RPS17, SYNCRIP, RPS28, NOP56, RPS19, RPL14, WDR43, HNRNPD, IMP4, CDC2, ARL6IP4, 
RPS7, CPSF6, WDR75, RPS16, SNRNP70, HNRNPUL1, CPSF3, AARS, LSM4, HNRNPAB, SNRNP40, 
SSB 
 Gene Expression 1.33E-03 - 3.66E-02 AKAP12, FN1, LGALS3, RAC1, PDPK1, KLF13, KLF4, EIF4E, HNRNPK, CDC2, NBN, YY1, SSBP1, SREBF1, EIF5, DAB2, PUF60, CTNNB1, HNRNPAB, LGALS1, SSB 
 Carbohydrate Metabolism 1.74E-03 - 3.66E-02 AP2M1, FN1, KIT, PSAP, ANXA2, NANS, CTNNB1, LGALS1 
 Lipid Metabolism 1.74E-03 - 3.77E-02 GSTP1, AP2M1, ACSL3, RAB4A, FN1, ANXA2, ADH5, EBP, INSIG2, PTGES3, SREBF1, KIT, PSAP, PTGS2, SFN, PDHB, LGALS1, PRDX2 
 Cell-To-Cell Signaling and Interaction 2.36E-03 - 4.46E-02 AP2M1, FN1, C3, LGALS3, RAC1, LGALS4, KLF4, LRPAP1, NCL, KRT8, KRT18, EPCAM, DAB2, DSG2 
DNA Replication, Recombination, and Repair 3.57E-03 - 3.66E-02 MCM6, GSTP1, LMNA, EIF4E, CDC2, MLH1, FUS, NBN, NCL, ATPIF1, YY1, TOP2A, HNRNPAB 
Cellular Growth and Proliferation 6.42E-03 - 4.05E-02 AKAP12, LGALS3, C3, FN1, PA2G4, RPS19, LGALS4, GATA2, KLF4, CTSL2, NCL, EPCAM, KIT, PTGS2, SFN, CTNNB1, SIRT1, UBE2C 
 Energy Production 7.61E-03 - 1.39E-02 ATPIF1, ATP5O, ATP5B, TOP2A, ATP5L, MLH1, CDC2, ATP5I 
 Nucleic Acid Metabolism 7.61E-03 - 1.39E-02 ATPIF1, ATP5O, ATP5B, TOP2A, ATP5L, MLH1, CDC2, ATP5I 
 Vitamin and Mineral Metabolism 1.24E-02 - 3.66E-02 ADH5, EBP, INSIG2 
 Molecular Transport 2.25E-02 - 3.66E-02 UROD, FN1, RAB4A, PRDX1, PRDX5, PSAP, PTGS2, LGALS1, PRDX2 
 Amino Acid Metabolism 3.66E-02 - 3.66E-02 ADH5, ANXA2 
aNumbers in the p-value column showed a range of p-values for the genes from each category 
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Table 4 The canonical pathways from the Ingenuity Pathway Analysis Knowledge Base that involve transcripts over-expressed in the blastocyst 
derived from superovulated heifers  
 
 
 
 
 
 
 
 
 
Pathway -Log (P-value) Ratio Transcripts 
 
Oxidative Phosphorylation 
 
15.17 
 
0.157 
 
ATP5B, ATP5G3, ATP5H, ATP5I, ATP5L, ATP5O, ATP6VOD2, COX4I1, COX5A, COX7B, CYC1, NDUFA1, 
NDUFA5, NDUFA6, NDUFA12, NDUFA13, NDUFA9, NDUFB2, NDUFB8, NDUFB10, NDUFC2, NDUFS2, 
NDUFV1, UCRC, UQCR, UQCRB  
Ubiquinone Biosynthesis 7.23 0.109 FTSJ2, NDUFA1, NDUFA5, NDUFA6, NDUFA12, NDUFA13, NDUFA9, NDUFB2, NDUFB8, NDUFB10, 
NDUFC2, NDUFS2, NDUFV1  
Methan Metabolism 2.07 0.045 PRDX1, PRDX2, PRDX5 
Integrin-linked kinase  
Signalling 
2.03 0.059 ACTB, ACTN1, CTNNB1, FN1, GSK3A, KRT18, MYL6, PDPK1, PPP2R5E, PTGS2, RAC1   
Pentose Phosphate Pathway 1.85 0.045 PDHB, PRPSAP2, RBKS, TKT 
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Table 5 Gene symbol, Affymetrix probe ID, gene description and fold change of transcripts involved in oxidative phosphorylation 
pathway and up-regulated with ≥2 fold change in blastocysts derived from superovulated heifers. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Gene Symbol Affy Probe ID Gene description Fold change 
 
NDUFA6 Bt.63.1.S1_at NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 6, 14kDa 7.5 
COX7B Bt.400.1.S1_at cytochrome c oxidase subunit VIIb 7.3 
COX5A Bt.9826.1.S1_at COX5A protein 7.2 
ATP5B Bt.4431.1.S1_a_at ATP synthase, H+ transporting, mitochondrial F1 complex, beta polypeptide 6.2 
UCRC Bt.1819.1.S1_at ubiquinol-cytochrome c reductase complex 7.2 kDa protein 5.6 
UQCR Bt.5040.1.S1_at ubiquinol-cytochrome c reductase (6.4kD) subunit 5.7 
ATP5G3 Bt.8047.1.S1_at ATP synthase, H+ transporting, mitochondrial F0 complex, subunit C3 (subunit 9) 5.3 
NDUFA12 Bt.298.1.S1_at NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 12 4.4 
COX4 Bt.16025.1.S1_at cytochrome c oxydase subunit 4 4.2 
NDUFA1 Bt.69.1.S1_at NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 1, 7.5kDa 4.0 
NDUFA5 Bt.4704.1.S1_at NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 5, 13kDa 3.5 
ATP5I Bt.378.1.S1_at ATP synthase, H+ transporting, mitochondrial F0 complex, subunit e 3.4 
NDUFB2 Bt.60.1.S1_at NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 2, 8kDa 3.2 
NDUFC2 Bt.21.1.S1_at NADH dehydrogenase (ubiquinone) 1, subcomplex unknown, 2, 14.5kDa 3.1 
ATP5O Bt.442.1.S1_at ATP synthase, H+ transporting, mitochondrial F1 complex, O subunit 3.0 
ATP5L Bt.2816.1.S1_at ATP synthase, H+ transporting, mitochondrial F0 complex, subunit G 3.0 
NDUFB8 Bt.5378.1.S1_at NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 8, 19kDa 2.9 
UQCRB Bt.25083.1.A1_at Ubiquinol-cytochrome c reductase binding protein 2.8 
NDUFA13 Bt.8950.1.S1_at NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 13 2.4 
NDUFS2 Bt.4475.1.S1_at NADH dehydrogenase (ubiquinone) Fe-S protein 2, 49kDa  2.3 
CYC1 Bt.1808.1.S1_at cytochrome c-1 2.2 
ATP6V0D2 Bt.11010.1.S1_at ATPase, H+ transporting, lysosomal 38kDa, V0 subunit d2 2.2 
NDUFV1 Bt.4072.1.S1_at NADH dehydrogenase (ubiquinone) flavoprotein 1, 51kDa 2.2 
NDUFB10 Bt.70.1.S1_at NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 10, 22kDa 2.1 
NDUFA9 Bt.5541.1.S1_at NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 9, 39kDa 2.1 
ATP5H Bt.5029.1.S1_at ATP synthase, H+ transporting, mitochondrial F0 complex, subunit d 2.1 
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Table S1 Gene symbol, Affymetrix probe ID, gene description and fold change of DEGs with ≥2 fold difference in blastocysts 
derived from superovulated heifers. 
Gene Symbol Affy Probe ID Gene description Fold 
change 
IFT122 Bt.8829.1.S1_at intraflagellar transport 122 homolog (Chlamydomonas) 28.1 
ZNF238 Bt.15860.1.S1_at zinc finger protein 238 20.8 
HSPA14 Bt.19575.1.S1_at heat shock 70kDa protein 14 16.6 
KRT18 Bt.1745.1.S1_at keratin 18 14.8 
LOC517284 Bt.16595.1.A1_at Similar to Protein piccolo (Aczonin) 13.6 
CPSF3 Bt.5045.1.S1_at cleavage and polyadenylation specific factor 3, 73kDa 12.2 
PTGES3 Bt.7247.1.S1_at prostaglandin E synthase 3 (cytosolic) 12.1 
NAT11 Bt.15937.1.A1_at N-acetyltransferase 11 11.1 
AGPAT5 Bt.22170.2.A1_at 1-acylglycerol-3-phosphate O-acyltransferase 5 (lysophosphatidic acid acyltransferase, epsilon) 10.5 
MKRN1 Bt.11395.1.A1_at makorin ring finger protein 1 10.2 
LOC533514 Bt.7150.2.S1_at Similar to KIAA1289 protein 10.1 
HSPE1 Bt.504.1.S1_at heat shock 10kDa protein 1 (chaperonin 10) 9.7 
HNRNPUL1 Bt.21035.2.S1_a_at heterogeneous nuclear ribonucleoprotein U-like 1 9.5 
JARID2 Bt.7008.1.S1_at jumonji, AT rich interactive domain 2 9.5 
CISD1 Bt.10154.1.S1_at CDGSH iron sulfur domain 1 9.1 
RPS17 Bt.3839.1.S1_at ribosomal protein S17 9.0 
MAPT Bt.2289.1.S1_at microtubule-associated protein tau 8.7 
TMEM184B Bt.10312.1.A1_at transmembrane protein 184B 8.7 
MYO1D Bt.22679.1.S1_at myosin ID 8.6 
LOC540136  Bt.5542.1.A1_at similar to Nucleosome assembly protein 1-like 1 (NAP-1-related protein) (hNRP)  8.6 
GOLGA4 Bt.26662.1.S1_at golgi autoantigen, golgin subfamily a, 4 8.4 
POLR2F Bt.11138.1.S1_at polymerase (RNA) II (DNA directed) polypeptide F 8.3 
SLC30A5 Bt.26811.1.S1_at Solute carrier family 30 (zinc transporter), member 5 8.2 
KIT Bt.26445.1.A1_at V-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog 8.2 
HSPA8 Bt.12309.1.S1_at heat shock 70kDa protein 8 8.0 
LOC100138102 Bt.9459.1.S1_at similar to 3-phosphoinositide-dependent protein kinase 1 (hPDK1) 7.9 
PAN3 Bt.1861.1.S1_at PAN3 polyA specific ribonuclease subunit homolog (S. cerevisiae) 7.8 
CCDC47 Bt.15698.2.A1_at Coiled-coil domain containing 47 7.8 
LOC784987 Bt.16464.1.A1_at Hypothetical protein LOC784987 7.7 
PSAP Bt.5467.1.S2_at prosaposin 7.5 
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Gene Symbol Affy Probe ID Gene description Fold 
change 
NDUFA6 Bt.63.1.S1_at NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 6, 14kDa 7.5 
COX7B Bt.400.1.S1_at cytochrome c oxidase subunit VIIb 7.3 
CALM3 Bt.12896.1.S1_at calmodulin 3 (phosphorylase kinase, delta) 7.3 
LOC533514 Bt.7150.1.S1_at Similar to KIAA1289 protein 7.2 
HNRNPF Bt.23314.1.A1_s_at heterogeneous nuclear ribonucleoprotein F 7.2 
COX5A Bt.9826.1.S1_at COX5A protein 7.2 
RPL6 Bt.5348.1.S2_at ribosomal protein L6 7.0 
RAB11A Bt.19522.1.S1_at RAB11A, member RAS oncogene family 7.0 
C18H16ORF61 /// 
LOC100138086 Bt.29655.1.S1_a_at chromosome 16 open reading frame 61 ortholog /// similar to MGC137594 protein 6.9 
RANBP1 Bt.8189.2.A1_at RAN binding protein 1 6.8 
ATPIF1 Bt.380.1.S1_at ATPase inhibitory factor 1 6.7 
ANKS1A Bt.19167.1.A1_at Ankyrin repeat and sterile alpha motif domain containing 1A 6.7 
CLTA Bt.1617.2.S1_a_at clathrin, light chain (Lca) 6.6 
HSD17B11 Bt.11993.1.S1_at hydroxysteroid (17-beta) dehydrogenase 11 6.5 
H11CXORF26 Bt.24704.1.S1_at Chromosome X open reading frame 26 ortholog 6.5 
RPL13A Bt.1432.1.S1_a_at ribosomal protein L13a 6.4 
LMNA Bt.28432.1.S1_at lamin A/C 6.4 
RPL38 Bt.7658.1.S1_at ribosomal protein L38 6.4 
RPS24 Bt.8015.1.S1_a_at ribosomal protein S24 6.4 
LOC518469 Bt.20788.1.A1_at Similar to RP5-1022P6.2 6.3 
VPS53 Bt.13360.1.S1_at vacuolar protein sorting 53 homolog (S. cerevisiae) 6.3 
USMG5 Bt.5571.1.S1_at up-regulated during skeletal muscle growth 5 homolog (mouse) 6.3 
PA2G4 Bt.4896.2.S1_at proliferation-associated 2G4, 38kDa 6.3 
CLIC1 Bt.23174.2.S1_at chloride intracellular channel 1 6.3 
ATP5B Bt.4431.1.S1_a_at ATP synthase, H+ transporting, mitochondrial F1 complex, beta polypeptide 6.2 
TOPORS Bt.15703.1.S1_at topoisomerase I binding, arginine/serine-rich 6.2 
SUZ12 Bt.24502.1.S1_at suppressor of zeste 12 homolog (Drosophila) 6.1 
MGC128036 Bt.9457.1.S1_at similar to COX17 homolog, cytochrome c oxidase assembly protein 6.1 
CROP Bt.1595.1.S1_at cisplatin resistance-associated overexpressed protein 6.1 
UBA6 Bt.2174.2.A1_at Ubiquitin-like modifier activating enzyme 6 6.1 
RPL36A  Bt.9814.1.S1_at ribosomal protein L36a /// similar to mCG7611 6.1 
TOP2A Bt.20277.1.S1_at topoisomerase (DNA) II alpha 170kDa 6.0 
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Gene Symbol Affy Probe ID Gene description Fold 
change 
PRDX1 Bt.1823.1.S1_at peroxiredoxin 1 6.0 
CPT2 Bt.1065.1.S1_at carnitine palmitoyltransferase II 5.9 
C3 Bt.4209.2.S1_at complement component 3 5.9 
PPP2R5E Bt.1549.2.S1_at protein phosphatase 2, regulatory subunit B', epsilon isoform 5.7 
CCDC72 /// 
MGC148581 Bt.6032.1.S1_s_at coiled-coil domain containing 72 /// hypothetical LOC615251 5.7 
RPL34 Bt.23548.1.S1_at ribosomal protein L34 5.7 
UQCR Bt.5040.1.S1_at ubiquinol-cytochrome c reductase (6.4kD) subunit 5.7 
TKT Bt.4750.1.S1_at transketolase 5.7 
UCRC Bt.1819.1.S1_at ubiquinol-cytochrome c reductase complex 7.2 kDa protein 5.6 
RPL27 Bt.4721.1.S1_at ribosomal protein L27 5.5 
SAFB2 Bt.8079.1.S1_a_at scaffold attachment factor B2 5.4 
RPL27A Bt.23343.2.S1_a_at ribosomal protein L27a 5.3 
ATP5G3 Bt.8047.1.S1_at ATP synthase, H+ transporting, mitochondrial F0 complex, subunit C3 (subunit 9) 5.3 
HSPA4 Bt.22168.1.A1_at heat shock 70kDa protein 4 5.3 
RPS13 Bt.2623.1.S1_at ribosomal protein S13 5.3 
BSG Bt.3791.1.S1_at basigin 5.3 
GSK3A Bt.1147.1.S1_at glycogen synthase kinase 3 alpha 5.3 
MRPS31 Bt.13610.1.A1_at mitochondrial ribosomal protein S31 5.2 
ALDH7A1 Bt.22086.2.A1_at aldehyde dehydrogenase 7 family, member A1 5.2 
THOP1 Bt.21827.1.A1_s_at thimet oligopeptidase 1 5.2 
TACSTD1 Bt.9569.1.S1_at tumor-associated calcium signal transducer 1 5.2 
ACTN1 Bt.7700.1.S1_at actinin, alpha 1 5.2 
TMSB10 Bt.2798.1.S1_a_at thymosin beta 10 5.1 
POMP Bt.6111.1.S1_at proteasome maturation protein 5.1 
RPS20 Bt.23001.1.S1_a_at ribosomal protein S20 5.0 
EBP Bt.3786.1.S1_a_at emopamil binding protein (sterol isomerase) 5.0 
LOC505221 Bt.28640.1.A1_at similar to BTB/POZ domain-containing protein KCTD3 (Renal carcinoma antigen NY-REN-45) 5.0 
RPLP2 Bt.5346.1.S1_at ribosomal protein, large, P2 4.9 
KRT8 Bt.23608.1.S1_s_at keratin 8 4.8 
TNRC6C Bt.19479.2.A1_a_at trinucleotide repeat containing 6C 4.8 
ERCC6L Bt.7620.1.S1_at excision repair cross-complementing rodent repair deficiency, complementation group 6-like 4.7 
RPLP1 Bt.8125.1.S1_a_at ribosomal protein, large, P1 4.7 
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Gene Symbol Affy Probe ID Gene description Fold 
change 
GATA2 Bt.6408.2.A1_at GATA binding protein 2 4.7 
FN1 Bt.23418.1.S1_at fibronectin 1 4.7 
BZW1 Bt.20692.1.A1_at Basic leucine zipper and W2 domains 1 4.7 
WDR43 Bt.6782.1.A1_at WD repeat domain 43 4.7 
SLC25A5 Bt.9559.1.S1_at solute carrier family 25 (mitochondrial carrier; adenine nucleotide translocator), member 5 4.6 
CKB Bt.5084.1.S1_at creatine kinase, brain 4.6 
KIAA1715 Bt.26009.1.A1_at KIAA1715 4.6 
SSB Bt.15513.1.S1_at Sjogren syndrome antigen B (autoantigen La) 4.6 
DAB2 Bt.3814.1.S1_at Disabled homolog 2, mitogen-responsive phosphoprotein (Drosophila) 4.6 
LASP1  Bt.7980.1.S1_at LIM and SH3 protein 1 /// similar to LIM and SH3 protein 1 4.6 
EZR Bt.3583.1.S1_at ezrin 4.5 
CD99 Bt.13829.1.S1_at CD99 molecule 4.5 
SAPS1 Bt.21710.1.S1_at SAPS domain family, member 1 4.5 
NDUFA12 Bt.298.1.S1_at NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 12 4.4 
DCP1B Bt.24459.1.A1_at DCP1 decapping enzyme homolog B (S. cerevisiae) 4.4 
MRPL22 Bt.17490.1.S1_a_at mitochondrial ribosomal protein L22 4.4 
ZNF207 Bt.13679.1.S1_at zinc finger protein 207 4.4 
RPS10 Bt.3921.1.S1_at ribosomal protein S10 4.4 
LOC100141158 Bt.11588.1.A1_at similar to ubiquitin specific protease 48 4.4 
PPHLN1 Bt.27337.1.S1_at Periphilin 1 4.4 
RPS28 Bt.22772.1.S1_at ribosomal protein S28 4.3 
LOC654400 Bt.24023.1.A1_at GATA-6 4.3 
TAF9 Bt.1121.1.S1_at TAF9 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 32kDa 4.3 
THOC4 Bt.1768.1.A1_at THO complex 4 4.3 
LOC613525 Bt.7358.1.S1_at similar to Selenoprotein H 4.3 
LOC616065 Bt.4283.1.S1_at similar to 60S ribosomal protein L22 (Heparin binding protein HBp15) 4.2 
RPS3A Bt.4967.1.S1_at ribosomal protein S3A 4.2 
COX4 Bt.16025.1.S1_at cytochrome c oxydase subunit 4 4.2 
RPS21 Bt.12469.1.S1_at ribosomal protein S21 4.2 
HSPB1 Bt.4415.1.S1_at heat shock 27kDa protein 1 4.2 
NARS Bt.6688.1.S1_at asparaginyl-tRNA synthetase 4.2 
SYNCRIP Bt.23038.1.A1_at Synaptotagmin binding, cytoplasmic RNA interacting protein 4.2 
RPS12 Bt.1269.1.S1_a_at ribosomal protein S12 4.1 
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Gene Symbol Affy Probe ID Gene description Fold 
change 
RPS5 Bt.1874.1.S1_at ribosomal protein S5 4.1 
FBXL11 Bt.9278.1.S1_at F-box and leucine-rich repeat protein 11 4.1 
EFHD2 Bt.15561.1.S1_at EF-hand domain family, member D2 4.1 
UQCRB Bt.23361.1.S1_at Ubiquinol-cytochrome c reductase binding protein 4.1 
CDC2 Bt.2.1.S1_at cell division cycle 2, G1 to S and G2 to M 4.1 
NME2 Bt.1582.1.S1_at non-metastatic cells 2, protein (NM23B) expressed in 4.1 
ADH5 Bt.2561.1.S1_at alcohol dehydrogenase 5 (class III), chi polypeptide 4.1 
AHCYL2 Bt.15900.1.A1_at S-adenosylhomocysteine hydrolase-like 2 4.1 
TFRC Bt.13834.1.S1_at transferrin receptor (p90, CD71) 4.0 
SLC11A2 Bt.8364.1.S1_at solute carrier family 11 (proton-coupled divalent metal ion transporters), member 2 4.0 
DSTN Bt.15705.1.S1_at destrin (actin depolymerizing factor) 4.0 
MDH2 Bt.7915.1.S1_at malate dehydrogenase 2, NAD (mitochondrial) 4.0 
FAM60A Bt.15602.1.S1_at family with sequence similarity 60, member A 4.0 
NDUFA1 Bt.69.1.S1_at NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 1, 7.5kDa 4.0 
ACTB Bt.14186.1.S1_at actin, beta 3.9 
RPL14 Bt.15931.1.S1_at ribosomal protein L14 3.9 
DSG2 Bt.16441.1.A1_at desmoglein 2 3.9 
RBM26 Bt.14007.3.A1_at RNA binding motif protein 26 3.8 
UBE2E1 Bt.13684.1.S1_at ubiquitin-conjugating enzyme E2E 1 (UBC4/5 homolog, yeast) 3.8 
PTPN2 Bt.24652.1.A1_at protein tyrosine phosphatase, non-receptor type 2 3.8 
LGALS4 Bt.9082.1.S1_at lectin, galactoside-binding, soluble, 4 3.8 
LRPAP1 Bt.2982.1.S1_at low density lipoprotein receptor-related protein associated protein 1 3.8 
LOC504861 Bt.6372.1.A1_at similar to cationic amino acid transporter 5 3.8 
LOC532409 Bt.11711.1.A1_at similar to high-mobility group box 3 3.8 
RPL28 Bt.1226.1.S1_a_at ribosomal protein L28 3.8 
ANXA2 Bt.4314.1.S1_at annexin A2 3.7 
FCF1 Bt.20900.1.S1_at FCF1 small subunit (SSU) processome component homolog (S. cerevisiae) 3.7 
HNRNPD Bt.3809.2.S1_a_at heterogeneous nuclear ribonucleoprotein D (AU-rich element RNA binding protein 1, 37kDa) 3.7 
TAF13 Bt.26935.1.A1_at TAF13 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 18kDa 3.7 
WDR57 Bt.20560.1.S1_at WD repeat domain 57 (U5 snRNP specific) 3.7 
PSMB4 Bt.4966.1.S1_at proteasome (prosome, macropain) subunit, beta type, 4 3.7 
C15H11orf46 Bt.24242.1.S1_at chromosome 11 open reading frame 46 ortholog 3.7 
LSM4 Bt.20499.1.S1_at LSM4 homolog, U6 small nuclear RNA associated (S. cerevisiae) 3.7 
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Gene Symbol Affy Probe ID Gene description Fold 
change 
NOL5A Bt.10277.2.S1_a_at nucleolar protein 5A (56kDa with KKE/D repeat) 3.7 
RPL36 Bt.14228.1.S1_at ribosomal protein L36 3.7 
RPL21 Bt.5211.1.S1_at ribosomal protein L21 3.7 
PRDX2 Bt.2689.1.S1_at peroxiredoxin 2 3.7 
OXA1L Bt.1719.1.S1_at oxidase (cytochrome c) assembly 1-like 3.6 
RBM47 Bt.22438.1.S1_at RNA binding motif protein 47 3.6 
EIF4E Bt.1148.1.S1_at eukaryotic translation initiation factor 4E 3.6 
ARS2 Bt.20029.1.S1_at arsenate resistance protein 2 3.6 
LGALS3 Bt.1416.1.S1_at lectin, galactoside-binding, soluble, 3 3.6 
RPL36A /// RPL36AL Bt.3404.1.S1_at ribosomal protein L36a /// similar to mCG7611 /// ribosomal protein L36a-like 3.6 
PICALM Bt.9107.1.S1_a_at phosphatidylinositol binding clathrin assembly protein 3.6 
MTBP Bt.26326.1.A1_at Mdm2, transformed 3T3 cell double minute 2, p53 binding protein (mouse) binding protein, 104kDa 3.6 
HINT2 Bt.11196.1.S1_at histidine triad nucleotide binding protein 2 3.6 
NANS Bt.3388.1.S1_at N-acetylneuraminic acid synthase 3.6 
NDUFA5 Bt.4704.1.S1_at NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 5, 13kDa 3.5 
FUS Bt.2474.1.S1_at fusion (involved in t(12;16) in malignant liposarcoma) 3.5 
H3F3A /// H3F3B Bt.5388.1.S1_at H3 histone, family 3A /// similar to Histone H3.3B CG8989-PA 3.5 
UBE2O Bt.24878.1.A1_at ubiquitin-conjugating enzyme E2O 3.5 
SR140 Bt.6832.1.S1_at U2-associated SR140 protein 3.5 
NCL Bt.7403.1.S1_at Nucleolin 3.5 
HERC4 Bt.15687.1.S1_at Hect domain and RLD 4 3.5 
RPS7 Bt.7187.1.S1_at ribosomal protein S7 3.5 
RPS8 Bt.1034.1.S1_at ribosomal protein S8 3.5 
PTRH2 Bt.15787.1.S1_at peptidyl-tRNA hydrolase 2 3.5 
DC2 Bt.3114.1.A1_at DC2 protein 3.5 
MGC165939 Bt.17889.1.A1_at Hypothetical LOC517231 3.4 
ATP5I Bt.378.1.S1_at ATP synthase, H+ transporting, mitochondrial F0 complex, subunit e 3.4 
SFRS9 Bt.23552.1.S1_at splicing factor, arginine/serine-rich 9 3.4 
TMED7 Bt.12099.1.A1_at Transmembrane emp24 protein transport domain containing 7 3.4 
SCPEP1 Bt.6357.1.S1_at serine carboxypeptidase 1 3.4 
EIF3C Bt.2516.1.S1_at eukaryotic translation initiation factor 3, subunit C 3.4 
C10H14orf179 Bt.18569.1.A1_at chromosome 14 open reading frame 179 ortholog 3.4 
ABCB6 Bt.14310.1.S1_a_at ATP-binding cassette, sub-family B (MDR/TAP), member 6 3.3 
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WDR82 Bt.24362.1.A1_at WD repeat domain 82 3.3 
RAB11FIP4 Bt.5300.1.S1_at RAB11 family interacting protein 4 (class II) 3.3 
GLTSCR2 Bt.1429.3.A1_s_at glioma tumor suppressor candidate region gene 2 3.3 
Rpl3 Bt.3616.1.S1_at ribosomal protein L3 3.3 
CASK Bt.6686.1.S1_at calcium/calmodulin-dependent serine protein kinase (MAGUK family) 3.3 
LOC535156 Bt.9425.3.A1_at Similar to presenilin-like protein 4 3.2 
WDR75 Bt.28680.1.S1_at WD repeat domain 75 3.2 
SREBF1 Bt.15667.1.S1_at Sterol regulatory element binding transcription factor 1 3.2 
ANLN Bt.4995.1.A1_at anillin, actin binding protein 3.2 
ATP5E Bt.5510.1.S1_at ATP synthase, H+ transporting, mitochondrial F1 complex, epsilon subunit 3.2 
RPL13 Bt.23317.1.S1_at ribosomal protein L13 3.2 
OSTF1 Bt.2888.1.S1_at osteoclast stimulating factor 1 3.2 
HNRNPAB Bt.3928.1.S1_at heterogeneous nuclear ribonucleoprotein A/B 3.2 
RBM39 Bt.12348.1.A1_at RNA binding motif protein 39 3.2 
RPS16 Bt.2686.1.S1_at ribosomal protein S16 3.2 
DNMT3A Bt.22981.1.S1_at DNA (cytosine-5-)-methyltransferase 3 alpha 3.2 
NDUFB2 Bt.60.1.S1_at NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 2, 8kDa 3.2 
CTSL2 Bt.3987.1.S1_at cathepsin L2 3.2 
NBN Bt.24703.1.S1_at Nibrin 3.2 
C22H3orf60 Bt.8279.2.S1_at Chromosome 3 open reading frame 60 ortholog 3.1 
NDUFC2 Bt.21.1.S1_at NADH dehydrogenase (ubiquinone) 1, subcomplex unknown, 2, 14.5kDa 3.1 
ARL6IP4 Bt.20547.1.S1_a_at ADP-ribosylation-like factor 6 interacting protein 4 3.1 
CTBP2 Bt.6440.1.S1_at C-terminal binding protein 2 3.1 
C7H5orf32 Bt.10278.1.S1_at chromosome 5 open reading frame 32 ortholog 3.1 
GPRC5C Bt.21454.1.S1_at G protein-coupled receptor, family C, group 5, member C 3.1 
BZW2 Bt.5495.1.S1_at basic leucine zipper and W2 domains 2 3.1 
DYRK1A Bt.27934.1.S1_at dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 1A 3.1 
PRKAR1A Bt.10903.2.S1_at protein kinase, cAMP-dependent, regulatory, type I, alpha (tissue specific extinguisher 1) 3.1 
ALAD Bt.9585.1.S1_at aminolevulinate, delta-, dehydratase 3.1 
INSIG2 Bt.20716.2.A1_at insulin induced gene 2 3.1 
NBEAL1 Bt.16647.1.S1_at neurobeachin-like 1 3.1 
UBE2C Bt.2725.1.S1_at ubiquitin-conjugating enzyme E2C 3.1 
CCDC59 Bt.13559.1.S1_at coiled-coil domain containing 59 3.1 
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PDPN Bt.12295.1.S1_at podoplanin 3.0 
ATP5L Bt.2816.1.S1_at ATP synthase, H+ transporting, mitochondrial F0 complex, subunit G 3.0 
IDH2 Bt.5520.1.S1_at isocitrate dehydrogenase 2 (NADP+), mitochondrial 3.0 
MYL6 Bt.2847.1.S1_a_at myosin, light chain 6, alkali, smooth muscle and non-muscle 3.0 
ATP5O Bt.442.1.S1_at ATP synthase, H+ transporting, mitochondrial F1 complex, O subunit 3.0 
COL11A2 Bt.4741.1.S1_at collagen, type XI, alpha 2 3.0 
RPL39 Bt.9548.1.S1_at ribosomal protein L39 3.0 
SIRT1 Bt.20465.1.S1_at sirtuin (silent mating type information regulation 2 homolog) 1 (S. cerevisiae) 2.9 
ZNRF1 Bt.15887.2.S1_a_at zinc and ring finger 1 2.9 
LGALS1 Bt.5472.1.S1_at lectin, galactoside-binding, soluble, 1 2.9 
RPL23 Bt.3091.1.S1_at ribosomal protein L23 2.9 
NDUFB8 Bt.5378.1.S1_at NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 8, 19kDa 2.9 
ELMO2 Bt.26400.1.A1_at engulfment and cell motility 2 2.9 
RBM8A Bt.6706.1.S1_at RNA binding motif protein 8A 2.9 
PEPD Bt.3082.1.S1_at peptidase D 2.9 
CTNNB1 Bt.1125.1.S1_at catenin (cadherin-associated protein), beta 1, 88kDa 2.9 
LOC535277 Bt.9589.1.S1_at hypothetical LOC535277 2.9 
LOC530342 Bt.6001.1.S1_s_at similar to Chromosome 16 open reading frame 24 2.9 
PAK1IP1 Bt.27921.1.S1_at PAK1 interacting protein 1 2.9 
ARPC2  Bt.6846.1.S1_at actin related protein 2/3 complex, subunit 2, 34kDa /// similar to actin related protein 2/3 complex subunit 2 2.9 
SLC15A4 Bt.20185.1.A1_at solute carrier family 15, member 4 2.8 
LOC784459 Bt.6063.1.S1_at Similar to Heat shock 70kDa protein 9B (mortalin-2) 2.8 
LOC533763 Bt.6589.1.A1_at Similar to glycogen branching enzyme 2.8 
UQCRB Bt.25083.1.A1_at Ubiquinol-cytochrome c reductase binding protein 2.8 
MGC152585 Bt.13422.2.A1_at Hypothetical LOC507035 2.8 
LZTFL1 Bt.22150.2.S1_at leucine zipper transcription factor-like 1 2.8 
LOC614731 Bt.13966.1.S1_at similar to BolA-like protein 2 2.8 
ABCA9 Bt.8673.1.S1_a_at ATP-binding cassette, sub-family A (ABC1), member 9 2.8 
EIF3F Bt.21463.1.S1_at eukaryotic translation initiation factor 3, subunit F 2.8 
YY1 Bt.1718.3.S1_at YY1 transcription factor 2.8 
GSTP1 Bt.13949.1.S1_at glutathione S-transferase pi 1 2.8 
CPSF6 Bt.27146.1.A1_at Cleavage and polyadenylation specific factor 6, 68kDa 2.7 
RER1 Bt.7896.1.S1_at RER1 retention in endoplasmic reticulum 1 homolog (S. cerevisiae) 2.7 
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MLH1 Bt.5658.1.S1_s_at mutL homolog 1, colon cancer, nonpolyposis type 2 (E. coli) 2.7 
EIF5 Bt.9042.1.A1_at eukaryotic translation initiation factor 5 2.7 
NUPL1 Bt.17812.1.S1_at nucleoporin like 1 2.7 
PUF60 Bt.5143.1.A1_at poly-U binding splicing factor 60KDa 2.7 
C8H9orf80 Bt.14380.1.S1_at Chromosome 9 open reading frame 80 ortholog 2.6 
LOC511121 Bt.6419.1.S1_at 
Similar to Ubiquitin carboxyl-terminal hydrolase 47 (Ubiquitin thioesterase 47) (Ubiquitin-specific-processing 
protease 47) (Deubiquitinating enzyme 47) 2.6 
CCT3 Bt.5096.1.S1_at chaperonin containing TCP1, subunit 3 (gamma) 2.6 
ATP6V1D Bt.3998.1.S1_at ATPase, H+ transporting, lysosomal 34kDa, V1 subunit D 2.6 
SS18L2 Bt.20445.1.S1_at synovial sarcoma translocation gene on chromosome 18-like 2 2.6 
SFN Bt.9957.1.S1_at stratifin 2.6 
LUC7L Bt.13181.9.S1_at LUC7-like (S. cerevisiae) 2.6 
RPL31 Bt.1601.1.S1_at ribosomal protein L31 2.6 
HCCS Bt.26718.1.S1_a_at holocytochrome c synthase 2.6 
RAB18 Bt.13979.1.S1_at RAB18, member RAS oncogene family 2.6 
CCDC127 Bt.3386.1.S1_at coiled-coil domain containing 127 2.6 
GHDC Bt.9402.1.S1_at GH3 domain containing 2.6 
RPL19 Bt.23191.1.S1_at ribosomal protein L19 2.6 
AARS Bt.12364.1.S1_at alanyl-tRNA synthetase 2.6 
SLC6A20 Bt.28747.1.S1_at Solute carrier family 6 (proline IMINO transporter), member 20 2.6 
LOC782444 Bt.27075.1.A1_at similar to tripartite motif-containing 8 2.5 
VPS37C Bt.9228.1.A1_at vacuolar protein sorting 37 homolog C (S. cerevisiae) 2.5 
COX6B Bt.75.1.S1_at cytochrome c oxidase subunit VIb 2.5 
RNASEH2C Bt.21833.1.S1_at ribonuclease H2, subunit C 2.5 
TGIF1 Bt.20778.3.A1_at TGFB-induced factor homeobox 1 2.5 
ERRFI1 Bt.23905.2.S1_at ERBB receptor feedback inhibitor 1 2.5 
IMP4 Bt.5241.1.S1_at IMP4, U3 small nucleolar ribonucleoprotein, homolog (yeast) 2.5 
FTSJ2 Bt.20021.1.S1_at FtsJ homolog 2 (E. coli) 2.5 
KLF4 Bt.1424.1.S1_at Kruppel-like factor 4 (gut) 2.5 
LOC767909 Bt.23496.1.S1_at 6.8 kDa mitochondrial proteolipid 2.5 
HNRPK Bt.3183.3.A1_at Heterogeneous nuclear ribonucleoprotein K 2.5 
RPL10A Bt.23381.1.S1_at ribosomal protein L10a 2.5 
TP53I13 Bt.11370.1.A1_at tumor protein p53 inducible protein 13 2.5 
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CCNC Bt.16826.1.A1_s_at cyclin C 2.4 
PTGS2 Bt.15758.1.S1_at prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) 2.4 
NOL7 Bt.4096.1.S1_s_at nucleolar protein 7, 27kDa 2.4 
IFT122 Bt.8829.1.S1_a_at intraflagellar transport 122 homolog (Chlamydomonas) 2.4 
PSMA6 Bt.15837.1.S1_at proteasome (prosome, macropain) subunit, alpha type, 6 2.4 
AKAP12 Bt.10458.2.S1_at A kinase (PRKA) anchor protein (gravin) 12 2.4 
RBKS Bt.13335.1.S1_at ribokinase 2.4 
EEF1G Bt.3631.1.S1_at eukaryotic translation elongation factor 1 gamma 2.4 
RPS19 Bt.7648.1.S1_at ribosomal protein S19 2.4 
NDUFA13 Bt.8950.1.S1_at NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 13 2.4 
ERAS Bt.21077.1.S1_at ES cell expressed Ras 2.4 
PHF3 Bt.15306.1.A1_at PHD finger protein 3 2.4 
NT5DC1 Bt.18484.1.A1_at 5'-nucleotidase domain containing 1 2.4 
NDUFS2 Bt.4475.1.S1_at NADH dehydrogenase (ubiquinone) Fe-S protein 2, 49kDa (NADH-coenzyme Q reductase) 2.3 
LOC614048 Bt.9905.1.S1_at Similar to bromodomain-containing 4 2.3 
DDX27 Bt.2644.1.S1_at DEAD (Asp-Glu-Ala-Asp) box polypeptide 27 2.3 
SSBP1 Bt.21217.1.S1_at single-stranded DNA binding protein 1 2.3 
EFHA1 Bt.28154.1.S1_at EF-hand domain family, member A1 2.3 
DRG1 Bt.26551.1.S1_at developmentally regulated GTP binding protein 1 2.3 
AHCTF1 Bt.13722.2.A1_at AT hook containing transcription factor 1 2.3 
RPL24 Bt.5054.1.S1_a_at ribosomal protein L24 2.3 
TRIB2 Bt.18822.1.A1_at tribbles homolog 2 (Drosophila) 2.3 
APOO Bt.27908.1.S1_at apolipoprotein O 2.3 
PWWP2A Bt.9719.2.A1_at PWWP domain containing 2A 2.3 
UCHL5 Bt.4689.1.S2_at ubiquitin carboxyl-terminal hydrolase L5 2.3 
AHNAK Bt.23331.1.S1_at AHNAK nucleoprotein 2.3 
LAMP2 Bt.2606.1.S1_at lysosomal-associated membrane protein 2 2.2 
TCEB2 Bt.6661.1.S1_at transcription elongation factor B (SIII), polypeptide 2 (18kDa, elongin B) 2.2 
LOC782444 Bt.9660.1.A1_s_at similar to tripartite motif-containing 8 2.2 
UROD Bt.26622.1.S1_a_at uroporphyrinogen decarboxylase 2.2 
AEBP2 Bt.9715.1.S1_at AE binding protein 2 2.2 
MCM6 Bt.21433.1.S1_at Minichromosome maintenance complex component 6 2.2 
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PSMB1 Bt.7040.1.S1_at proteasome (prosome, macropain) subunit, beta type, 1 2.2 
NDUFV1 Bt.4072.1.S1_at NADH dehydrogenase (ubiquinone) flavoprotein 1, 51kDa 2.2 
ATP6V0D2 Bt.11010.1.S1_at ATPase, H+ transporting, lysosomal 38kDa, V0 subunit d2 2.2 
KIF5B Bt.14058.1.S1_at Kinesin family member 5B 2.2 
RAC1 Bt.22865.1.S1_at ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1) 2.2 
IGF2BP1 Bt.27949.1.A1_at insulin-like growth factor 2 mRNA binding protein 1 2.2 
PSMD4 Bt.22831.1.A1_s_at proteasome (prosome, macropain) 26S subunit, non-ATPase, 4 2.2 
CYC1 Bt.1808.1.S1_at cytochrome c-1 2.2 
PRDX5 Bt.4355.1.S1_at peroxiredoxin 5 2.2 
LOC505941 Bt.4937.1.S1_at similar to KIAA1398 protein 2.2 
PLDN Bt.7131.1.S1_at pallidin homolog (mouse) 2.2 
LOC508529 Bt.23131.1.S1_s_at hypothetical LOC508529 2.2 
TNP1 Bt.333.1.S1_at transition protein 1 (during histone to protamine replacement) 2.2 
SLC2A5 Bt.19805.1.A1_at solute carrier family 2 (facilitated glucose/fructose transporter), member 5 2.2 
YWHAZ Bt.2128.1.S1_at Tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, zeta polypeptide 2.1 
RAB4A Bt.21708.1.S1_at RAB4A, member RAS oncogene family 2.1 
AP2M1 Bt.7552.1.S1_at adaptor-related protein complex 2, mu 1 subunit /// similar to adaptor-related protein complex 2, mu1 subunit 2.1 
KLF13 Bt.20394.1.A1_at Kruppel-like factor 13 2.1 
FAU Bt.4618.1.S1_at Finkel-Biskis-Reilly murine sarcoma virus (FBR-MuSV) ubiquitously expressed 2.1 
NDUFB10 Bt.70.1.S1_at NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 10, 22kDa 2.1 
NDUFA9 Bt.5541.1.S1_at NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 9, 39kDa 2.1 
NFU1 Bt.25072.1.S1_at NFU1 iron-sulfur cluster scaffold homolog (S. cerevisiae) 2.1 
CBX3 Bt.10198.1.S1_at chromobox homolog 3 (HP1 gamma homolog, Drosophila) 2.1 
NBEAL1 Bt.16647.2.A1_at neurobeachin-like 1 2.1 
SNRP70 Bt.12748.1.S1_at small nuclear ribonucleoprotein 70kDa polypeptide (RNP antigen) 2.1 
PDHB Bt.2973.2.S1_a_at pyruvate dehydrogenase (lipoamide) beta 2.1 
LHFPL2 Bt.3015.1.A1_at lipoma HMGIC fusion partner-like 2 2.1 
MAPK1IP1L Bt.1400.1.S1_at mitogen-activated protein kinase 1 interacting protein 1-like 2.1 
ATP5H Bt.5029.1.S1_at ATP synthase, H+ transporting, mitochondrial F0 complex, subunit d 2.1 
MTDH Bt.13983.2.S1_at metadherin 2.0 
MPV17 Bt.11135.1.S1_at MpV17 mitochondrial inner membrane protein 2.0 
COMMD8 Bt.2125.1.A1_at COMM domain containing 8 2.0 
MGC148714 Bt.1334.1.S1_at similar to Cytochrome c oxidase polypeptide VIc-2 2.0 
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SPC24 Bt.9517.1.S1_a_at SPC24, NDC80 kinetochore complex component, homolog (S. cerevisiae) 2.0 
CLGN Bt.17314.2.A1_at calmegin -116.2 
LOC510240 Bt.6982.1.S1_at similar to RRP1-like protein B -33.2 
CHMP1B Bt.803.1.A1_at chromatin modifying protein 1B -11.7 
LOC100174924 Bt.16614.1.A1_s_at hypothetical LOC100174924 -10.9 
MGC152033 Bt.22756.1.A1_at Hypothetical LOC515055 -10.4 
CLGN Bt.17314.1.S1_at calmegin -10.1 
FUT1 Bt.16029.1.S2_at fucosyltransferase 1 (galactoside 2-alpha-L-fucosyltransferase, H blood group) -10.1 
NHLRC2 Bt.20833.3.A1_at NHL repeat containing 2 -8.5 
PNRC2 Bt.16143.2.A1_at proline-rich nuclear receptor coactivator 2 -6.9 
ZNF45 Bt.5423.2.A1_at Zinc finger protein 45 -4.1 
PRPSAP2 Bt.21104.1.S1_at phosphoribosyl pyrophosphate synthetase-associated protein 2 -4.0 
SIRT2 Bt.19604.1.A1_at Sirtuin (silent mating type information regulation 2 homolog) 2 (S. cerevisiae) -3.8 
NAT9 Bt.2329.1.A1_at N-acetyltransferase 9 -3.7 
LOC505941 Bt.24973.1.A1_at similar to KIAA1398 protein -3.1 
PPP3CC Bt.2191.1.A1_at Protein phosphatase 3 (formerly 2B), catalytic subunit, gamma isoform -3.0 
LRRFIP2 Bt.13852.3.S1_a_at Leucine rich repeat (in FLII) interacting protein 2 -2.8 
CNPY2 Bt.27267.1.S1_at canopy 2 homolog (zebrafish) -2.8 
ZC3H18 Bt.20159.1.S1_at zinc finger CCCH-type containing 18 -2.3 
LOC616839 Bt.24278.1.A1_at hypothetical LOC616839 -2.3 
SOSTDC1 Bt.27202.1.A1_at sclerostin domain containing 1 -2.2 
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Table S2 The networks from the IPA Knowledge Base that involve molecules differentially expressed (bold) in the blastocyst derived from 
superovulated heifers compared to those derived from synchronized heifers. 
 
ID Molecules in Network Top Functions 
1 ↑ACTB, ↑ACTN1, Alpha Actinin, Alpha catenin, ↑ANLN, ↑ANXA2, Cadherin, Calpain, ↑CD2AP, ↑CTBP2, ERK1/2, 
GNRH, ↑HNRNPK, ↑KLF13, ↑MRPS31, ↑RAB4A, ↑RPL13, ↑RPL14, ↑RPL19, ↑RPL28, ↑RPL31, ↑RPL34, 
↑RPL27A, ↑RPS5, ↑RPS7, ↑RPS8, ↑RPS10, ↑RPS13, ↑RPS19, ↑RPS20, ↑RPS12, ↑RPS3A, ↑SNRNP70, ↑TGIF1, 
↑UBE2O 
Protein Synthesis, RNA Post-
Transcriptional Modification, 
Cell Cycle 
2 ↑ABLIM1, adenosine-tetraphosphatase, ↑ALAD, ↑ALDH7A1, Alpha tubulin, ↑ANKS1A, ↑ ATP5B, ↑ATP5G3, 
↑ATP5H, ↑ATP5I, ↑ATP5L, ↑ATP5O, ↑ATP6V0D2, ↑EPCAM, ↑ERRFI1, H+-exporting ATPase, H+-transporting 
two-sector ATPase, ↑HSPE1, MAP2K1/2, NFkB (complex), Pak, ↑PAK1IP1, ↑PDPK1, peroxidase (miscellaneous), 
↑PRDX1, ↑PRDX2, ↑PRDX5, ↑PTPN2, Raf, ↑SFN, ↓SIRT2, ↑SLC2A5, TCR, ↑TOP2A 
Energy Production, Nucleic 
Acid Metabolism, Small 
Molecule Biochemistry 
3 Akt, Caspase, Cdc2, CDC2, CTSL2, Cyclin A, Cyclin E, Cytochrome c, E2f, ↑EIF4E, Eif4g, ↑ERCC6L, ↑GSK3A, 
↑HNRNPD, Hsp27, ↑HSPA4, ↑HSPB1, ↑JARID2, ↑KRT8, ↑KRT18, ↑LGALS3, ↑MCM6, ↑MLH1, ↑MPV17, ↑NBN, 
p70 S6k, ↑PA2G4, ↓PPP3CC, Rb, ↑RPL24, ↑RPL27, ↑RPLP1, ↑RPLP2, ↑RPS16, ↑UBE2C 
Cellular Assembly and 
Organization, Hepatic System 
Development and Function 
4 Adaptor protein 2, Ap1, ↑AP2M1, Calcineurin protein(s), Ck2, Clathrin, ↑CLTA, ↑DAB2, ↑FUS, ↑GATA2, ↑GSTP1, 
↑HELZ, Histone h3, Hsp70, Hsp90, ↑HSPA8, ↑HSPA9, ↑HSPA14, ↑IGF2BP1, Jnk, ↑KIT, ↑NCL, ↑PICALM, 
↑POLR2F, ↑PTGES3, ↑PUF60, ↑RBM8A, RNA polymerase II, Rsk, ↑SIRT1, ↑SSB, ↑SYNCRIP, ↑TAOK3, ↑TCEB2, 
↑ZNF238 
RNA Damage and Repair, Cell 
Cycle, Cellular Development 
5 Calmodulin, ↑CASK, ↑CBX3, ↑CTNNB1, ↑DNMT3A, ↑EIF3F, Histone h4, ↑HNRNPF, IKK (complex), Insulin, 
Interferon alpha, ↓LRRFIP2, ↑MKRN1, NADH2 dehydrogenase, ↑NDUFA1, ↑NDUFA9, ↑NDUFC2, ↑NDUFV1, 
↑PDHB, ↑PEPD, peptidase, Pka, Pkc(s), ↑RBM39, ↑RPL6, ↑RPL10A, ↑SSBP1, ↑SUZ12, Tgf beta, ↑THOP1, ↑TKT, 
↑TRIB2, ↑YWHAZ, ↑YY1, ↓ZNF45 
Genetic Disorder, Metabolic 
Disease, Organ Development 
6 AGT, ALPP, ↑ARL6IP4, ARRB2, BMP2, ↑BOLA2, CDKN1A, CER1, ↓CLGN, CUL4B, ↑CXORF26, ↑DDX27, ↑EBP, 
GRWD1, HIRA, KIF2C, ↑LUC7L3, MIR194-2, MIR298, ↑NAT11, ↑NFU1, PPP1R16A, ↑PSAP, ↑RPL14, RPL15, 
↑RPL28, ↑RPS8, ↑RPS13, ↑RPS17, ↑SLC30A5, ↑SNRNP40, ↓SOSTDC1, ↑SPIN1, WDR5, ↑WDR82 
Cell Death, Renal Necrosis/Cell 
Death, Cell Morphology 
7 ADI1, ↑COMMD8, EIF2C2, ↑FAM173A, HSP90AB1, HTT, ↑LUC7L, ME2, ↑MYO1D, NADH2 dehydrogenase 
(ubiquinone), ↑NANS, NDUFA2, ↑NDUFA5, ↑NDUFA6, ↑NDUFA12, ↑NDUFA13, NDUFA10, NDUFA4L2, 
↑NDUFA9, NDUFAF1, NDUFB1, ↑NDUFB2, NDUFB4, ↑NDUFB8, ↑NDUFB10, ↑NDUFC2, NFKBIE, ↑NUPL1, 
↑OSTC, ↑OXA1L, oxidoreductase, ↑RPL38, ↑SAPS1, TM7SF2, TSC22D1 
Carbohydrate Metabolism, 
Small Molecule Biochemistry, 
Amino Acid Metabolism 
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ID Molecules in Network Top Functions 
8  20s proteasome, 26s Proteasome, AKAP12, COL11A2, Collagen type I, Collagen(s), FN1, Ikb, Immunoproteasome 
Pa28/20s, Integrin, LAMP2, LMNA, Mapk, NADH dehydrogenase, NAP1L1, NDUFA5, NDUFB2, NDUFB8, 
NDUFS2, Pdgf, PDGF BB, PI3K, POMP, PP2A, PPP2R5E, Proteasome PA700/20s, PSMA6, ↑PSMB1, ↑PSMB4, 
↑PSMD4, ↑TAF9, ↑TAF13, Tcf/lef, Ubiquitin, ↑UCHL5 
Connective Tissue Disorders, 
Genetic Disorder, Ophthalmic 
Disease 
9  Actin, ↑ARPC2, ↑CCNC, ↑CCT3, CD3, ↑CKB, Cofilin, Creatine Kinase, ↑DSTN, ↑EZR, F Actin, Fascin, ↑KLF4, 
Laminin, ↑LASP1, ↑LGALS4, ↑LRPAP1, ↑LZTFL1, ↑MAPK1IP1L, MIR1, MIR124, Nfat (family), P38 MAPK, 
↑PLDN, ↑RAC1, ↑RANBP1, Ras homolog, ↑RBM47, Rock, ↑SFRS9, ↑SLC15A4, ↑TPM4, ↑USP48, VitaminD3-
VDR-RXR, ↑VPS37C 
Cellular Assembly and 
Organization, Cellular Function 
and Maintenance, Cell 
Morphology 
10 ↓CNPY2, ↑EEF1G, ↑EIF5, ↑ELMO2, ERN1, GBP2, ↑HCCS, IFNB1, IKBKE, ↑IMP4, NDUFB9, NR3C1, PFDN5, 
↑PTGES3, ↑PTRH2, Rab11, ↑RAB11A, RAB11FIP2, RAB11FIP3, ↑RAB11FIP4, RAB11FIP5, ↑RPL3, RPL18, 
↑RPL36AL, ↑RPS19, ↑RPS28, RSP5, SPI1, ↑SSB, ST13, TMEM189-UBE2V1, ↑TOPORS, ↑UBE2E1, XIAP, 
↑ZNRF1 
Protein Synthesis, Genetic 
Disorder, Hematological Disease 
11 ↑ACSL3, BCCIP, ↓CCDC93, ↑CPSF3, DCAF7, DLST, ↑DYRK1A, ↑HNRNPAB, ↑HNRNPF, IL2, KITLG, MDM2, 
↑MTBP, ↓NAT9, NCBP1, PARD3B, PRKX, PRPF19, PRPS1, ↓PRPSAP2, ↑PSMB4, ↑PTRH2, ↑RPL23, ↑RPL13A, 
↑RPS7, ↑RPS21, ↑SCPEP1, SFRS4, SLC25A3, SLC2A4, SMAD1, YWHAG, YWHAQ, ↓ZC3H18, ↑ZNF207 
Cell Cycle, Cell Death, Cellular 
Growth and Proliferation 
12 ↑AARS, ↑ATPIF1, ↑C3, Cbp/p300, ↑CPSF6, Creb, ↑CYC1, ERK, ↑FAU, Fgf, FSH, Gsk3, hCG, IgG, IL1, ↑INSIG2, 
LDL, ↑LGALS1, Lh, Mek, N-cor, NADPH oxidase, ↑OSTF1, PLC, ↑PRKAR1A, ↑PTGS2, Ras, ↑RPL39, ↑SREBF1, 
↑THOC4, ubiquinol-cytochrome-c reductase, ↑UCRC, ↑UQCR, ↑UQCRB, Vegf 
Cancer, Reproductive System 
Development and Function, 
Digestive System Development 
and Function 
13  ARL6IP1, BRF1, ↑BZW1, ↑BZW2, ↑C9ORF80, ↑CISD1, DNAJA2, ↑EPCAM, ERH, ↑HNRNPUL1, HUWE1, 
↑IGF2BP1, IPO9, MARS, MIRLET7B, ↑MTDH, MYC, ↑NAP1L1, ↑NARS, NDC80, NUF2, PERP, PPAT, PRKAB1, 
↑RPS7, ↑SPC24, SPC25, ↑SR140, STK11, ↑TMED7, ↑TNRC6C, Top2, ↑TOP2A, TP53, ↑UBA6 
 Cell Cycle, Cellular 
Development, Cellular 
Assembly and Organization 
14  ↑ABCB6, ↑AHCYL2, ↑CCDC59, COX1, COX2, COX3, COX17, ↑COX4I1, ↑COX5A, COX5B, ↑COX7B, 
Cytochrome c oxidase, ↑DCP1B, DDR2, DNAJC13, ↑DRG1, ↑DSG2, GEM, ↑HDGFRP3, HSPA1L, IFNG, IRAK2, 
iron, LOC100289404, MIR297-2, ↑NDUFAF3, NRF1, ↑RAB18, SMURF1, ST13, TGFB1, ↑TMEM184B, TRAF6, 
↑UNQ1887, ↑UROD 
Molecular Transport, Small 
Molecule Biochemistry, Cellular 
Growth and Proliferation 
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ID Molecules in Network Top Functions 
15 ARL1, ↑CCDC47, CEACAM1, CHMP1A, ↓CHMP1B, ↑CPT2, DNAJB9, ↑GBE1, ↑GLTSCR2, ↑GOLGA4, 
↑GPRC5C, GSTK1, HNF4A, HTRA2, ↑KIAA1715, LSM3, ↑LSM4, LSM5, ↑MRPL22, ↑MYL6, ↑NOL7, NR1H4, 
NR2F1, ↑RBKS, SART3, ↑SLC25A5, SPAST, STAMBP, USP8, VDAC1, VDAC2, VPS4A, VPS4B, WASF2, ZNF277 
Gene Expression, Lipid 
Metabolism, Molecular 
Transport 
16 beta-estradiol, CHAT, CLIC1, CRADD, CYB5A, cyclic AMP, DIO1, DIO3, E2F1, ↑ERAS, ERH, ↑FAM60A, ↓FUT1, 
GRB10, H19, ↑HSD17B11, ↑IDH2, ↑IFT122, ↑LHFPL2, MIRN330, MMP16, ↑NOP56, NRP2, ↑PA2G4, PDE4B, 
↑PHF3, PTGER3, RAF1, ↑RER1, SELE, SELPLG, SFRS5, ↑SLC6A20, SP4, ↑TOP2A 
Neurological Disease, Skeletal 
and Muscular Disorders, 
Reproductive System 
Development and Function 
17 ↑ADH5, APOA1, APOA2, APOB, APOC3, CHD3, dehydroisoandrosterone, HDL, ↑KDM2A, KPNB1, linoleic acid, 
↑LMNA, MEN1, mevalonic acid, MSTN, NFATC2, Nos, NOS2, NOS3, NR2F1, ↑PDPK1, PLA2G2A, PLA2G4A, 
↑PPHLN1, PPL, RIPK2, Rock, ↓RRP1B, ↑SAFB2, SMAD3, ↑SRRT, SUMO2, TOMM20, TXN, VIM 
Lipid Metabolism, Molecular 
Transport, Small Molecule 
Biochemistry 
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Figure 1 An overview of the overall experiment to investigate the effect of controlled ovarian 
hyperstimulation treatment on embryo development and the global transcriptome profile of 
blastocysts. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2 Progesterone concentrations (mean ± s.e.m.) from Day 1 to Day 6 in unstimulated 
recipients (n=4; ◊) and superovulated heifers (n=9; ■).  
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Figure 3 Hierarchical clustering and heatmap for all differentially expressed genes (a) and for 
those genes with fold change ≥ 8 (b) in blastocysts derived from superovulated (Sup) or 
unstimulated (Uns) heifers. The red blocks represent higher expression of genes while the 
green blocks represent lower expression of genes. Columns represent individual 
hybridizations, rows represent individual genes. 
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Figure 4 Functional grouping of differentially expressed genes in the two blastocysts groups 
(derived from superovulated or unstimulated heifers) using Ingenuity Pathways Analysis 
software. The most significant functional groups (p<0.05) are presented graphically. The bars 
represent the p-value on a logarithmic scale for each functional group. The numbers on each 
bar represent the number of differentially expressed genes involved in each function. 
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Figure 5 The most prominent canonical pathways related to the data set (p<0.05). The bars 
represent the p-value for each pathway. The orange irregular line is a graph of the ratio (genes 
from the data set/total number of genes involved in the pathway) for the different pathways. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6 Diagrammatic illustration showing the five protein complexes involved in electron 
transport and oxidative phosphorylation pathway. As the electrons are passed down the 
electron transport chain (Complex I-IV), they lose much of their free energy. Some of this 
energy can be captured and stored in the form of a proton gradient that can be used to 
synthesize ATP from ADP (Complex V). Dark circles represent the gene complexes which 
are overexpressed in the blastocysts derived from superovulated heifers. 
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Figure 7 A network showing the relationships between members of the ubiquinol-
cytochrome-c reductase complex, one of oxidative phosphorylation pathway complexes, 
which are overexpressed in the blastocysts derived from superovulated heifers. The type of 
association between two molecules is shown as a letter on the line that connects them. The 
number in parenthesis represents the number of bibliographic references currently available in 
the Ingenuity Pathways Knowledge Base that support each one of the relationships. Direct or 
indirect relationships between molecules are indicated by solid or dashed connecting lines, 
respectively. P, phosphorylation; A, gene activation; E, involved in expression; PP, protein-
protein interaction; PD, protein-DNA binding; MB, membership in complex; LO, 
localization.  
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Figure 8 Quantitative real-time PCR validation of 14 differentially expressed genes between 
blastocysts derived from superovulated heifers (Sup) and those derived from unstimulated 
heifers (Uns) as identified by microarray analysis. (*) indicates significant differences 
(P<0.05) between Sup group (white bar) and Uns group (black bar). 
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Abstract 
Understanding gene expression patterns in response to altered environmental conditions 
during different time points of preimplantation period would improve our knowledge on 
regulation of embryonic development. Here we aimed to examine the effect of 
alternative in vivo and in vitro culture conditions during the time of major embryonic 
genome activation (EGA) on development and transcriptome profile of bovine 
blastocysts. Four different blastocyst groups were produced under alternative in vivo 
and in vitro culture conditions before or after major EGA. Completely in vitro (IVP) 
and in vivo produced blastocysts were also produced and used as controls. We 
compared gene-expression pattern between each blastocyst group and in vivo blastocyst 
control group using EmbryoGENE’s bovine microarray. The data showed that changing 
culture conditions from in vivo to in vitro or vice versa either before or after the time of 
major EGA had no effect on the developmental rates, however in vitro conditions 
during that time critically influenced the transcriptome of produced blastocysts. The 
source of oocyte critically determined the developmental rates and the ability of embryo 
to react with changing culture conditions. Ontological classification evidenced the 
presence of a clear contrast in expression patterns for lipid metabolism and oxidative 
stress between blastocysts generated in vivo vs. in vitro, with opposite trends. Molecular 
mechanisms and pathways that are influenced by altered culture conditions during EGA 
were defined. These results will help in development of new strategies to modify culture 
conditions at this critical stage to enhance development of competent blastocysts. 
Introduction  
Early embryonic development is one of the most critical periods of mammalian 
development. This early phase involves various morphological and biochemical 
changes related to genomic activity and comprise a complex set of physiological 
processes, many of which are still unknown. These processes are controlled by several 
molecular mechanisms and pathways that have a fundamental role in the coordination of 
homeostatic and metabolic processes. During the post-fertilization developmental 
period, several critical events occur in the embryo which  should be regulated by a 
harmonized expression of genes under ideal culture conditions (Niemann and 
Wrenzycki 2000). However, the exact influence of in vitro culture conditions during 
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each of these critical events/steps is still unknown. Among these events is the time at 
which the embryo switches from using the mRNA derived from the maternal genome to 
those resulted from the embryonic genome activation (EGA). Initiation of EGA is a 
species-specific time point, which occurs at the 2-cell stage in mouse (Schultz 1993), at 
the 4-cell stage in human (Braude et al. 1988) and at the late 8-cell stage in bovine 
embryos (Memili and First 2000). EGA is considered as the most critical event for 
viability during early development (Meirelles et al. 2004) and it is associated with the 
first differentiation events, successful embryo implantation, and fetal development 
(Niemann and Wrenzycki 2000). The time between fertilization until the initiation of 
EGA is known to be a transcriptionally silent period which is required for DNA-
chromatin epigenetic reprogramming (Baroux et al. 2008). Epigenetic modifications are  
involved in gene expression regulation in the embryo and play a crucial role in 
controlling reprogramming events during early embryogenesis (Li 2002) which appears 
to be particularly sensitive to culture conditions (Doherty et al. 2000). Accordingly, the 
impact of environmental factors during this window of development, from maturation 
until EGA, requires much more investigations. 
There are evidences demonstrating that the environment to which the oocyte is exposed 
during maturation can influence the pattern of transcripts in the matured oocyte and in 
the resulting blastocyst (Lonergan et al. 2003, Russell et al. 2006). However, other 
evidences suggest that the pattern of mRNA abundance in the blastocyst is dictated by 
the post-fertilization culture conditions (Lonergan et al. 2006, Rizos et al. 2002a, 
Tesfaye et al. 2004). Nevertheless, oocyte quality, beside the process of fertilization, 
seems to be the main critical factor affecting the proportion of immature oocytes 
developing to the blastocyst stage (see Merton et al. 2003 for review). This raise a 
question, how ‘high quality’ zygotes, produced by in vivo maturation and fertilization, 
leads to the production of high number of poor quality blastocysts when they cultured in 
vitro?  
To resolve this fundamental question, there is an inevitable need for an experiment 
combining in vitro and in vivo culture systems during specific developmental time 
points. This analysis would facilitate a comprehensive understanding of early embryo 
development yielding insights into the molecular pathways controlling early 
development and to improve our knowledge in regulation of embryonic development. In 
the current study, we explored the influences of alternative culture conditions (in vivo or 
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in vitro) before and during EGA event on embryonic developmental rate, gene 
expression pattern and subsequent influences on pathways and biological functions 
controlling bovine embryo development. For this purpose we have used the 
combination of in vivo culture in oviduct of recipients and a new bovine micro-array 
harbouring 40,000 different targets based on the completed bovine genome and 
RNAseq to identify splice variants, non translated regions and alternative UTR variant 
from bovine embryo libraries. 
Materials and Methods 
Embryo production 
Six different blastocyst groups were produced under alternative in vivo and in vitro 
culture conditions (Figure 1). The first two groups (Vitro_4-cell and Vitro_16-cell) 
were matured, fertilized and cultured in vitro until 4- and 16-cell stage, respectively 
then transferred to synchronized recipients and cultured in vivo until day 7 blastocyst 
stage. The second two groups (Vivo_4-cell and Vivo_16-cell) were matured, fertilized 
and cultured in vivo until 4- and 16-cell stage, respectively then flushed out and 
cultured in vitro until day 7 blastocyst stage. Complete in vitro (IVP) and in vivo 
(control group) produced blastocysts were used as controls in this comparison. 
In vitro embryo production, endoscopic tubal transfer and embryo recovery 
Bovine oocytes were recovered from slaughterhouse ovaries and embryos were 
produced in vitro as described previously (Tesfaye et al. 2003). For fertilization, semen 
was used from the same bull that had been used for AI of the donor animals. Embryos 
were harvested at different time points (see above) and transferred directly to 
synchronized recipients by transvaginal endoscopic tubal transfer (Besenfelder and 
Brem 1998) to generate blastocysts of Vitro_4-cell and Vitro_16-cell groups. At day 7, 
blastocysts were collected by nonsurgical uterine flushing as described previously 
(Besenfelder et al. 2001) and pooled in groups of 10. In vitro blastocysts were produced 
with the same procedure and harvested at day 7 to be pooled in groups of 10. 
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In vivo embryo production and collection of embryos 
Simmental heifers were superovulated and artificially inseminated two times with the 
same frozen–thawed commercial bull semen and embryos were produced in vivo as 
described previously (Tesfaye et al. 2004). Embryos were flushed out at different time 
points as described previously (Besenfelder et al. 2001) and transferred to the in vitro 
culture to generate blastocysts of Vivo_4-cell and Vivo_16-cell groups. Blastocysts 
were harvested at day 7 and pooled in groups of 10. Complete in vivo blastocysts were 
produced with the same procedure and flushed out at day 7 by nonsurgical uterine 
flushing (Besenfelder et al. 2001). 
RNA isolation, amplification and microarray hybridization 
Total RNA isolation was performed using the PicoPure RNA isolation kit (Arcturs, 
Munich, Germany) according to the manufacturer's instruction. Genomic DNA 
contamination was removed by performing on column DNA digestion using RNase-free 
DNase (Qiagen GmbH, Hilden, Germany). RNA was eluted in 11 µl of elution buffer 
and the quantity and quality of the extracted RNA was verified on a 2100 Bioanalyzer 
(Agilent Technologies Inc, CA, USA). Samples were stored at -80°C until used. 
Amplified RNA (aRNA) was produced with a two round amplification protocol using 
RiboAmp HS RNA amplification kit (Applied Biosystems). Quantity of aRNA was 
determined using a Nanodrop ND-1000 (NanoDrop Technologies, Wilmington, DE, 
USA). Two micrograms of aRNA from each sample were conjugated with either Cy-3 
or Cy-5 dyes using ULS Fluorescent labelling kit for Agilent arrays (Kreatech 
Diagnostics, Amsterdam, Netherlands). The labelled product was then purified using the 
PicoPure RNA extraction kit (Applied Biosystems) to remove uncoupled dyes. Samples 
from the three pools (biological replicates) of each blastocyst group and the in vivo 
control group were hybridized together on EmbryoGENE’s bovine microarray (Made 
by Agilent 4 x 44k) using a dye-swap design (technical replicates) for a total of six 
arrays for each comparison as described previously (Robert et al. 2011). In total, 30 
array slides were scanned using Agilent’s High-Resolution C Scanner (Agilent 
Technologies, CA, USA) and features were extracted with the Agilent's Feature 
Extraction software (Agilent Technologies, CA, USA).   
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Global data analysis 
Microarray data analysis was performed using the Flex Array version 1.6 (Genome 
Quebec, genomequebec.mcgill.ca/FlexArray). Data were submitted to a simple 
background correction, a Loess within array normalization, a Quantile between array 
normalization, and statistically analyzed using Linear Models for Microarray Data 
Analysis (LIMMA) (Smyth 2005). Genes were considered differentially expressed at a 
fold-change > 2 with adjusted p-value of < 0.05 using the Benjamini and Hochberg false 
discovery rate method. All data analyses procedures are performed using R version 
2.12.1 and limma package version 3.6.9. Principal component analysis (PCA) was 
performed with the PAST 2.07 software (Hammer et al. 2001) 
(http://folk.uio.no/ohammer/past). The raw data have been submitted to Gene 
Expression Omnibus (GEO) under series GSE33314. 
Pathways and networks analysis   
A list of the DEG’s (differently expressed genes) from each comparison was uploaded 
into IPA (Ingenuity Systems, www.ingenuity.com) to identify relationships between the 
genes of interest and to uncover common processes and pathways. The ‘‘Functional 
Analysis’’ tool of the IPA software was used to identify the biological functions that 
were most significant in the data set. Canonical pathway analysis was also utilized to 
identify the pathways from the IPA library of canonical pathways that were most 
significant. In addition, the significance of the association between the data set and the 
canonical pathway was calculated as the ratio of the number of genes from the data set 
that mapped to the pathway divided by the total number of genes that mapped to the 
canonical pathway. 
Validation of results using quantitative real-time PCR 
To confirm the ability of this microarray analysis to resolve the differences in 
expression levels, fifteen genes that showed significant differences in four experimental 
groups (Vitro_4-cell, Vitro_16-cell, Vivo_4-cell and IVP) compared to in vivo control 
group were selected and GAPDH was used as endogenous control. Sequence specific 
primers (Table 1) were designed using Primer Express v 2.0 (Applied Biosystems, 
Foster City, CA). Each pair of primers was tested to achieve efficiencies close to 1. 
Independent RT-PCR for the aRNA (3 replicates for each group) has been done and 
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quantitative real-time PCR was performed in a 20 µl reaction volume containing iTaq 
SYBR Green Supermix with ROX (Bio-Rad Laboratories, Munich, Germany), the 
cDNA samples and the specific forward and reverse primer in StepOnePlus™ real time 
PCR system (Applied Biosystem). The thermal cycling parameter was set as 95°C for 3 
min, 40 cycles of 95°C for 15 s and at 60°C for 1 min. After the end of the last cycle, 
dissociation curve was generated by starting the fluorescence acquisition at 60°C and 
taking measurements every 7 s interval until the temperature reached 95°C. The 
comparative cycle threshold (CT) method was used to quantify expression levels as 
previously described (Bermejo-Alvarez et al. 2010).   
Statistical analysis  
Data were analysed using the Statistical Analysis System (SAS) version 8.0 (SAS 
Institute Inc., Cary, NC, USA) software package. Mean developmental rates of embryos 
were analysed by ANOVA followed by a multiple pair wise comparison (Tukey Test). 
The relative expression data were analysed using General Linear Model (GLM) of SAS. 
Differences in mean values were tested using ANOVA followed by a multiple pair wise 
comparison using t-test. Differences of  p< 0.05 were considered to be significant. 
Results  
Embryo recovery and developmental rates 
Alternative culture conditions (in vivo or in vitro) either before or after the time of EGA 
have no effect on the developmental rates, however the origin of the oocyte determines 
the developmental rates. Total developmental rates based on pre- and post-transfer 
development of in vitro originated embryos which transferred to in vivo conditions at  
4-cell (Vitro_4-cell) or 16-cell (Vitro_16-cell) until day 7 were 24.1 and 27.5%, 
respectively. On the other hand, total developmental rates based on pre- and post-
flushing development of in vivo originated embryos which flushed at 4-cell (Vivo_4-
cell) or 16-cell (Vivo_16-cell) and cultured in vitro until day 7 were 64.4 and 68.2%, 
respectively. The percentage of total oocytes that developed to morula/blastocyst stage 
under complete in vitro conditions (IVP) was 33.6 % (Table 2). In general, development 
rates of in vivo originated embryos were significantly higher than in vitro originated 
ones (P<0.05). The lowest blastocyst:morula ratios have been found in Vitro_16-cell 
and IVP groups (0.2 and 0.6, respectively). However, the highest blastocyst:morula 
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ratio has been found in Vivo_4-cell group with 9.9 (Table 2). The morphology of 
bovine embryos produced in vivo and in vitro at different developmental stages is 
shown in Figure 2. In vitro-generated embryos tended to have a darker overall 
appearance at all stages compared to in vivo originated ones. 
Global transcriptome analyses: transcription dynamics 
Principal component analysis (PCA) revealed that the source of greatest variation in the 
transcriptional profile of the produced blastocysts was the in vitro culture conditions 
during the time of EGA. Blastocyst groups which spent the time of EGA under in vitro 
conditions, originated either from in vitro (Vitro_16-cell) or in vivo conditions (Vivo_4-
cell), clustered away from the other groups (Figure 3). Compared to the complete in 
vivo control groups, these two groups showed higher number of differentially expressed 
genes (882 and 1918 DEGs, respectively) than those which spent the time of EGA 
under in vivo culture conditions, originated either from in vitro (Vitro_4-cell) or in vivo 
conditions (Vivo_16-cell) (633 and 311 DEGs, respectively), or than IVP group (841 
DEGs). Numbers of common DEGs between different groups are presented in 
Supplemental Figure S1. Chromosome distribution of DEGs from all groups showed a 
higher percentage of genes to be located on X-chromosome and most of these genes 
were up-regulated in all blastocyst groups compared to complete in vivo blastocyst 
group (Figure 4). 
Functional classification and pathway analyses 
Ontological classification of DEGs based on the information in the IPA indicated that 
metabolic processes including lipid, carbohydrate, nucleic acid and amino acid, cell 
related functions including cell death, cellular growth and proliferation, cell cycle and 
cell-to-cell signalling, as well as embryonic development and gene expression processes 
were the most significant common functions affected in all blastocyst groups exposed to 
in vitro conditions compared to the in vivo group (Supplemental Table S1). 
Comparative analysis of DEGs in all groups (Figure 5) showed that lipid metabolism 
was the most significant biological function affected in Vitro_16-cell group with down-
regulation for most of the genes involved in this function comparing to in vivo control 
group. An example of these genes is shown in one of the networks created from 
Vitro_16-cell group data set (Figure 6), as genes involved in metabolism of cholesterol 
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(HSD17B7, CYP11A1), metabolism of steroids (HSD3B1, CYP11A1, APOA1), 
excretion and translocation of lipid (ABCC2) and metabolism of lipid (MSMO1, 
ANXA1, ANXA2) were down-regulated. The same pattern of lipid metabolism genes has 
been found in Vitro_4-cell and IVP blastocyst groups but with lower number of genes 
involved. In contrast, Vivo_4-cell group showed opposite pattern in which most of 
DEGs involved in lipid metabolism were up-regulated compared to in vivo group. 
Cellular development related genes involved in cell death and apoptosis, gene 
expression and cellular proliferation were significantly up-regulated in the 2 blastocyst 
groups which spent the EGA time under in vitro culture conditions (Vitro_16-cell and 
Vivo_4-cell), irrespective to the origin of these blastocyst and they were highly 
significant in Vivo_4-cell group (Figure 5). Pathway analysis using IPA generated 
several pathways for each group with ratios ranging from 3 to 22% (proportion of DEGs 
involved in the pathway out of the total genes of this pathway) and p-value <0.05 (Table 
S2). NRF2-mediated oxidative stress response pathway was the dominant pathway in 
Vivo_4-cell group (Figure 7) and showed up-regulation for most of the involved genes, 
especially genes encoding for antioxidant enzymes. In this pathway, nuclear factor 
(erythroid-derived 2)-like 2 gene (NFE2L2, also known as NRF2) is the central gene 
which is acting as a transcriptional factor and regulating the expression of sets of genes 
including antioxidant, detoxifying, stress response and proteasomal degradation related 
genes. Antioxidant genes in this pathway (PRDX1, SOD1, TXNRD1, GPX2, CAT) 
showed an opposite pattern in the groups which spent EGA under in vitro culture 
conditions with up-regulation in Vivo_4-cell group and down-regulation in Vitro_16-
cell group which showed also down-regulation of NRF2 gene compared to in vivo 
control blastocyst group. Retinoic acid receptor activation pathways (LXR/RXR and 
FXR/RXR) and signalling pathways (ILK, and Integrin signalling) were the dominant 
pathways in Vitro_4-cell and Vitro_16-cell groups. Genes involved in retinoic acid 
receptor activation pathways were found to be down-regulated in Vitro_16-cell group. 
An indirect relationship between retinoic acid and different lipid metabolism genes are 
shown in the same network generated from Vitro_16-cell data set compared to in vivo 
group (Figure 6).  
A group of 68 genes found to be exclusively differentially expressed in the two groups 
which spent the time of EGA under in vitro conditions (Vitro_16-cell and Vivo_4-cell). 
Most of these genes showed an opposite pattern between the two groups with 50 genes 
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up-regulated in Vivo_4-cell and down-regulated in Vitro_16-cell compared to the 
complete in vivo control group (Figure 8). Amongst these genes were a group of genes 
involved in lipid metabolism (MSMO1, ANXA1, ANXA3, HMGCR, HSD17B11, LDLR, 
ACAT2) and oxidative stress response (PRDX1).  
Array data validation by quantitative real-time PCR 
A total of 15 selected genes (Table 1) from microarray analysis were quantified in 3 
biological replicates from control and four experimental groups by quantitative real-
time PCR. Results showed the expression of the genes to be in agreement with the array 
results except in one case (PGRMC1 in IVP group). All transcripts showed significant 
differences in expression (P<0.05) between each blastocyst group and in vivo control 
group (Figure 9). 
Discussion 
In this study, we analysed the transcriptome of bovine blastocysts developed under in 
vivo and in vitro alternative culture conditions during the embryonic genome activation 
(EGA). Indeed, combination of in vitro and in vivo culture systems during specific time 
points of early mammalian embryonic development should enhance our understanding 
of molecular mechanisms and pathways controlling early development and could 
highlight potential candidate genes which could be used as markers for competent 
embryos. Moreover, with this study we could be able to identify specific stage of bovine 
embryo development which is critically influenced by the culture environment. One of 
the most critical time points of preimplantation embryogenesis is the major EGA at 
which the embryo switches from using the mRNA and proteins derived from the 
maternal genome to those resulted from  de novo transcription from the embryonic 
genome (Memili and First 2000). During that time, availability of transcription factors, 
which are regulated by cell cycle-dependent mechanisms, are required (Latham and 
Schultz 2001). These mechanisms are highly influenced by a change in environmental 
conditions and subsequently affected embryo quality with potentially severe effects on 
fetal, prenatal and postnatal viability (Niemann and Wrenzycki 2000).  
Previous studies have shown that while the in vivo or in vitro origin of oocyte is the 
main factor determining embryo developmental rate (Hendriksen et al. 2000, Rizos et 
al. 2002b), the post fertilization culture environment is known to be the most important 
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factor determining the quality of the resulting embryos (Rizos et al. 2003, Rizos et al. 
2002a). This is not only true when in vitro and in vivo culture systems are compared, 
but also when comparisons of different in vitro culture systems are made (Doherty et al. 
2000, Fair et al. 2004, Natale et al. 2001). In agreement to these studies, our results 
showed that changing  culture conditions from in vivo to in vitro or vice versa  either 
before or after the time of major EGA have no effect on the developmental rates, 
however in vitro conditions during that time was critically influenced the gene 
expression pattern of the resulting blastocysts. The highest number of DEGs amongst all 
groups compared to in vivo produced blastocyst has been found in Vivo_4-cell group 
followed by Vitro_16-cell group, indicating the sensitivity of embryos towards in vitro 
culture conditions during EGA time. Although both groups spent the time of EGA 
under in vitro conditions, they showed opposite patterns for most of the differentially 
expressed transcripts. Ontological classification of these transcripts revealed that lipid 
metabolism and oxidative stress response related genes were the most affected genes 
and they were up-regulated in Vivo_4-cell and down-regulated in Vitro_16-cell groups. 
Previous studies on mammalian oocytes and embryos reported that intracellular lipid 
contents may determine embryo quality, developmental potential and cryotolerance 
(Jeong et al. 2009, Nagano et al. 2006). During preimplantation embryo development, 
excess lipid may be sequestered within the cell and used by mitochondria for increased 
production of ATP required for compaction and blastocyst formation (Tarazona et al. 
2006). However, one of the common characteristic of in vitro produced embryos is 
darker cytoplasm and a lower buoyant density as a consequence of lipid accumulation in 
these embryos compared with their in vivo counterparts (Abe et al. 2002, Rizos et al. 
2002b). Lipids can accumulate in the embryo by uptake from the culture environment 
(McEvoy et al. 2001), or as a result of culture-induced impaired activity of 
mitochondria and their inability to metabolise complex lipids (Barcelo-Fimbres and 
Seidel 2007). In our results, a clear pattern of down-regulation for lipid metabolism 
related genes has been found in the in vitro originated groups with high significance 
level especially for the Vitro_16-cell group. This down-regulation indicated that 
embryos originated and cultured under in vitro conditions until the time of EGA were 
unable to use internal lipids for the production of ATP and this could be due to in vitro 
environmental factors impaired mitochondrial activity. This was also reflected on the 
morphology of in vitro originated embryos which showed a darker cytoplasm at 
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different developmental stages (Figure 2). However, in vivo originated groups showed 
up-regulation of lipid metabolism related genes and a clear transparent cytoplasm. This 
finding could highlight a critical influence of culture conditions during maturation and 
early developmental stages on the metabolic activity and the ability of embryos to adapt 
with changing culture conditions. Supporting to this argument, a recent study by Somfai 
et al. (2011) showed that supplementation of IVM medium with L-carnitine, ammonium 
compound play a primary role in the transportation of fatty acids from the cytosol into 
mitochondria, increased mitochondrial activity, enhanced lipid metabolism and 
improved cleavage rates in porcine embryos, suggesting the importance role of 
mitochondria and lipid metabolism in the maturation process and early development. 
Another study (Sturmey et al. 2006) reported that inhibition of fatty acid oxidation 
during IVM has been found to impair porcine embryo development, giving further 
evidence for the importance of lipid metabolism for developmental competence. This 
could explain the higher developmental rates for in vivo originated groups, as they had 
acquired in vivo the ability to metabolise lipids during culturing in vitro, compared to in 
vitro originated ones. Moreover, recent study in human embryos provided further 
evidence for a developmental role of lipoproteins in early embryonic development 
(Mains et al. 2011). In that study it is reported that apolipoprotein A-I (APOA1), the 
major lipoprotein of HDL cholesterol, is upregulated by human preimplantation 
embryos of higher morphologic grade. In our results, this gene was amongst the lipid 
metabolism related genes which were down-regulated in Vitro_16-cell blastocyst group 
compared to in vivo control group. 
During oocyte maturation and early embryo development, various environmental stress 
factors such as oxidative stress can impair mitochondrial integrity and activity that 
results in either apoptosis or abnormal embryonic development (Kadenbach et al. 2004). 
Oxidative stress occurred as an imbalance between antioxidants and reactive oxygen 
species (ROS) production which is believed to be induced by endogenous and 
exogenous factors during in vitro culturing of embryos (Guerin et al. 2001). Enhanced 
embryo development under lower oxygen conditions is thought to be attributable to 
improved embryo metabolism and decreased ROS production (Du and Wales 1993).  
Several defence mechanisms are present in embryos to protect against oxidative stress 
and to decreased level of ROS. One mechanism by which cells defend themselves 
against oxidative stress is through the transcriptional up-regulation of cytoprotective 
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genes like heat-shock proteins. Under oxidative stress conditions, the transcription 
factor NRF2 binds to the antioxidant response element (ARE) to induce antioxidant and 
phase II detoxification enzymes (Wild et al. 1999). Recent studies provided evidence 
that NRF2 function was not only associated with induction of genes involved in 
oxidative stress response, but also with lipogenic pathways that result in inhibition of 
lipid accumulation in mouse liver (Huang et al. 2010; Tanaka et al. 2008). However, the 
role of NRF2 in oxidative stress and lipid metabolism in preimplantation embryos has 
not yet been investigated. In the present study, NRF2-mediated oxidative stress 
response pathway was the dominant pathway in Vivo_4-cell blastocyst group with high 
ratio (13%) and up-regulation for most of the antioxidant related genes which are 
controlled by the transcription factor NRF2. This indicates that embryos flushed out and 
transferred to in vitro condition before the time of EGA were highly sensitive to 
oxidative stress compared to embryos which were transferred to in vitro conditions after 
the time of EGA (Vivo_16-cell group), which showed  a much lower ratio (3%) of 
DEGs involved in this pathway. In contrast, Vitro_16-cell blastocyst group showed the 
opposite pattern of expression for the same pathway with significant down-regulation of 
NRF2 and its down stream genes related to antioxidant and detoxification enzymes. 
These data emphasize the role of culture conditions before the EGA in determining 
embryonic ability to adapt with suboptimal culture conditions.  
The oviduct and the uterus environment probably contain many substances that sustain 
embryo development or remove toxic factors. To mimic these conditions in vitro, 
different substances that decrease the concentrations of ROS in embryos have been 
added to culture. For example, addition of superoxide dismutase (SOD) or catalase to 
murine (Orsi and Leese 2001) and bovine (Iwata et al. 1999) embryos improved their 
development with up-regulation of glutathione (GSH) synthesis controlling the redox 
environment. Another example, the addition of retinoic acid as an antioxidant reagent to 
the oocyte maturation culture medium was found to be beneficial to improve subsequent 
development of porcine (Atikuzzaman et al. 2011) and bovine (Livingston et al. 2004) 
embryos. Interestingly, retinoic acid receptor activation pathways (LXR/RXR and 
FXR/RXR activation) were significantly affected in Vitro_4-cell and Vitro_16-cell 
groups with down-regulation for most of the genes involved in these pathways 
compared to in vivo control group. We have previously demonstrated that the transcript 
levels of retinoid X receptors (RXRA, RXRB, RXRG) were consistently lower in bad-
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quality embryos in comparison with good-quality embryos (Mamo et al. 2005). In 
addition, the network generated from Vitro_16-cell group data set (Figure 6) showed the 
indirect relationship between retinoic acid and different lipid metabolism related genes. 
These results with the recent evidences on the function of NRF2 gene in lipid 
metabolism described above, may suggest a crucial role of antioxidants during 
maturation and early stages of embryo development.  
Epigenetic reprogramming during early embryonic development is an essential process 
to ensure a proper selection of the genes to be transcribed during EGA time (Baroux et 
al. 2008). Epigenetic based primarily on the methylation of the DNA sequence which 
controls imprinting, X chromosome inactivation (XCI), genome stability and tissue-
specific expression (Bird and Wolffe 1999). During early preimplantation embryonic 
development, paternally imprinted XCI is established in all cells of XX embryos 
(Okamoto et al. 2004). Since in vitro production systems may have an influence on 
DNA methylation patterns which could interfere with the gene expression patterns and 
the XCI process and subsequently could compromise embryo quality and pregnancy 
rates (Ferreira et al. 2010, Lucifero et al. 2004, Shi and Haaf 2002). In our results, the 
chromosome distribution for the total differentially expressed transcripts in the five 
blastocyst groups showed a high number of DEGs to be located on X-chromosome and 
a high proportion of these genes were up-regulated in all 5 groups of blastocysts 
compared to in vivo control group (Figure 4). This may suggest a negative impact of in 
vitro culture conditions during preimplantation development on the DNA methylation 
pattern which lead to incomplete paternal XCI process. However, this point needs more 
investigation to provide more evidence of XCI disturbance under in vitro culture 
conditions in preimplantation bovine embryos.   
In conclusion, this is the first comprehensive study to provide detail information on 
molecular mechanisms and pathways that are influenced by altered culture conditions 
during specific embryonic developmental time points. Our results evidenced the 
significant impact of in vitro culture conditions during the time of EGA on the 
transcriptome profile of bovine blastocyst which showed different patterns between 
distinct originated embryos. This data will improve our knowledge on regulation of 
embryonic development and could be used to launch new strategies to modify the in 
vitro culture conditions at this critical stage of development to enhance the development 
of competent embryos. 
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Table 1 Details of primers used for real-time PCR quantitative analysis. 
 
Gene Accession 
number Primer sequences 
Annealing 
temperature 
(°C) 
Product size 
(bp) 
GAPDH NM_001034034            F:acccagaagactgtggatgg  R:acgcctgcttcaccacctt  60 247 
CYP51A1 NM_001025319 F:gagctcatcgggagatcaag R:ccatccaggcactggtagtt 55 207 
MSMO1 NM_001098863 F:caatcctctgcaggaaccat R:tccattggttttcccatgtt 51 209 
ANXA1 NM_175784 F:aagcccctggatgaagttct R:ctgaggcgatgtctttagcc 55 244 
PTGS2 NM_174445 F:cgatgagcagttgttccaga R:gaaagacgtcaggcagaagg 55 215 
HSD17B11 NM_001046286 F:ggtgaaggcagaagttggag R:aagaaggggaccccagtatg 55 228 
PRDX1 NM_174431 F:tggatcaacacacccaagaa R:gtctcagcgtctcatccaca 53 217 
ABCC2 NC_007327 F:ctgattgggaacctgatcgt R:caacagccacaatgttggtc 54 172 
HMOX1 NM_001014912 F:caaggagaaccccgtctaca R:ccagacaggtctcccaggta 56 225 
SOD1 NM_174615 F:agaggcatgttggagacctg R:cagcgttgccagtctttgta 54 189 
NFE2L2 NM_001011678 F:cccagtcttcactgctcctc R:tcagccagcttgtcattttg 54 165 
RARRES1 NM_001075430 F:gcagtgtcaagcagtggaaa R:gaggcctcttctggtgtctg 55 163 
IFNT2 NM_001015511 F:gcagtgcttcaacctcttcc R:tccttcccatgtcagagtcc 55 155 
SFN NM_001075912 F:cacccagaacctgaccactt R:gcagacatgctttccctctc 55 217 
POU5F1 NM_174580 F:gttttgaggctttgcagctc R:ctccaggttgcctctcactc 55 182 
PGRMC1 NM_001075133 F:gcctttgcatctttctgctc R:atgagtatacgcgggtcctg 54 163 
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Table 2 Overall data and transferable rates. 
 
  
Pre trans/flush 
Development (PD)  Post trans/flush Development (PP) 
 
Total 
Development 
Group Total 
 
4-cell 
stage 
 
16-cell 
stage 
Transfer Subtotal FR  Morula (Ma) 
Blastocysts 
(Bla) Mo/Bla  Bla : Mo  
 
PD x PP 
 N   (%)  (%) N N (%) N (%) N (%) N (%) Ratio  (%) 
Vitro_4-cell 1048 (61.3) - 642 568 (88.5)   72  (12.7) a 151  (26.6) b 223  (39.3) a 2.1 b  (24.1) A 
Vitro_16-cell 1667 -  (48.7)  811 620 (76.4)   284 (45.8) c 66  (10.6) a 350  (56.5) b 0.2 a  (27.5) A 
IVP 681 -  - - 681  146 (21.4) b 83  (12.2) a 229  (33.6) a 0.6 a  (33.6) A 
Vivo_4-cell 280 * (70.6)  -        95**    8 (8.4) a 79  (83.3) c  87  (91.6) c 9.9 c  (64.4) B 
Vivo_16-cell 347 * -  (72.3)  -        53**    13 (24.5) b 37  (69.8) c  50  (94.3) c 2.9 b  (68.2) B 
*: total number of flushed embryos 
**: only embryos of 4- or 16-cell stage embryos were evaluated for subsequent developmental capacity 
Values with different superscript within colums differ significantly (a:b:c: p<0.05, A:B: p< 0.01, ANOVA, Tukey Test) 
FR: Flushing rate 
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Table S1  The functional categories and the corresponding genes that were differentially expressed in blastocyst groups compared to in vivo 
group.  
 
Group Functional category p-value1 Transcripts 
Nucleic Acid 
Metabolism 2.35E-05 - 1.64E-02 CRMP1, SLC23A1, TDG, UGP2, ERH, DPM1, UPP1, PRPSAP2, CDA, ELOVL6, ACOT8, PRNP 
Cellular Development 4.47E-05 - 1.64E-02 
ENAH, CD55, LGALS4, IL6, APP, BARX2, CHEK1, CD47, GP1BA, HNF4A, ACADM, CITED2, PRNP, 
EFNA2, EPHB4, PAK4, IL4R, MAEL, CNP, TDGF1, RAC1, MAPK8, VIM, PAWR, KLF4, NDN, AVIL, 
EFNA1, ABCC2, IL18, NANOG, RND3, ZAP70, LFNG, IL2RA, EDN3, PLAU, AKR1B1, SFN, CXCL2, 
ITGA7, A2M, POU5F1, GZMB 
Cell-To-Cell Signaling 
and Interaction 8.37E-05 - 1.64E-02 
CD55, LRP6, LGALS4, IL6, APP, CD47, GP1BA, CDC42EP1, DMBT1, PRNP, PHB, EFNA2, IL4R, 
RHOC, RAC1, MAPK8, VIM, KLF4, EFNA1, IL18, CDH2, HSPG2, LTA, SERPINA5, ZAP70, SNX1, 
TFRC, IL2RA, LFNG, PLAU, CXCL2, DSG2, ITGA7, A2M, POU5F1, GZMB 
Protein Synthesis 1.41E-04 - 1.64E-02 ENAH, IL18, CD47, RHOQ, NCKIPSD, RAC1, CDC42EP1 
Cell Death 1.95E-04 - 1.64E-02 
CHRNA1, DNMT3A, UNC5B, LGALS4, IL6, DNAJC15, LMNB1, HNRNPA1, IP6K3, AHSA1, VAMP3, 
JUND, CALB1, PHB, EFNA2, IL4R, YWHAE, CNP, RAC1, TDGF1, PAWR, KLF4, NDN, RASD1, 
SLAMF6, ITPK1, IL18, CDH2, NANOG, RND3, TFRC, SRXN1, ITGA7, INPP1, LRP6, CD55, RAD9A, 
FKBP1A, SYCP3, ASNS, APP, PTPN5, CHEK1, AQP3, CD47, UBE2K, MAP1LC3B, DUSP14, HNRNPC, 
CITED2, PRNP, PAK4, EPHB4, MAEL, RHOC, ELL, MAPK8, SCIN, EFNA1, SERPINB4, LTA, LINGO1, 
TEX11, IL2RA, PLAU, CXCL2, SFN, A2M, DSG2, AMIGO2, GZMB, POU5F1, PINK1 
Cell Cycle 2.67E-04 - 1.64E-02 
FKBP1A, RAD9A, LGALS4, SYCP3, IL6, ASNS, APP, CHEK1, CARD10, JUND, HNF4A, CITED2, 
PRNP, PHB, IL4R, MAEL, YWHAE, NUBP1, MAPK8, RAC1, PAWR, SCIN, KLF4, DDB1, KIF15, 
NANOG, TEX11, TFRC, LFNG, ASCL2, EDN3, PLAU, SFN, AKR1B1, A2M, TM4SF1 
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Embryonic 
Development 7.92E-04 - 1.64E-02 
EPHB4, RHOC, LRP6, TDGF1, RAC1, MAPK8, IL6, APP, CHEK1, IL18, NANOG, ASCL2, PLAU, 
EDN3, CCL16, CITED2, POU5F1 
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Group Functional category p-value1 Transcripts 
Gene Expression 2.58E-03 - 1.64E-02 YWHAE, APBB1IP, EID1, ELL, LRP6, ADCY6, MAPK8, RAC1, ETV1, IL6, HNRNPA1, IL18, ERBB2IP, CARD10, ZAP70, IL2RA, JUND, CXCL2, HNF4A, A2M, CITED2, POU5F1, PRNP 
Lipid Metabolism 2.58E-03 - 1.64E-02 ARV1, BCO2, SC4MOL, FKBP1A, IL6, APP, ELOVL6, ABCC2, SUCLA2, RHOQ, FADS2, SLC27A3, HNF4A, FADS1, ACOT8 
Post-Translational 
Modification 2.99E-03 - 1.63E-02 
EFNA2, PRMT3, DPM1, CD55, FKBP1A, IL6, DDB1, APP, EFNA1, IMPACT, CD47, TCEB2, 
SUV420H2, CARD10, ZAP70, NHLRC1, UBE2E1 
Amino Acid 
Metabolism 3.84E-03 - 8.91E-03 CTNS, ENPEP, SLC1A4, NAALAD2 
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Molecular Transport 3.84E-03 - 1.64E-02 CTNS, ABCC2, HSPG2, SLC1A4, YWHAE, OSTM1, TFRC, PAWR, HNF4A, NHLRC1, PHAX, APP 
Lipid Metabolism 4.1E-07 - 2.24E-02 
LTA4H, GSTP1, ACAT2, IDI1, XDH, MYC, FDFT1, HRH1, ALDH1A1, GPD2, CHPT1, SERPINE1, 
CALB1, SLCO2B1, BDH2, SC4MOL, ANXA2, ELOVL1, ABCC2, IGF2, IL1RN, SLC22A5, FADS2, 
AKR1B1, EEA1, SCD, SQLE, IL1A, HSD3B1, SLC10A1, APOA1, RLBP1, UGCG, GK, HMOX1, GPC1, 
INSIG2, ANXA1, PI4K2B, AGPAT9, NFE2L2, CYP51A1, PLSCR1, PRNP, CYP11A1, STX12, LIPH, 
PDZK1, HSD17B7, ACADSB, SEPP1, FDPS, B4GALT6, LDLR, FABP5, S1PR1, PSAP, PLAU, PTGS2, 
HMGCR, PTGR1, LGALS1 
Vitamin and Mineral 
Metabolism 4.1E-07 - 3.14E-04 
CYP11A1, SCD, SQLE, HSD3B1, ACAT2, IDI1, APOA1, RLBP1, HSD17B7, FDPS, FDFT1, LDLR, 
INSIG2, ALDH1A1, CALB1, HMGCR, CYP51A1 
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Cellular Development 3.55E-05 - 2.02E-02 
RAC2, LGALS3, LHX2, XDH, CCL17, NCK1, NID1, MYC, HRH1, ALDH1A1, EZR, SMARCB1, RNF128, 
SERPINE1, DSP, BDH2, RAB27A, TDGF1, ANXA2, TPD52, KLF13, RAP1A, KLF4, NDN, ABCC2, 
IGF2, NANOG, GAB1, IL1RN, GFI1, ZAP70, AKR1B1, AGRN, CYR61, CDK5RAP2, SCD, HIST1H1C, 
IL1A, RAB1A, EPB41L3, MCC, AKTIP, HSPB8, HIF1A, CLIC4, KLHL20, HMOX1, GPC1, WASL, 
TFAP2A, ANXA1, SLC11A2, STAP2, ARID3A, PLAC8, NFE2L2, PLSCR1, PEX11A, PRNP, MUC1, 
ENPP1, KHDRBS1, TXNIP, GABBR1, SCIN, ERBB3, KIFAP3, EFNA1, ERBB2IP, FABP5, ENO1, 
S1PR1, PLAU, PTGS2, SFN, A2M, CTNND1, LGALS1 
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Group Functional category p-value1 Transcripts 
Cell Death 3.85E-05 - 2.24E-02 
RAC2, GSTP1, LGALS3, XDH, NCK1, DNAJC15, GSTZ1, MYC, FDFT1, ALDH1A1, EZR, KRT18, 
SMARCB1, SERPINE1, CALB1, SH3KBP1, DSP, S100A10, TNFRSF21, DDIT4, TIA1, TDGF1, TPD52, 
KLF13, KLF4, NDN, EI24, UBD, ANKRD1, IGF2, GAB1, IL1RN, GFI1, SRXN1, GNG2, CYR61, 
HIST1H1C, SCD, IL1A, APOA1, PRDX1, AKTIP, HSPB8, UGCG, HIF1A, NUAK2, CLIC4, GLIPR1, 
PTPN5, PTPRF, LOXL2, HMOX1, GPC1, CD5L, KRT19, TFAP2A, ANXA1, ZFAND5, NFE2L2, PLAC8, 
CCBL1, GMFB, PRNP, PLSCR1, MUC1, MAP4K2, PDZK1, DUT, SDC1, KHDRBS1, TXNIP, GABBR1, 
ERBB3, SCIN, KIFAP3, EFNA1, LDLR, SWAP70, ENO1, LGALS3BP, CIDEB, S1PR1, PROCR, PSAP, 
TEX11, PTGS2, PLAU, CTH, SFN, A2M, TXNDC17, PINK1, LGALS1, AKAP1 
Cell-To-Cell Signaling 
and Interaction 7.24E-05 - 2E-02 
IL1A, LGALS3, APOA1, ACTA2, CCL17, NCK1, HIF1A, PTPRF, MYC, HRH1, GPC1, ANXA1, SPAM1, 
SERPINE1, NFE2L2, PRNP, S100A10, MUC1, SDC1, FERMT2, ANXA2, ERBB3, SNAP25, RAP1A, 
P2RY2, IGF2, LDLR, TRIM63, IL1RN, LGALS3BP, GFI1, S1PR1, GNG2, PTGS2, PLAU, CYR61, 
PTPRA, A2M, CTNND1, LGALS1, EEA1 
Carbohydrate 
Metabolism 3.65E-04 - 2.15E-02 
SCD, SLC10A1, APOA1, HIF1A, TPI1, GK, PTPRF, MYC, FUT8, SLC23A1, GPD2, CXCL14, 
SMARCB1, TKTL1, CHPT1, DHDH, SPAM1, SERPINE1, STX12, PFKFB3, NAGPA, ERBB3, CHST12, 
ITPKA, SEPP1, IGF2, MGAT4A, FABP5, IL1RN, PTGS2, PLAU, AKR1B1 
Embryonic 
Development 5.01E-04 - 1.28E-02  RAC2, IL1A, ENPP1, XDH, EFNA1, HMOX1, HRH1, IGF2, KRT19, GAB1, IL1RN, KRT18, PTGS2 
Gene Expression 5.01E-04 - 2.24E-02  MYC, LGALS3, NFE2L2, LGALS1 
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Cellular Growth and 
Proliferation 5.1E-04 - 2E-02 
RAC2, XDH, KLK6, NCK1, BCAT1, HRH1, URGCP, EZR, SMARCB1, RNF128, SERPINE1, THEM4, 
TNFRSF21, ANXA2, TPD52, NDN, ABCC2, GAB1, GFI1, FADS2, GNG2, CYR61, PTPRA, PRDX1, 
HSPB8, CXCL5, TFAP2A, STARD13, STAP2, PLAC8, PDZK1, IGF2BP3, ENPP1, KHDRBS1, TXNIP, 
EFNA1, KIF15, B4GALT6, SWAP70, FABP5, ENO1, IMPDH1, S1PR1, PSAP, PTGS2, CTH, PLAU, 
SFN, CTNND1, GSTP1, LGALS3, NUDC, MYC, FDFT1, ALDH1A1, TNN, CRIP1, LAMA1, IFI30, DSP, 
CALM1, PFKFB3, TDGF1, NUMBL, KLF4, EI24, ANKRD1, IGF2, NANOG, IL1RN, ZAP70, LIMA1, 
AKR1B1, IL1A, RAB1A, EPB41L3, APOA1, AKTIP, MCFD2, RARRES1, UGCG, HIF1A, PTPRF, GPC1, 
HMOX1, ANXA1, ARID3A, SPAM1, PLSCR1, PRNP, MUC1, UPP1, QSOX1, GABBR1, SCIN, ERBB3, 
KIFAP3, ZDHHC17, ERBB2IP, NFIB, YME1L1, HMGCR, A2M, LGALS1 
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Group Functional category p-value1 Transcripts 
Cell Cycle 5.29E-04 - 2.24E-02 
IL1A, LGALS3, KPNA2, HIF1A, MYC, BCAT1, HMOX1, GPC1, KRT19, SMARCB1, PLAC8, PRNP, 
BANP, TXNIP, ERBB3, SCIN, KLF4, UBD, IGF2, GAB1, GFI1, S1PR1, TEX11, PSAP, PTGS2, PLAU, 
SFN, CYR61, PTPRA, TM4SF1, LGALS1, CTNND1 
Cellular Function and 
Maintenance 1.1E-03 - 2.03E-02 
HIST1H1C, RAC2, IL1A, LGALS3, LHX2, AKTIP, CCL17, HIF1A, NCK1, CKB, MYC, WASL , EZR, 
ANXA1, DSTN, RNF128, SLC40A1, STAP2, DSC2, NFE2L2, PRNP, MUC1, ERBB3, KLF13, KIFAP3, 
EFNA1, P2RY2, ABCC2, IGF2, IL1RN, GFI1, ZAP70, S1PR1, PTGS2, CYR61, PTPRA, LGALS1 
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Molecular Transport 1.27E-03 - 2.24E-02 
SCD, IL1A, SLC10A1, ACAT2, APOA1, XDH, HIF1A, PTPRF, MYC, HRH1, FDFT1, HMOX1, INSIG2, 
GPD2, ANXA1, SLC11A2, SLC40A1, AGPAT9, SERPINE1, NFE2L2, SLCO2B1, PRNP, STX12, 
CYP11A1, GCH1, PDZK1, GGCT, ERBB3, ABCC2, IGF2, LDLR, IL1RN, SLC16A1, SLC22A5, FADS2, 
PSAP, PTGS2, PLAU, SFN, HMGCR, AKR1B1, EEA1, LGALS1 
Lipid Metabolism 8.54E-05 - 3.34E-02 
PDPN, SCD, HSD3B1, IL1A, CLN8, C3ORF57, BCO2, FKBP1A, F2, HMOX1, SUCLA2, ALDH1A1, 
PRKAA1, FAR2, CALB1, MUC1, CYP11A1, SC4MOL, ELOVL6, ABCC2, SCP2, SREBF2, AKR1B10, 
FADS2, NR5A2, CPNE7, PLAU, SLC27A3, PTGR1, FADS1 
Cellular Development 1.53E-04 - 3.59E-02 
UPK3A, F2, ALDH1A1, AHSA1, EZR, LAMA1, C1QBP, TMBIM1, PEG3, DMBT1, EFNA2, PRKCQ, 
TWIST2, EID1, OSTM1, DDX4, TDGF1, CITED1, KLF4, RASD1, OTX2, ABCC2, HSPG2, PPP1R13L, 
GAB1, ZAP70, FADS2, LFNG, AGRN, NOTCH1, ITGA7, PDPN, RAP1B, SCD, IL1A, EPB41L3, PA2G4, 
NID2, NFKB1, HNRNPK, BARX2, CCNA2, HMOX1, NFKBIA, NLK, TFAP2A, GP1BA, LAMP1, 
CITED2, PRNP, MUC1, PAK4, EPHB4, AGFG1, MAEL, S1PR2, SDC1, SYNE2, MAPK8, GABBR1, 
SCIN, AVIL, EFNA1, TRPM6, F11R, ERBB2IP, ENO1, LTA, ASCL2, PLAU, SFN, CXCL2, A2M, GZMB I
V
P
 
Embryonic 
Development 1.53E-04 - 3.54E-02 
SBDS, EPHB4, SLC31A1, DNMT3A, LRP6, TDGF1, MAPK8, RAD9A, F2, EFNA1, PLCD3, KRT19, 
GINS1, TFAP2A, GAB1, TPM3, KRT18, LAMA1, NR5A2, LFNG, ASCL2, NOTCH1, CITED2, DMBT1 
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Group Functional category p-value1 Transcripts 
Cell Death 4.28E-04 - 3.56E-02 
SLC31A1, CLN8, DNMT3A, DNAJC15, GRIA4, F2, PLCD3, ALDH1A1, AHSA1, EZR, KRT18, PRKAA1, 
C1QBP, CALB1, SH3KBP1, PEG3, EFNA2, PRKCQ, YWHAE, DDX4, TDGF1, PDE4B, KLF4, RASD1, 
OTX2, UBD, SLAMF6, ITPK1, PPP1R13L, GAB1, SCP2, SRXN1, GNG2, AGRN, ITGA7, NOTCH1, SCD, 
IL1A, INPP1, PA2G4, LRP6, CD55, RAD9A, FKBP1A, SYCP3, NFKB1, PTPN5, RPLP0, PTPRF, 
CCNA2, HMOX1, NLK, KRT19, PSMG2, NFKBIA, TFAP2A, RNPS1, LAMP1, MAP1LC3B, CITED2, 
PRNP, MUC1, EPHB4, PAK4, SDC1, S1PR2, MAEL, PPP1R8, RHOC, ELL, MAPK8, CD48, GABBR1, 
SCIN, PLK1, LYAR, FCN2, EFNA1, SERPINB4, TPM3, SREBF2, ENO1, LTA, EEF1A1, MSH6, TEX11, 
PLAU, SFN, CXCL2, A2M, PTGR1, GZMB 
Cell Cycle 1.61E-03 - 3.56E-02 IL1A, YWHAE, MAPK8, RAD9A, PLK1, NFKB1, DDB1, KLF4, PTPRF, F2, UBD, CCNA2, HMOX1, NFKBIA, ASCL2, PLAU, SFN, NOTCH1, PRNP 
Cellular Growth and 
Proliferation 2.16E-03 - 3.3E-02 
TRIM24, F2, CTSZ, PLCD3, ALDH1A1, CRIP1, LAMA1, PRKAA1, IFI30, SCPEP1, C1QBP, PRKCQ, 
DDX4, TDGF1, CITED1, KLF4, RASD1, OTX2, ABCC2, HSPG2, GAB1, LIMA1, ZAP70, AKR1B10, 
GNG2, NOTCH1, ITGA7, RAP1B, PDPN, ENPEP, IL1A, PA2G4, PRDX4, LRP6, RAD9A, FKBP1A, 
IL20RA, NFKB1, PTPRF, HNRNPK, CCNA2, HMOX1, NFKBIA, CITED2, PRNP, MUC1, EPHB4, 
S1PR2, PPP1R8, RHOC, MAPK8, CD48, QSOX1, GABBR1, SCIN, PLK1, IL20RB, EFNA1, F11R, 
KIF15, ERBB2IP, TACC2, TPM3, ENO1, LTA, EEF1A1, NR5A2, ASCL2, PLAU, CXCL2, SFN, A2M, 
CARM1, GZMB 
Carbohydrate 
Metabolism 2.5E-03 - 3.28E-02 SCD, GNPDA1, IL1A, SCP2, ENO1, LTA, MAPK8, PRKAA1, C1QBP, TPI1, F2 
Gene Expression 6.07E-03 - 3.53E-02 
TRIM24, DNMT3A, ETV1, F2, SNRPC, PRKCQ, TWIST2, YWHAE, EID1, TDGF1, SPIC, SAP30, 
CITED1, DDB1, KLF4, OTX2, BRD7, DDX6, ATXN7L3, ZAP70, GNG2, AGRN, NOTCH1, IL1A, PA2G4, 
LRP6, RAD9A, ZNF219, FKBP1A, NFKB1, ZBTB33, HNRNPK, BARX2, CCNA2, NLK, NFKBIA, RNPS1, 
TFAP2A, SORBS3, CITED2, PRNP, MUC1, MAEL, S1PR2, TDG, APBB1IP, PPP1R8, TAF15, RHOC, 
ELL, ADCY6, MAPK8, ZNF345, ERBB2IP, SREBF2, ENO1, LTA, LRRFIP1, RCOR2, EEF1A1, NR5A2, 
PLAU, CXCL2, A2M, STAG2, CARM1 
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Molecular Transport 6.07E-03 - 3.54E-02 CTNS, SCD, IL1A, AGFG1, SLC1A4, SLC31A1, YWHAE, U2AF2, F2, RAE1, ABCC2, HMOX1, HSPG2, SCP2, FADS2, NR5A2, C1QBP 
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Group Functional category p-value1 Transcripts 
Cell-To-Cell Signaling 
and Interaction 3.34E-03 - 3.55E-02 
RAP1B, IL1A, CD55, F2, NFKBIA, GP1BA, CDC42EP1, C1QBP, DMBT1, PAK4, SDC1, S1PR2, 
PRKCQ, RHOC, FERMT2, CD48, EFNA1, F11R, HSPG2, TPM3, LTA, ZAP70, SNX1, GNG2, PLAU, 
AGRN, CXCL2, ITGA7, NOTCH1, GZMB 
Amino Acid 
Metabolism 6.07E-03 - 2.07E-02 CTNS, ALDH4A1, ENPEP, SLC1A4, NAALAD2, GABBR1 I V
P
 
Cellular Function and 
Maintenance 6.07E-03 - 2.87E-02 
AGFG1, PRKCQ, PTPRF, F2, EFNA1, CKB, ABCC2, KRT18, EZR, ZAP70, C1QBP, PLAU, NOTCH1, 
PRNP 
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Cellular Growth and 
Proliferation 2.95E-07 - 1.4E-02 
XDH, IL6, PTPRC, LAMC1, LUM, JARID2, SERPINE1, HNF4A, AHCY, PDIA5, EGLN2, AKT2, IL4R, 
PRKCQ, JAG2, PRKRIR, OTX2, NDNL2, CTSL1, ARAF, FADS2, TFRC, PRDX1, PRDX4, RBBP7, 
HSPB8, MTCH1, CD47, GADD45A, NDUFAB1, NGFR, CD38, CASP8, TMSB4X, ABCB1, EPHB4, 
GPN3, MECP2, RHOC, VIM, MAD2L1, LDLR, IMPDH1, SHMT1, SLC6A4, PIN1, GZMB, LOXL4, 
ARL6IP5, PTTG1, CCT2, CSNK1A1, LIMK1, CTSD, ANXA11, JUND, CAPZA1, SMAD1, TSPAN31, 
TJP2, THBS1, EPOR, CNP, TDGF1, BAMBI, DNAJC2, DDB1, FOSB, APBB1, ANKRD1, DUSP1, 
AKR1B10, ZAP70, IGFBP3, EPCAM, CAPN2, ACTN4, DNAJB6, S100A11, B2M, PEBP1, TNFAIP8, 
CRLF2, GTF2I, NRG1, MCFD2, RAD9A, CCL24, ETS2, IL20RA, PDCD10, APP, WDR6, MLH1, 
HNRNPK, TOM1L1, CCNA2, BAI1, ARID3A, ENPP2, LASP1, SOD1, UPP1, SMARCE1, CD36, APAF1, 
ERO1L, STK3, SKP1, SHB, TACC2, PSMD2, CAT, WNK1, CXCL2, A2M, GATA4, CTGF, TCIRG1, 
TYRO3, POMC, EEF1D, RFFL, CCNG1, CTSL2, AHSA1, BAG1, EZR, PSMD10, MGAT4B, PDXK, 
MCL1, TIMP2, NDRG1, RBM3, DDX4, RPA1, MMP2, L1CAM, LDOC1, CDH2, HSPG2, BSG, ACP1, 
RTN4, SPINT2, HPRT1, GNG2, EDN3, ITGA7, NOTCH1, LDHA, CASC3, ENAH, EMILIN2, PPP1R12C, 
PTPN13, CD55, LRP6, CTNNA1, FKBP1A, NAA35, RCHY1, STARD13, BID, TBX2, FKBP5, CITED2, 
GSTM1, PDZK1, ENPP1, PPP1R8, ELL, MAPK8, PLK1, TSG101, CDK1, EFNA1, FIS1, F11R, KIF20B, 
SPRY2, CNN1, LTA, NR5A2, IHH, HOXB4, IL2RA, PTGS2, FBN2, UTP6, GAB2, CHRNA1, MAPK1, 
UNC5B, SHFM1, LGALS4, CDA, TOP1, RPS3A, TNN, ALDH1A1, LAMB1, PRKAA1, UBE2E3, CDC37, 
EID2, CLTC, RAC1, SH3BP2, PAWR, BCAR3, RASD1, EIF2AK4, IL33, PRDX3, IL18, NANOG, S100B, 
PTPRS, AK2, FADS1, PDPN, EPB41L3, PA2G4, SAT1, DTYMK, NFKBIA, HNRNPR, PARK7, MAP3K7, 
ANXA1, GMNN, MMP12, PIK3IP1, PLSCR1, PAK4, DAP, TFAP2C, S1PR2, CD48 
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Group Functional category p-value1 Transcripts 
Cell Death 4.06E-06 - 1.52E-02 
XDH, DNAJC3, IL6, PTPRC, VAMP3, SERPINE1, EGLN2, IL4R, AKT2, JAG2, PRKCQ, PRKRIR, OTX2, 
NDNL2, SCP2, PPP2R2B, TFRC, PRDX1, HSPB8, NUF2, AQP3, CD47, NAIP, GADD45A, NGFR, 
NDUFAB1, ZFAND5, UBE2K, CD38, CASP8, RAD21, TMSB4X, ABCB1, EPHB4, MECP2, RHOC, 
APBB3, SAP18, MAD2L1, SERPINB4, LDLR, MSH2, PIN1, AMIGO2, GZMB, PTTG1, CCT2, CSNK1A1, 
DNAJC15, CTSD, BLOC1S2, PRR13, JUND, SMAD1, TJP2, YWHAE, THBS1, EPOR, CNP, TDGF1, 
PDE4B, FOSB, C14ORF153, APBB1, ANKRD1, RND3, DUSP1, IGFBP3, DNAJB6, ACTN4, S100A11, 
THOC5, TNFAIP8, PEBP1, B2M, CRLF2, NRG1, MCFD2, MPG, RAD9A, ETS2, CLIC4, EIF2S1, 
PDCD10, APP, MLH1, CCNA2, EGLN1, KRT19, MAEL, SOD1, ATF1, PTP4A2, CD36, SMARCE1, 
APAF1, UGT8, STK3, CAT, TEX11, CXCL2, A2M, GATA4, CTGF, DENND4A, TYRO3, SH3BGRL3, 
POMC, MDH1, GRIA4, GLO1, EEF1D, CCNG1, CTSL2, NDUFS1, CD2AP, AHSA1, BAG1, EZR, 
PDXK, TIMP2, MCL1, EFNA2, WAPAL, TWIST2, ZC3HC1, NDRG1, DDX4, L1CAM, MMP2, RPA1, 
CDH2, BSG, TMX1, RTN4, SPINT2, HPRT1, GNG2, NOTCH1, ITGA7, LDHA, AZI2, INPP1, EMILIN2, 
PTPN13, LRP6, CD55, CTNNA1, NRF1, FKBP1A, NAA35, SYCP3, RCHY1, ASNS, PTPN5, PSMG2, 
LAMP1, BID, FAIM, MAP1LC3B, DUSP14, FKBP5, CITED2, GSTM1, PDZK1, PPP1R8, ELL, SPC25, 
MAPK8, PLK1, TSG101, CDK1, EFNA1, FIS1, SREBF2, LTA, SPRY2, IHH, IL2RA, PTGS2, GAB2, 
CHRNA1, MAPK1, CLN8, DNMT3A, UNC5B, SHFM1, LGALS4, PLA2G7, LMNB1, TOP1, WDR85, 
ALDH1A1, RPS3A, ADCY5, SUB1, PRKAA1, M6PR, CDC37, RAC1, PAWR, RASD1, IL33, EIF2AK4, 
ITPK1, PRDX3, IL18, S100B, UTP11L, CREBL2, PA2G4, SAT1, DTYMK, NFKBIA, PARK7, MAP3K7, 
ANXA1, GMNN, PEBP4, MMP12, ACTC1, PIK3IP1, PLSCR1, TFAP2C, DAP, PAK4, S1PR2, GSTA1, 
PERP, CD48, NDUFS3, ATP6AP2, GNAS,  
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Gene Expression 7.35E-06 - 1.52E-02 
CTGF, TLE1, POMC, IL6, PAIP2, EEF1D, THRAP3, BAG1, JARID2, STK16, SERPINE1, HNF4A, 
AKT2, JAG2, PRKCQ, TWIST2, BCOR, NUFIP1, REEP5, RAP1A, OTX2, BRD7, NDNL2, ATXN7L3 
(includes EG:56970), GNG2, SLC44A2, NOTCH1, AZI2, LRP6, CD55, RBBP7, FKBP1A, NRF1, 
ABLIM1, ZXDC, NAA15, MACF1, CD47, GADD45A, GRINL1A, CARD10, TBX2, FKBP5, CASP8, 
RAD21, CITED2, RSF1, MECP2, TDG, RHOC, PPP1R8, ELL, MRPL12, ADCY6, MAPK8, TSG101, 
CDK1, SAP18, TRAPPC2, SREBF2, LTA, NR5A2, IHH, IL2RA, HOXB4, PIN1, PTGS2, GAB2, POLR2D, 
MAPK1, DNMT3A, PTTG1, ETV1, LGALS4, TOP1, BLOC1S2, SUB1, UCHL5, JUND, SMAD1, CDC37, 
EPOR, EID2, EID1, RAC1, TDGF1, PAWR, SNW1, DDB1, CCRN4L, IL33, FOSB, APBB1, IL18, 
ANKRD1, DDX6, NANOG, DUSP1, ZAP70, IGFBP3, ELP4, LCOR, DNAJB6, MTDH, TAGLN2, 
CREBL2, PEBP1, NR2C1, RBM25, TFEB, PA2G4, GTF2I, NRG1, MPG, RBBP8, MEIS2, ETS2, ZNF219, 
BTF3, EIF2S1, APP, HNRNPK, TOM1L1, BARX2, CCNA2, AP1G2, NFKBIA, PARK7, MAP3K7, SENP3, 
PSMG4, ARID3A, SORBS3, SUDS3, NFYB, ENY2, TFAP2C, S1PR2, MAEL, APBB1IP, ATF1, TAF15, 
SMARCE1, STRAP, GNAS, HRSP12, ZNF345, ERBB2IP, ZNF326, LRRFIP1, RCOR2, WNK1, IL10RB, 
NKRF, UTP15, CXCL2, A2M, CARM1, GATA4 
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Group Functional category p-value1 Transcripts 
Cell Cycle 1.41E-05 - 1.52E-02 
POMC, IL6, RFFL, PTPRC, CCNG1, CD2AP, CENPE, JARID2, HNF4A, AHCY, TIMP2, IL4R, PRKCQ, 
ZC3HC1, RPA1, ARAF, PPP2R2B, TFRC, EDN3, SGOL1, NOTCH1, RAB35, FKBP1A, NUP214, SYCP3, 
NUF2, RCHY1, ASNS, CETN2, PSMG2, GADD45A, CARD10, PROS1, NGFR, RHOU, BID, CD38, 
ZWILCH, RAD21, CITED2, GPN3, APBB3, SPC25, MAPK8, PLK1, TSG101, CDK1, MAD2L1, FIS1, 
MSH2, SPRY2, KIF20B, HOXB4, PTGS2, PIN1, TM4SF1, GAB2, MAPK1, PTTG1, TOP3A, CSNK1A1, 
LGALS4, LIMK1, TOP1, DSTN, SUGT1, JUND, YWHAE, THBS1, EPOR, RAC1, SH3BP2, DNAJC2, 
PAWR, DDB1, APBB1, NANOG, DUSP1, IGFBP3, LFNG, PEBP1, PDPN, SH3BP4, PA2G4, GTF2I, 
NRG1, RBBP8, MPG, RAD9A, DTYMK, WDR6, APP, MLH1, PFDN1, CCNA2, KRT19, NFKBIA, 
MAP3K7, CCDC99, ANXA1, MPHOSPH6, GMNN, ARID3A, SOD1, MAEL, S1PR2, SMARCE1, APAF1, 
GNAS, CENPI, CAT, PNPT1, TEX11, A2M 
Amino Acid 
Metabolism 1.42E-04 - 1.16E-02 MAPK1, GCSH, MAPK8, SHMT1, PCYOX1, GLDC, GATM, LIMK1 
Post-Translational 
Modification 1.42E-04 - 1.16E-02 
MAPK1, UBE2L3, XDH, DPM1, IL6, LIMK1, RFFL, PTPRC, FBXW2, ALDH1A1, NHLRC1, EFNA2, 
PDIA5, AKT2, EPOR, THBS1, STK38L, LMAN1, RPN1, UGT1A1, DDB1, UBL4A, CAND1, ERCC8, 
ERP29, TPST1, BSG, ARAF, DUSP1, ZAP70, ACP1, S100B, ERO1LB, IGFBP3, CAPN2, DNAJB6, 
SUV420H1, UBE2E1, PEBP1, EPB41L3, PTPN13, PRDX1, PRDX4, NRG1, CD55, FKBP1A, RCHY1, 
APP, PTPN5, CD47, PARK7, CARD10, MAP3K7, SENP3, CD38, FKBP5, PFDN4, GATM, STT3B, 
PPME1, MECP2, CD36, CD48, MAPK8, ERO1L, VWF, CANX, SENP2, RELN, TSG101, CDK1, EFNA1, 
SHB, SUV420H2, GCSH, CAT, GLDC, CARM1 
Cell-To-Cell Signaling 
and Interaction 7.54E-04 - 1.2E-02 
GAB2, CTGF, MAPK1, ITGB1BP1, TYRO3, JAM2, LGALS4, IL6, PTPRC, CTSL2, LAMC1, CD2AP, 
BAG1, LAMB1, SERPINE1, CCL16, DMBT1, AKT2, JAG2, PRKCQ, THBS1, RAB13, TDGF1, RAC1, 
MMP2, L1CAM, RAP1A, IL33, CDH2, IL18, HSPG2, SELP, BSG, RND3, TRIM63, ACP1, ZAP70, 
IGFBP3, EPCAM, CAPN2, GNG2, EDN3, ACTN4, C1GALT1, NOTCH1, ITGA7, PDPN, NID2, NRG1, 
CD55, CTNNA1, APP, ITGAE, CD47, NFKBIA, ANXA1, GP1BA, BAI1, CD38, ROBO2, CASP8, 
TMSB4X, PAK4, S1PR2, RHOC, PERP, CD48, CD36, TPM2, VIM, VWF, RELN, F11R, MAD2L1, TPM3, 
SPRY2, CDH17, SLC6A4, IL2RA, PTGS2, CXCL2, DSG2, GZMB 
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Embryonic 
Development 1.2E-03 - 1.29E-02 
SBDS, TFAP2C, NDRG1, MAPK1, LRP6, RAC1, TDGF1, ETS2, STK3, LAMC1, GINS1, IHH, SMAD1, 
DMBT1 
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Group Functional category p-value1 Transcripts 
Lipid Metabolism 1.49E-03 - 1.49E-02 
ACAT2, CLN8, ARV1, XDH, C3ORF57, POMC, IL6, PLA2G7, ALDH1A1, FAR2, PRKAA1, SULT1E1, 
HNF4A, M6PR, ACSL3, IMPA1, PON2, THBS1, PEX7, RAC1, SC4MOL, UGT1A1, PRDX3, PIP5K1A, 
NUDT7, SCP2, AKR1B10, SLC22A5, DLD, FADS2, CPNE7, ACOT4, PNLIP, FADS1, PDPN, HAO2, 
APP, SUCLA2, ANXA1, LAMP1, ENPP2, ABCB1, SOD1, MECP2, CD36, FAR1, UGT8, LARGE, RDH8, 
SEPP1, MYO5A, LDLR, SREBF2, CAT, NR5A2, PTGS2, SLC27A3, HMGCR 
Nucleic Acid 
Metabolism 2.28E-03 - 1.01E-02 
DPYS, ERH, UPP1, DGUOK, REXO2, CRMP1, MSH2, SCP2, NUDT7, IMPDH1, SLC22A5, HPRT1, 
ACOT4, PRPSAP2, AK2, HNF4A 
Free Radical 
Scavenging 2.3E-03 - 2.3E-03 CD47, APBB3, XDH, CD36, CCL24, APP 
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Molecular Transport 2.3E-03 - 1.52E-02 
ACAT2, XDH, CCL24, POMC, IL6, DNAJC15, APP, CD47, PTS, LAMP1, SULT1E1, HNF4A, M6PR, 
ABCB1, PON2, SOD1, MECP2, APBB3, THBS1, CD36, PRDX3, LDLR, SREBF2, SCP2, CAT, PTPRS, 
SLC6A4, NR5A2 
Cell Cycle 1.39E-04 - 2.04E-02 MAEL, SPP1, TNP1, KRAS, MLH1, UBD, SKA2, NANOG, PEA15, JARID2, TEX11, ASCL2, A2M, PLAC8, TM4SF1, MMP9, TIMP2, PRNP 
Embryonic 
Development 1.39E-04 - 2.04E-02 
SBDS, SPP1, TDGF1, KRAS, RELN, CDH2, NANOG, CASP9, ALDH1A1, PEA15, ASCL2, CASP8, 
MMP9, TIMP2 
Cell-To-Cell Signaling 
and Interaction 2.46E-04 - 2.04E-02 
TFF3, NID2, ACTA2, DLG2, KRAS, CKAP4, GPNMB, CASP9, PPBP, CASP8, TMSB4X, PRNP, SPP1, 
GRM8, CNP, CD36, TDGF1, TPM2, RELN, IL33, CDH2, S100B, ZAP70, KCNMB4, AGRN, TFPI, 
SLC11A1, MMP9, HS3ST5 
Cell Death 2.76E-04 - 2.04E-02 TFF3, SPP1, CNP, CD36, KRAS, CHMP4B, MLH1, IL33, UBD, CDH2, ALDH1A1, CASP9, PPBP, S100B, PEA15, AGRN, SETMAR, CASP8, A2M, PLAC8, MMP9, TMSB4X, TIMP2, PRNP 
Lipid Metabolism 6.84E-04 - 2.04E-02 CYP1A1, ALDH1A1, PPBP, BCO2, CD36, A2M 
Vitamin and Mineral 
Metabolism 6.84E-04 - 2.04E-02 CYP1A1, ALDH1A1, BCO2 
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Amino Acid 
Metabolism 1.62E-03 - 2.04E-02 TPST1, SLC25A12, ZAP70, TDGF1, RELN, HS3ST5 
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Group Functional category p-value1 Transcripts 
Carbohydrate 
Metabolism 1.62E-03 - 1.36E-02 SPP1, PPBP, CD36, GNS, GUSB, TFPI, PRNP 
Cellular Growth and 
Proliferation 1.62E-03 - 2.04E-02 
CASC3, LOXL4, TFF3, KRAS, ATP5G2, MLH1, COL1A2, TNN, CASP9, ALDH1A1, PPBP, JARID2, 
CASP8, PLAC8, TMSB4X, PRNP, TIMP2, CYP1A1, SPP1, ACTB, TDGF1, TPM2, IL33, NANOG, CNN1, 
S100B, ZAP70, PEA15, ASCL2, S100A11, A2M, MMP9 
Post-Translational 
Modification 1.62E-03 - 1.99E-02 CASP9, TPST1, ZAP70, TDGF1, CASP8, RELN, HS3ST5, TIMP2 
Cell Signaling 3.44E-03 - 4.13E-03 COL1A2, CDH2, DLG2, KRAS, AGRN, RELN, TIMP2 
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Molecular Transport 5.23E-03 - 2.04E-02 ALDH1A1, SLC25A12, PPBP, CD36, SLC28A3, A2M, SLC11A1 
 
1Numbers in the p-value column showed a range of p-values for the genes from each category 
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Table S2  The canonical pathways from the IPA knowledge base that involve transcripts differentially expressed in the blastocyst groups 
compared to in vivo control group. 
 
 
Group Pathway -Log (P-value) Ratio Transcripts 
Integrin Signaling 2.32 0.04 PAK4, RHOQ, RND3, RHOC, MAPK8, RAC1, CAPN2, TSPAN6, ITGA7 
Cell Cycle: G2/M DNA 
Damage Checkpoint Regulation 2.24 0.08 YWHAE, PTPMT1, SFN, CHEK1 
Myc Mediated Apoptosis 
Signaling 1.73 0.06 YWHAE, MAPK8, RAC1, SFN 
Propanoate Metabolism 1.72 0.03 SUCLA2, ECHS1, ABAT, SLC27A3, ACADM 
FXR/RXR Activation 1.63 0.04 ABCC2, IL18, MAPK8, RAC1, HNF4A 
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RAR Activation 1.62 0.03 MAPK8, RAC1, ADCY6, SORBS3, SNW1, RDH13, CITED2 
ILK Signaling 4.12 0.07 MUC1, RAC2, FBLIM1, MYL6, ACTA2, FERMT2, HIF1A, MYL7, MYC, CFL2, KRT18, ACTG2, PTGS2, DSP 
LXR/RXR Activation 3.34 0.09 SCD, IL1A, LDLR, IL1RN, APOA1, IL1F5, PTGS2, HMGCR 
FXR/RXR Activation 2.76 0.08 RAC2, ABCC2, IL1A, SLC10A1, SDC1, IL1RN, APOA1, IL1F5 
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Biosynthesis of Steroids 2.55 0.05 FDPS, SQLE, FDFT1, IDI1, NUDT12, HMGCR 
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Group Pathway -Log (P-value) Ratio Transcripts 
Synthesis and Degradation of 
Ketone Bodies 2.22 0.15 BDH2, ACAT2, HMGCS1 
Tight Junction Signaling 2.33 0.05 CLDN10, RAC2, CLDN23, CLDN8, MYL6, ACTA2, JAM2, ACTG2, MYL7 
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NRF2-mediated Oxidative 
Stress Response 1.69 0.05 
HMOX1, ABCC2, GSTP1, PRDX1, ACTA2, HSPB8, DNAJC15, ACTG2, 
NFE2L2 
TNFR2 Signaling 2.62 0.12 NFKBIA, LTA, MAPK8, NFKB1 
RAR Activation 2.48 0.05 ALDH1A1, PRKCQ, TRIM24, PNRC1, MAPK8, ADCY6, SORBS3, NFKB1, CARM1, CITED2 
TNFR1 Signaling 1.81 0.08 PAK4, NFKBIA, MAPK8, NFKB1 
Inositol Phosphate Metabolism 1.79 0.04 PLCD3, ISYNA1, INPP4B, INPP1, PRKCQ, PRKAA1, MAPK8, PLK1 
Glycerolipid Metabolism 1.75 0.04 ALDH4A1, AGPAT5, ALDH1A1, AKR1B10, GK, PTGR1, DHRS4 
I
V
P
 
ATM Signaling 1.65 0.07 NFKBIA, TLK1, MAPK8, RAD9A 
NRF2-mediated Oxidative 
Stress Response 5.13 0.13 
AKR7A2, MAPK1, PRDX1, HSPB8, DNAJC3, DNAJC15, MAP3K7, UBE2K, 
JUND, UBE2E3, FKBP5, ACTC1, GSTM1, SOD1, PRKCQ, GSTA1, GSTM3, 
MAPK8, ERP29, CAT, DNAJC14, DNAJC18, CDC34, DNAJB6, PTPLAD1 
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Protein Ubiquitination Pathway 4.25 0.11 
B2M, HSPB3, USP24, UBE2L3, HSPB8, DNAJC3, DNAJC15, USP48, USO1, 
PSMC6, BAG1, PSMD10, UCHL5, SUGT1, UBE2E3, UCHL3, DNAJC2, 
SKP1, PSMB7, USP32, HSCB, PSMD2, DNAJC14, DNAJC18, PSMA4, 
DNAJB6, CDC34, UBC, USP34, UBE2E1 
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Group Pathway -Log (P-value) Ratio Transcripts 
Integrin Signaling 3.28 0.11 
PAK4, CAPN6, AKT2, MAPK1, RHOC, ARPC5, MAPK8, RAC1, BCAR3, 
RAP1A, MYL7, ITGAE, RHOQ, WASL, RND3, RHOU, ARPC1A, CAPN2, 
ACTN4, TSPAN6, ACTC1, ITGA7 
DNA Methylation and 
Transcriptional Repression 
Signaling 
2.51 0.22 MECP2, DNMT3A, RBBP7, SUDS3, SAP18 
Apoptosis Signaling 2.38 0.12 CAPN6, NAIP, PRKCQ, NFKBIA, MAPK1, MAPK8, APAF1, BID, CAPN2, CASP8, CDK1 
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Ephrin Receptor Signaling 2.33 0.09 EFNA2, PAK4, EPHB4, AKT2, MAPK1, PTPN13, ARPC5, RAC1, RAP1A, EFNA1, LIMK1, GNG10, GNAS, WASL, CFL2, ACP1, ARPC1A, GNG2 
NRF2-mediated Oxidative 
Stress Response 2.83 0.03 ERP29, GSTM3, ACTB, ACTA2, KRAS, ACTG2  
ILK Signaling 2.77 0.03 ACTB, ACTA2, ACTG2, MMP9, MYL7, TMSB4X 
Integrin Signaling 2.66 0.03 ACTB, ACTA2, KRAS, ACTG2, TSPAN6, MYL7 
Role of Oct4 in Mammalian 
Embryonic Stem Cell 
Pluripotency 
2.44 0.07 NANOG, SPP1, JARID2 
FAK Signaling 2.44 0.04 ACTB, ACTA2, KRAS, ACTG2  
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Myc Mediated Apoptosis 
Signaling 2.06 0.05 CASP9, KRAS, CASP8 
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Figure 1 Overview of the experimental groups. Six different blastocyst groups were 
produced under alternative in vitro (gray colour) and in vivo (white colour) culture 
conditions at different time points of development. In vivo produced blastocysts used as 
a control for all other blastocyst groups. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2 Morphology of bovine embryos produced in vivo (A-C) or in vitro (D-F). 
Images are representative of 4-cell embryos (A and D), 16-cell embryos (B and E), and 
blastocysts (C and F). 
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Figure 3 Principle component analysis (PCA). The PCA is a plot distribution indicating 
the source of greatest variation in the overall transcriptional profiles of the 5 blastocyst 
groups. Each dot represents one replicate. Note the clear separation of Vitro_16-cell and 
Vivo_4-cell blastocyst groups. 
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Figure 4 Chromosome distribution for the total differentially expressed transcripts in 
the five blastocyst groups (A). Percentages of up- and down-expressed genes located on 
X-chromosome for the five blastocyst groups compared to in vivo control blastocyst 
(B).
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Figure 5 Functional grouping of differentially expressed genes in the five blastocyst groups using Ingenuity Pathways Analysis software. The 
most significant functional groups (P < 0.05) are presented graphically. The bars represent the p-value on a logarithmic scale for each 
functional group.  
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Figure 6 Ingenuity pathway interaction network analysis. Differentially expressed 
genes between Vitro_16-cell and In vivo control groups involved in lipid metabolism, 
cell-to-cell signalling and small molecule biochemistry. The network displays nodes 
(genes/gene products) and edges (the biological relationship between nodes). The colour 
intensity of the nodes indicates the fold-change increase (red) or decrease (green) 
associated with a particular gene on Vitro_16-cell group compared to In vivo control 
group. Direct or indirect relationships between molecules are indicated by solid or 
dashed connecting lines, respectively. The type of the association between two 
molecules is shown as a letter on the line that connects them. P, phosphorylation; A, 
gene activation; E, involved in expression; PP, protein-protein interaction; PD, protein-
DNA binding; MB, membership in complex; LO, localization; RB, regulation of 
binding; T, transcription. The number in parenthesis next to the letter represents the nu 
mber of bibliographic references currently available in the Ingenuity Pathways 
Knowledge Base that support each one of the relationships. 
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Figure 7 Comparison of the most prominent canonical pathways related to the data sets of the five blastocyst groups (P < 0.05). The bars  
represent the p-value for each pathway.
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Figure 8 Heatmap of 68 transcripts found to be exclusively differentially expressed in 
Vitro_16-cell and Vivo_4-cell groups. The red blocks represent higher expression of 
genes while the green blocks represent lower expression of genes compared to In vivo 
control group. 
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Figure 9 Quantitative real-time PCR analysis of selected genes for microarray 
validation. The expression pattern of 15 selected genes was consistent with the results 
from the microarray analysis in the 4 selected groups except in one case (PGRMC1 in 
IVP group). All transcripts showed significant differences (P < 0.05) between each 
blastocyst group (white bar) and In vivo control group (black bar). 
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Figure S1 Venn diagrams showing the number of transcripts common or specific between Vitro_4-cell, Vitro_16-cell and IVP (A) and 
Vivo_4-cell, Vivo_16-cell and IVP (B). Fold-change >2, p-value <0.05 and false discovery rate (FDR) <0.05.  
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